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  Abstract 
 
How a neuron responds to and withstands injury is a central question in neurobiology.  Neuronal 
injury can be caused mechanically with force, chemically with toxic insults, or genetically with 
mutations in genes that lead to damage.  The axon, the neuron’s longest compartment, is often the 
focal point of degeneration due to traumatic injury, toxic insults, or neurodegenerative diseases. 
Damage to the axon can have drastic functional consequences for the organism.  In some cases 
axonal injury can lead to death of the neuron, while in others repair mechanisms are triggered that 
promote regeneration of the injured axon.  Important discoveries during the last decade have 
uncovered many components of the molecular machinery that regulate axonal degeneration and 
regeneration.  However, the precise ways in which these pathways converge and respond to 
different insults remains largely unknown.  Here, using the nematode Caenorhabditis elegans as an 
experimental model system, we present important discoveries outlining the cellular and molecular 
mechanisms underpinning axonal maintenance and regeneration.  Using forward and reverse 
genetic approaches, combined with optogenetic, genetic, and laser-injury tools, we identify critical 
components of these biological processes.  We demonstrate how genes functioning during axon 
development also have roles in mature axons, regulating both degeneration and regeneration.  
Firstly, we discover a role for MEC-7/β-tubulin in regulating both axon development and 
regeneration.  Second, we develop and characterize an optogenetic method to induce cell ablation 
and neurodegeneration using the genetically encoded photosensitizer KillerRed.  Third, we identify 
novel mutants with defects in axonal maintenance and describe a new phenomenon of neuronal 
fusion following genetically induced damage.  Finally, we demonstrate a role for conserved 
components of the apoptotic machinery in the recognition of damaged neurons during regeneration.  
These findings both extend our understanding of the molecular mechanisms of axonal degeneration 
and regeneration, as well as provide new paradigms in which these processes can be investigated. 
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  1.1 Axonal injury – finding the balance between destruction and repair 
 
Abstract 
 
Maintenance of neuronal circuitry is critical for the preservation of correct neuronal function.  
Injury to the axon can trigger degeneration of this neuronal compartment as well as, in some cases, 
the initiation of axonal regeneration.  A balancing act between these two seemingly opposite 
biological events can be critical for the rescue of the disrupted neuronal circuit.  Axonal 
degeneration is a key pathological hallmark of nearly all neurodegenerative conditions; however the 
molecular mechanisms underlying axonal degeneration remain poorly understood.  In contrast to 
degenerative mechanisms, axonal regeneration represents the quickest and most efficient means of 
re-establishing neuronal circuitry following injury to the axon.  Evidence suggests that specific 
molecular mechanisms regulate both these processes, and that competency for either is determined 
by a variety of intrinsic and extrinsic factors that decline with age.  Studies in vertebrates have 
suggested that axonal degeneration following injury is required for efficient regeneration.  We 
outline what is currently understood about each of these processes and discuss recent observations 
from invertebrate studies where declining capacities for both degeneration and regeneration 
coincide to facilitate rapid reconnection of damaged nerves.  
 
 
Introduction 
 
Connectivity of neural networks is fundamental for the correct functioning of the nervous system.  
The integrity of the axon, the primary efferent signalling component of every neuron, is essential to 
maintain circuitry.  Disruption of these connections can have catastrophic consequences for the 
organism.  This can occur as a result of vascular accidents, physical traumas, toxic insults, and 
neurodegenerative conditions.  Axons are also removed as part of normal development through 
axonal pruning.  A large body of knowledge has come from the study of axonal degeneration 
following physical transection, due to the commonality of axonal degeneration from multiple injury 
models and the underlying shared molecular machinery (Coleman, 2005).  Injury that results in 
transection of the axon splits the neuron into two distinct compartments: a distal axonal fragment 
that is separated from the neuronal cell body, and a proximal axonal fragment that remains 
connected with the soma (Figure 1.1a).  Following separation from the cell body the distal axonal 
fragment undergoes a stereotypical process of degeneration classically referred to as Wallerian 
degeneration (Figure 1.1b), characterized by a thinning and beading of the axonal process, followed 
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  by fragmentation and clearance of axonal debris (Waller, 1850).  A complementary process of 
regeneration occurs in the proximal axonal fragment that is still connected to the neuronal cell body, 
whereby a growth cone forms at the distal tip of the axonal stump and regrows towards its distal 
target (Figure 1.1c).  
 
The events that take place in both the distal and proximal axonal fragments are now understood to 
be active mechanisms that require the exquisite coordination of intrinsic and extrinsic mechanisms.  
Here we will outline and highlight some of the critical components of these distinct processes and 
the cell-intrinsic pathways that are activated in response to axonal injury.  We will give a special 
focus to recent evidence that suggests it is possible to reverse degeneration of the distal axonal 
compartment by inducing reconnection of the regrowing proximal fragment during regeneration.  
 
 
Initial neuronal response to axonal injury 
 
Ca2+ influx is critical for injury signalling in both degenerative and regenerative responses 
(Kerschensteiner et al., 2005; Knoferle et al., 2010; Ziv and Spira, 1995).  In the distal fragment the 
degeneration-promoting effect of Ca2+ is dependent upon calpain proteases and acts to initiate 
cytoskeletal breakdown (Billger et al., 1988; Johnson et al., 1991).  Preventing either Ca2+ influx or 
activation of calpain proteases is sufficient to protect axons from degeneration (Coleman, 2005).  
An increase in intracellular Ca2+ levels has been shown to promote regeneration in a variety of 
systems (Bhatt et al., 2004; Ghosh-Roy et al., 2010; Neumann et al., 2002; Pichichero et al., 1973; 
Ziv and Spira, 1995).  This is thought to be the result of a combination of Ca2+ influx through the 
site of injury, the activation of voltage-gated calcium channels, as well as release via intracellular 
stores (Knoferle et al., 2010; Kulbatski et al., 2004; Ziv and Spira, 1993).  Increased intracellular 
Ca2+ has been demonstrated to activate cAMP signalling to promote regeneration (Bhatt et al., 
2004; Ghosh-Roy et al., 2010; Neumann et al., 2002).  In C. elegans this occurs via adenylyl 
cyclase in a protein kinase A-dependent manner (Ghosh-Roy et al., 2010).  Importantly, in these 
experiments, it was total [Ca2+] that determined the regenerative response and not the magnitude of 
the transient.  This raises the possibility that the type of injury to the axon and the amount of Ca2+ 
influx triggered by it may be determining factors in regeneration.  Similarly the excitability of the 
neuron is able to modulate the regenerative response in a Ca2+-dependent manner.  It has been 
observed in invertebrate neurons that regenerative ability is affected by mutations in 
neurotransmitter-synthesizing enzymes, neurotransmitter receptors, and ion channels, all of which 
are components that alter the excitability of the neuron (Chen et al., 2011).  A higher excitability 
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(a) Injury
(b) Degeneration (c) Classical regeneration (d) Regeneration via axonal fusion
Figure 1.1.  Axonal injury triggers axonal degeneration and regeneration pathways.  A 
schematic diagram depicting a neuron connected to its distal target.  Axonal injury can trigger both 
degenerative and regenerative pathways.  a, injury to the axon that results in transection splits the 
axon into two compartments, a proximal fragment that is still connected to the cell body, and a distal 
fragment that is disconnected from the cell body.  b, the distal axonal fragment undergoes 
stereotypical Wallerian degeneration characterized by beading, thinning, and clearance.  c, in 
parallel with degeneration of the distal axonal fragment, injury can trigger regeneration of the 
proximal fragment.  Classically this proceeds via the generation of a growth cone from the proximal 
axonal fragment, followed by extension and regrowth which can directly, or indirectly, re-innervate 
the distal target tissue.  d, invertebrate neurons are capable of rapidly re-establishing neuronal 
circuitry via axonal fusion.  The proximal axonal fragment generates a growth cone, which extends 
towards the distal axonal fragment and is able to reconnect and re-establish membrane and 
cytoplasmic continuity.  
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  results in a better regenerative response, whereas the opposite is true for a neuron with decreased 
excitability.  Taken together, these findings demonstrate that Ca2+ is a critical early injury signal 
that acts to promote axonal degeneration and regeneration in the respective axonal compartments 
following axonal damage.  Once triggered, these specific programs coordinate the destruction and 
removal of the separated distal axonal fragment and the remodelling of the proximal axonal 
fragment into a regrowing axon.  
 
 
Degeneration of the distal axonal compartment: an active process 
 
Discovery of Wlds, Sarm, and DLK  
The initial debate surrounding the active or passive nature of axonal degeneration was mostly 
settled with the discovery and isolation of the Wallerian degeneration slow mutant (WldS) mouse, 
which presented with heavily delayed (two - three weeks instead of a few days) axonal degeneration 
pattern following transection (Lunn et al., 1989); this strongly suggested that Wallerian 
degeneration is an active event, rather than simply occurring passively due to lack of trophic 
support from the cell body.  Several successive studies in different model organisms have 
confirmed this notion, with one of the strongest examples being the recent discovery that loss of 
functions mutations in the gene encoding Sarm1 (sterile α/Armadillo/Toll-interleukin receptor 
homology domain protein) in Drosophila and mice strongly suppress Wallerian degeneration for 
weeks after axotomy (Osterloh et al., 2012).  The second important aspect of axonal degeneration is 
its distinction from neuronal cell death.  In humans, axonal degeneration is a pathological hallmark 
of many neurodegenerative diseases and conditions, including motor neuron disease, glaucoma, and 
Parkinson’s, Alzheimer’s and Huntington’s diseases (Coleman, 2005).  These are also characterized 
by neuronal cell death, and in many cases it is not clear in which neuronal compartment the 
pathological condition starts.  However, several lines of evidence in different model organisms 
suggest that the axon is a major component of neurodegenerative conditions.  First, the degeneration 
of the axonal compartment correlates well with the onset and progression of the disease (Conforti et 
al., 2007).  Second, WldS is able to delay axonal degeneration in mouse models of 
neurodegenerative diseases including progressive motor neuropathy (pmn mice; Ferri et al., 2003), 
Charcot-Marie-Tooth disease (myelin protein zero mutants; Samsam et al., 2003), and gracile 
axonal dystrophy (gad mutant mice; Mi et al., 2005).  Finally, blocking cell death by overexpression 
of the apoptotic protective gene bcl-2 did indeed reduce apoptosis but not axonal degeneration and 
the pathological symptoms (Sagot et al., 1995).  In summary, the serendipitous discovery of the 
WldS mutant mouse has prompted a different level of detail in the study of axonal degeneration.  
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  The protective effect of the WldS gene product against axonal degeneration induced by physical 
traumas, chemical insults, and a number of neurodegenerative conditions in both vertebrates and 
invertebrates has allowed its use in a variety of different paradigms, and revealed axonal 
degeneration to be an active mechanism that is largely universal and conserved across neuronal 
subtype and species.   
 
A candidate molecule as an early sensor of axonal damage is the dual leucine zipper kinase DLK.  
DLK is a conserved mitogen-activated protein triple kinase (MAP3K) shown to regulate both 
axonal degeneration and regeneration following injury (Tedeschi and Bradke, 2013).  Loss of DLK 
has been demonstrated to protect against axonal degeneration in mice and Drosophila (Ghosh et al., 
2011; Miller et al., 2009).  DLK activates both c-Jun N-terminal kinase (JNK) and p38 mitogen-
activated protein kinase (MAPK) pathways to promote axonal degeneration (Miller et al., 2009).   
Moreover, the loss of DLK in Drosophila neurons is protective against degeneration induced by 
both axotomy and toxic insults (Miller et al., 2009).  Together this supports a conserved role for 
DLK in promoting a general intrinsic mechanism of axonal degeneration following injury.  The 
degeneration-promoting targets of DLK activation are still unclear, but there is an emerging picture 
of converging downstream axonal degeneration mechanisms, which may act together or in parallel 
to eliminate the distal axonal compartment.  Elucidating the molecular elements of axonal 
degeneration programs is considered central to understanding the pathogenesis of 
neurodegenerative diseases.  The key effectors of this degenerative program are likely to be targets 
for the prevention of axonal degeneration caused by trauma, toxin exposure, ageing, and genetic 
predisposition.   
 
Functional axonal transport in axonal maintenance 
Normal axonal transport is required to maintain neuronal activity as well as to remove proteins 
targeted for degradation.  The morphology of axons, thin processes that are often projected over 
large distances, makes them particularly susceptible to trafficking defects, with disruption of normal 
axonal transport a causative event in axonal degeneration (Perlson et al., 2010).  The most extreme 
example of this occurrence is a physical transection of the axon, leading to degeneration of the 
distal fragment.  Disruption of components of the axonal transport machinery is also sufficient to 
cause degeneration.  Mutations in the retrograde motor complex of dynein-dynactin have been 
directly shown to induce death of the cell body of motor neurons in mice (Chen et al., 2007; 
Hafezparast et al., 2003; LaMonte et al., 2002), while defects in anterograde transport have been 
demonstrated to specifically cause axonal degeneration (Reid et al., 2002; Zhao et al., 2001).  In 
addition to motor proteins, disruption to the cytoskeletal network can in turn disrupt transport and 
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  lead to degenerative phenotypes.  Alterations to microtubule stability, either pharmacologically or 
genetically, can induce axonal degeneration.  For example, microtubule destabilization with the 
chemotherapeutic drugs vincristine or colchicine is able to trigger axonal degeneration (Singer et 
al., 1956; Wang et al., 2000).  In C. elegans sensory neurons, loss of the acetyl-transferase mec-
17/αTAT1 leads to altered stability of microtubules, which causes axonal transport defects, and loss 
of synaptic material, and leads to spontaneous degeneration of axons in aged animals (Neumann 
and Hilliard, 2014).  Consistent with the hypothesis that axonal transport is essential for axonal 
maintenance, axonal transport defects have been implicated in the pathology of Parkinson’s, 
Huntington’s, Alzheimer’s, and motor neuron diseases (Morfini et al., 2009; Perlson et al., 2010).  
However, it is still not clear if axonal transport defects are a primary or secondary deficit in disease 
pathology.   
 
The role of mitochondria in axonal maintenance 
The trafficking of mitochondria is one example of a specific organelle whose trafficking is critical 
for axonal maintenance.  Although axons are capable of generating mitochondria (Calkins and 
Reddy, 2011), a significant proportion (10-30%) of axonal mitochondria are trafficked large 
distances (Misgeld et al., 2007) and some axonal mitochondria are generated in the cell body (Amiri 
and Hollenbeck, 2008).  Altered mitochondrial transport has been observed in some 
neurodegenerative conditions and it is proposed that normal trafficking of mitochondria is a 
mechanism by which neurons are able to maintain a functional population of mitochondria in the 
axon (Court and Coleman, 2012).  The unique morphology of neurons places extreme demands on 
the function of axonal mitochondria.  Mitochondria are responsible for supplying adenosine 
triphosphate as well as buffering Ca2+ in the axon.  In some cases, preventing mitochondria from 
entering the axon is sufficient to induce spontaneous axonal degeneration (Fang et al., 2012; 
Rawson et al., 2014). Mitochondrial dysfunction is an almost ubiquitous feature of 
neurodegenerative diseases with an axonal degeneration component, with disruptions of 
mitochondrial quality-control mechanisms being the major source of mitochondrial dysfunction 
(Court and Coleman, 2012; Rugarli and Langer, 2012).  Mitochondrial fusion and fission are highly 
regulated dynamic processes that act to maintain a healthy mitochondrial population and confer 
protection against apoptosis (Westermann, 2010).  Fusion of healthy mitochondria with 
dysfunctional mitochondria facilitates the replenishment of damaged materials, while fission of 
dysfunctional mitochondria into fragments enables their destruction via mitophagy and prevents the 
release of pro-apoptotic molecules.  Both mitochondrial fusion and fission have been associated 
with axonal degeneration in human disease.  The outer mitochondrial membrane protein Mitofusin 
2, which mediates mitochondrial fusion (Chen et al., 2003), and GDAP1, which mediates 
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  mitochondrial fission (Niemann et al., 2005), are both mutated in patients with Charcot-Marie-
Tooth disease (Baxter et al., 2002; Zuchner et al., 2004).  Due to their multiple roles in energy 
production, buffering intracellular Ca2+, generation and detoxification of reactive oxygen species 
(ROS), as well as their dependence upon axonal trafficking, mitochondria represent an important 
convergence point in the molecular mechanisms of axonal degeneration.  
 
The function of ROS 
A byproduct of mitochondrial respiration is the production of ROS.  In addition to their important 
physiological signalling functions such as the activation of kinases and transcription factors 
(Bartosz, 2009; Corcoran and Cotter, 2013), ROS accumulation causes irreversible damage to 
cellular components (DiMauro and Schon, 2008; Uttara et al., 2009).  Neurons are particularly 
susceptible to this damage and increased ROS has been shown to induce Wallerian degeneration in 
axons (Press and Milbrandt, 2008).  As a consequence, there are several cellular mechanisms in 
place to detoxify ROS that, when disrupted, result in a damaging oxidative cellular environment.  
For example, deletion of the super oxide dismutase enzyme SOD1, which is part of the endogenous 
ROS detoxification system, causes spontaneous axonal degeneration in cultured rat dorsal root 
ganglia (Fischer and Glass, 2010).  Further evidence for the involvement of ROS in axonal 
degeneration can be found in many neurodegenerative diseases.  The biggest risk factor for 
neurodegenerative diseases is age, which is characterized by accumulation of mitochondrial 
mutations and oxidative damage (Lin and Beal, 2006).  Oxidative damage has been linked to 
Alzheimer’s and Parkinson’s diseases, amyotrophic lateral sclerosis (ALS), and multiple sclerosis 
(MS) (Uttara et al., 2009).  Since the first linkage of mutations in SOD1 with ALS in humans 
(Rosen, 1993), a large number of mutations have been identified, representing one of the largest 
causes of familial ALS (Andersen and Al-Chalabi, 2011).  The close link between the generation 
and detoxification of ROS and mitochondrial dysfunction, in both ageing and neurodegenerative 
disorders, suggests a pathological role for oxidative stress in axonal degeneration.  Recently it has 
been demonstrated that exposure to ROS is sufficient to inhibit axonal transport in cultured neurons 
(Fang et al., 2012), illustrating the close association and convergence of multiple mechanisms 
which, when disrupted, lead to the elimination of the axon.     
 
 
Regeneration of the proximal axonal compartment 
 
Following injury of regeneration-competent neurons, the proximal fragment that is still connected 
to the cell body undergoes a transformation into a developmental-like state, generating a growth 
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  cone and extending it in an attempt to recover the functional circuitry lost through injury.  This 
process has been observed in invertebrate and vertebrate neurons of the peripheral nervous system 
(PNS) (Liu et al., 2011), and is able to restore function (Bhatt et al., 2004; Yanik et al., 2004).  It 
has also been established that extrinsic molecules, such as those derived from myelin, are able to 
inhibit axonal regeneration (Yiu and He, 2006).  However, the emerging theme from the growing 
body of work in both invertebrates and vertebrates is that the main determinant of regenerative 
potential is intrinsic.  Much is now known about the regulation of specific regenerative events, 
including retrograde injury signals, initiation of growth cone formation, and pro-regenerative 
pathways; however a complete picture of how this process proceeds and how it can be controlled is 
still lacking. 
     
MAP kinases – the master regulators  
Axonal injury, and the subsequent production of Ca2+ transients, result in retrograde signals that are 
transported to the neuronal cell body and function as positive injury signals to regulate a 
regenerative response (Abe and Cavalli, 2008).  These injury signals include MAPKs, which are 
activated by axonal injury and retrogradely transported to the neuronal cell body (Perlson et al., 
2005).  Elegant genetic studies in C. elegans, utilizing a mutant with spontaneous axonal breakage 
followed by regeneration, have led to the identification of an entire regulatory pathway of MAPK 
signalling that is essential for axonal regeneration (Figure 1.2; Hammarlund et al., 2009; Nix et al., 
2011).  Intriguingly, the MAP3K DLK (DLK-1 in C. elegans) functions as an early injury signal for 
axonal regeneration in motor and sensory neurons in C. elegans (Hammarlund et al., 2009; Yan et 
al., 2009), a key role that matches the central function of this molecule in regulating degeneration of 
the distal axonal fragment, as discussed above (Ghosh et al., 2011; Miller et al., 2009).  In contrast 
to its role in promoting degeneration, DLK-1 functions in the proximal axonal compartment to 
promote regeneration together with a parallel pathway containing the MAP3K MLK-1 (Nix et al., 
2011).  These pathways share several common regulators and act at the time of injury, via 
downstream kinases, to regulate growth cone formation and axon extension.  Activation of the 
DLK-1 pathway results in the stabilization of the mRNA transcript of the CCAAT/enhancer binding 
factor homologue CEBP-1 (Yan et al., 2009).  Precisely how either of these pathways regulate 
regeneration is unknown.  Importantly, DLK-1 has been demonstrated to promote regeneration in 
Drosophila and mice, suggesting that this pathway represents a major conserved mechanism of 
axonal regeneration (Itoh et al., 2009; Xiong et al., 2010).  
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Figure 1.2.  The C. elegans mitogen-activated kinase cascade in regeneration.  Axonal injury 
triggers a rise in intracellular Ca2+ which activates DLK-1 and the DLK-1–MKK-4–PMK-3 
pathway.  In parallel the MLK-1–MEK-1–KBG-1 pathway is also activated in response to injury.  
RPM-1 coordinates the regulation of both regenerative pathways.  DLK-1, dual leucine zipper 
kinase 1; MKK-4, MAP kinase kinase ; PMK-3, p38-like MAP kinase; MAK-2, MAP 
kinase-activated protein kinase; CEBP-1, CCAAT/enhancer-binding protein 1; MLK-1, MAP kinase 
kinase kinase; MEK-1, MAP kinase kinase; KGB-1, c-Jun N-terminal-like MAP kinase; RPM-1, 
regulator of presynaptic morphology 1.  Diagram adapted from Nix et al. (2011).
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  Cytoskeletal dynamics 
Successful axonal regeneration requires large-scale changes to the state of the injured axon such 
that it is converted from a stable mature axon into a dynamic regrowing one.  Axonal injury triggers 
alterations to actin and microtubule networks which are intimately linked to injury signalling, 
growth cone formation, and axon extension (Chisholm, 2013).  Microtubules are polarized in axons, 
with polymers organized in a plus-end out orientation.  Studies in Aplysia, Drosophila, and C. 
elegans have examined the dynamics of microtubules following axonal injury.  Axotomy triggers 
local microtubule severing and depolymerization followed by the growth of polymers with mixed 
polarity (Erez and Spira, 2008; Ghosh-Roy et al., 2010; Stone et al., 2010).  Microtubule 
disassembly is likely triggered by a combination of the injury itself as well as a local Ca2+ influx 
triggering severing of microtubules by Ca2+-dependent enzymes (Gitler and Spira, 1998; Spira et 
al., 2003).  In addition to Ca2+, there is also evidence to suggest that microtubules are regulated by 
DLK.  In C. elegans sensory neurons, overexpression of DLK-1 increases the number of growing 
microtubules in un-injured axons, and the absence of DLK-1 reduces the number of dynamic 
microtubules following axonal injury (Ghosh-Roy et al., 2012).  Promoting catastrophe of 
microtubule polymers by overexpression of the Arf6 guanine nucleotide exchange factor EFA-6 in 
C. elegans inhibits regeneration, whereas loss-of-function mutants have enhanced regeneration 
(Chen et al., 2011).  Recently, two studies demonstrated that loss of PTRN-1, a C. elegans 
homologue of the microtubule minus-end binding calmodulin-regulated spectrin-associated family, 
reduces microtubule stability and triggers a repair-like mechanism, dependent on DLK-1 (Marcette 
et al., 2014; Richardson et al., 2014).  This supports a mechanism whereby DLK is downstream of 
microtubule destabilization in regeneration signalling.  Although the direct relationship between 
DLK, Ca2+ transients, and microtubule dynamics is not understood, there is much evidence to 
support the requirement of a dynamic microtubule network for successful initiation of axonal 
regeneration.  Much less is known about the requirement of microtubules at later stages of axonal 
regeneration, such as target reconnection.      
 
Regeneration via axonal fusion 
Successful regeneration requires re-innervation the target tissue following axonal injury.  This is 
generally considered as regrowth of the proximal axonal fragment along the entire length of the 
separated distal fragment, followed by innervation, either directly or indirectly through other 
neurons, of the distal target.  This regrowth can be initiated from the tip of the proximal axonal 
stump, or through sprouting from another axonal region, and can progress along the original axonal 
path, or via an ectopic route (Harel and Strittmatter, 2006; Yiu and He, 2006).  In axons of the 
vertebrate PNS, degeneration of the distal axonal fragment is required for efficient regrowth of the 
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  proximal fragment (Bisby and Chen, 1990; Brown et al., 1992; Brown et al., 1994).  An alternative 
mode of axonal regeneration has been observed in invertebrate neurons.  Here, the regrowing 
proximal axonal fragment generates a growth cone, which extends towards the distal axonal 
fragment and reconnects with it via a membrane fusion event, preventing degeneration of the distal 
axonal fragment and re-establishing the original axon.  This type of regeneration, termed 
regeneration via axonal fusion, has been observed in the axons of earthworms, leeches, crayfish, 
Aplysia, and most recently C. elegans (Bedi and Glanzman, 2001; Birse and Bittner, 1976; 
Deriemer et al., 1983; Ghosh-Roy et al., 2010; Hoy et al., 1967; Neumann et al., 2011).  In C. 
elegans sensory neurons, regenerative fusion events have been demonstrated to re-establish 
membrane and cytoplasmic continuity between the proximal and distal axonal fragments (Ghosh-
Roy et al., 2010; Neumann et al., 2011).  Axonal fusion between the proximal and distal fragments 
prevents Wallerian degeneration of the distal fragment, and halts regrowth of the proximal fragment 
through unknown signals.  This process is also highly specific, with regrowing axons selectively 
fusing with the correct distal axonal fragment despite the presence of associated axons from other 
neurons, suggesting the existence of a regulatory mechanism of recognition involved in repair 
(Neumann et al., 2011).  The C. elegans fusogen EFF-1, which mediates multiple developmental 
membrane fusion events, is required for axonal fusion during regeneration (Ghosh-Roy et al., 
2010).  Elevated Ca2+/cAMP levels have been demonstrated to increase axonal fusion rates, 
although it is unclear if this is a direct effect on fusion mechanisms or an indirect effect on 
regeneration/degeneration rates (Ghosh-Roy et al., 2010).  The mechanism by which fusion 
machinery is activated in regrowing neurons and the mechanisms of recognition between the distal 
and proximal fragments are currently unknown and are a major focus of this thesis.    
 
 
Age-related decline  
 
The rate of both axonal degeneration and axonal regeneration following injury has been observed to 
decline with age in C. elegans neurons (Annika Nichols and Massimo Hilliard, personal 
communication; Byrne et al., 2014; Gabel et al., 2008; Hammarlund et al., 2009; Nix et al., 2011; 
Wu et al., 2007; Zou et al., 2013).  A similar decline in regeneration rates has been observed in 
vertebrate neurons (Pestronk et al., 1980; Tanaka et al., 1992; Verdu et al., 1995; Verdu et al., 
2000).  In C. elegans motorneurons this decline in regenerative ability has been demonstrated to be 
regulated intrinsically by the insulin/IGF-1 receptor DAF-2 and the transcription factor DAF-
16/FOXO (Byrne et al., 2014).  A similar decline has been observed in the rate of degeneration of 
C. elegans sensory neurons, through unknown mechanisms (Annika Nichols and Massimo Hilliard, 
12 | Chapter 1
	  personal communication).  Interestingly, this decline in degeneration and regeneration rates 
overlaps with the appearance of axonal fusion during regeneration, which is observed at a lower rate 
in early larval stages compared to adult animals (Brent Neumann and Massimo Hilliard, personal 
communication).  It is unknown if there is a direct link between regenerative capacity and axonal 
fusion during regeneration.  
 
 
Research directions  
 
Here we have outlined how following axonal injury, the neuron is split into two distinct 
compartments, the proximal and distal axonal fragments.  Fascinatingly, injury-triggered Ca2+ influx 
disrupting microtubule stability and activation of the DLK pathway initiate completely opposing 
responses in each axonal compartment (Figure 1.3).  The execution of axonal degeneration in the 
distal axonal fragment involves the convergence of injury signals, cytoskeletal disassembly, axonal 
transport defects, and mitochondrial dysfunction.  On the contrary, the regrowth of the proximal 
axonal fragment requires the transition of a mature, stable axon into a labile dynamic structure more 
similar to a developing neuron, which requires injury-triggered changes to microtubule dynamics 
and the transmission of retrograde injury signals that cause alterations to gene expression.  We have 
also highlighted the phenomenon of axonal fusion during regeneration described in invertebrate 
neurons, where degeneration and regeneration are coordinated to facilitate rapid reconnection of 
axonal compartments.  To date axonal fusion during regeneration is the only scenario in which 
Wallerian degeneration cannot only be delayed, but also reversed.  It is tempting to speculate that 
the ability of a neuron to undergo axonal fusion during regeneration represents a fine balance 
between the rates of axonal degeneration and regeneration.  If this is the case it may be possible to 
manipulate these rates in vivo to facilitate axonal fusion in cases where it does not spontaneously 
occur.  It is unknown if axonal fusion is a normal occurrence in vertebrate neurons at the level of a 
single axon.  So far all studies have focused on surgical methods of fusion combined with the use of 
high molecular weight compounds to facilitate fusion between proximal and distal nerve bundles 
(Bittner et al., 2012; Britt et al., 2010; Dong et al., 2013; Silva et al., 2010; Spaeth et al., 2012).  
These methods have delivered extremely promising results, but at this stage it is unclear of the 
specificity of this process and if it represents a method of indirect re-innervation or something more 
similar to axonal fusion observed in invertebrates.  In fact, axonal fusion in C. elegans has not yet 
been demonstrated to restore function to the axon.  It is conceivable that although axonal fusion 
during regeneration may reverse Wallerian degeneration of the distal axonal fragment and restore 
cytoplasmic continuity between the neuronal cell body and its distal axon, function may remain 
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Figure 1.3.  Overlapping injury signals promote axonal degeneration and regeneration 
mechanisms.   A simplified diagram of known upstream regulators of axonal degeneration and 
regeneration.  Similar components in each axonal compartment activate completely opposing 
responses.  Ca2+, PHR (RPM-1 in C. elegans), and DLK (DLK-1 in C. elegans) represent key 
convergance points of axonal degeneration and regeneration mechanisms. 
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  disrupted.  In this case, axonal fusion may not be the optimal method of repairing injury.  There is 
much evidence from PNS regeneration in vertebrate models that supports a model in which 
degeneration and regeneration rates are proportional, whereby delaying degeneration of the distal 
axonal fragment inhibits regeneration of the proximal axonal fragment.  Degeneration of the distal 
fragment prevents axonal fusion and therefore, a priori, one would assume that delaying 
degeneration of the distal fragment might increase the likelihood of axonal fusion with the proximal 
fragment.  In this sense, axonal fusion during regeneration may represent an alternative to complete 
regeneration towards the distal target, with the preserved distal axonal fragment offering a shortcut 
to an ageing and slowly regrowing axon.  Given the obvious limitations to the regenerative capacity 
of vertebrate neurons, particularly those of the central nervous system, axonal fusion in any form 
represents a unique opportunity to repair functional circuitry with minimal regeneration.        
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  1.2 Summary and aims 
 
The review of literature presented as section 1.1 outlined what is currently known about the cellular 
mechanisms of axonal degeneration and regeneration following injury.  The emerging picture from 
these studies is that active mechanisms are present that regulate these two seemingly contradictory 
phenomena.  This section highlighted how both axonal degeneration and regeneration share 
components of the initial stages of injury signalling which lead to the activation of two distinct non-
developmental programs.  The main aim of this thesis was to develop novel injury strategies for use 
in C. elegans that would facilitate forward and reverse genetic approaches to discover the 
mechanisms of axonal degeneration and regeneration.  
 
Aim 1: Develop genetic methods of axonal damage to study degeneration and regeneration. 
 
Aim 2: Discover molecules that regulate degeneration and regeneration with forward and reverse 
genetic approaches. 
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  2.1 Introduction 
 
A critical event in neuronal development is neuronal polarization.  Neurons typically comprise two 
distinct processes: an axon, which sends signals to other neurons, and dendrites, which receive 
inputs from other neurons.  The establishment of these two neuronal compartments is essential for 
correct neuronal function, and occurs soon after the neuron is born.  Growing evidence, primarily 
from in vitro studies, suggests that regulation of the microtubule cytoskeleton provides key 
instructive signals to specify axon and dendrite identity (Polleux and Snider, 2010).  In addition to 
their role in neuronal polarity during development, microtubule dynamics have been recently 
implicated in axonal regeneration and degeneration (reviewed in chapter 1).  The emerging picture 
is that early developmental events can not only result in defects in axon and dendrite specification 
and development, but can also lead to deficits in axonal maintenance and regeneration after injury 
over the lifetime of the organism.   
 
The C. elegans anterior lateral mechanosensory neurons (ALM right and ALM left) are located 
symmetrically on the lateral sides of the animal’s body and are responsible for sensing anterior light 
mechanical stimulation (touch) to initiate a reversal response (Chalfie et al., 1985).  Each ALM is a 
highly polarized neuron with a single axon that extends anteriorly from the mid body of the animal, 
where the soma is located, into the head of the animal.  In the present study, together with two 
colleagues, we address how early defects in neuronal polarity affect both axonal morphology and 
specification, as well post-developmental events such as axonal regeneration.  We show that 
mutations in the gene mec-7/β-tubulin cause the extension of an ectopic neurite with axon-like 
properties.  We demonstrate that these defects are due to changes in the dynamics of microtubules, 
and that in addition to defects in neurite specification during development these animals have 
defects in axonal regeneration following injury.  
 
The critical aspect of this study relevant to this thesis is the demonstration that the regulation of 
microtubule dynamics is essential for axon outgrowth, maintenance, and repair.  This work was 
published in the peer-reviewed journal Molecular Biology of the Cell.   A copy of this article is 
presented as section 2.2 of this thesis. 
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  2.2 A dominant mutation in mec-7/β-tubulin affects axon development and regeneration in 
Caenorhabditis elegans neurons 
 
Kirszenblat, L., Neumann, B., Coakley, S. and Hilliard M.A. (2012) A dominant mutation in mec-
7/β-tubulin affects axon development and regeneration in Caenorhabditis elegans neurons. Mol 
Biol Cell 24, 285-96. 
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A dominant mutation in mec-7/β-tubulin affects 
axon development and regeneration in 
Caenorhabditis elegans neurons
Leonie Kirszenblat, Brent Neumann, Sean Coakley, and Massimo A. Hilliard
Queensland Brain Institute, The University of Queensland, Brisbane 4072, Australia
ABSTRACT Microtubules have been known for decades to be basic elements of the cytoskel-
eton. They form long, dynamic, rope-like structures within the cell that are essential for mito-
sis, maintenance of cell shape, and intracellular transport. More recently, in vitro studies have 
implicated microtubules as signaling molecules that, through changes in their stability, have 
the potential to trigger growth of axons and dendrites in developing neurons. In this study, 
we show that specific mutations in the Caenorhabditis elegans mec-7/β-tubulin gene cause 
ectopic axon formation in mechanosensory neurons in vivo. In mec-7 mutants, the ALM mech-
anosensory neuron forms a long ectopic neurite that extends posteriorly, a phenotype that 
can be mimicked in wild-type worms with a microtubule-stabilizing drug (paclitaxel), and sup-
pressed by mutations in unc-33/CRMP2 and the kinesin-related gene, vab-8. Our results also 
reveal that these ectopic neurites contain RAB-3, a marker for presynaptic loci, suggesting 
that they have axon-like properties. Interestingly, in contrast with the excessive axonal growth 
observed during development, mec-7 mutants are inhibited in axonal regrowth and remodel-
ing following axonal injury. Together our results suggest that MEC-7/β-tubulin integrity is 
necessary for the correct number of neurites a neuron generates in vivo and for the capacity 
of an axon to regenerate.
INTRODUCTION
A neuron becomes polarized early in its development, when it 
breaks its symmetry by extending an axon and dendrites. The polar-
ity of a neuron is defined by its orientation within the animal, the 
number of processes it extends, and the specification of neurite 
identity. In the nematode Caenorhabditis elegans, alterations to 
neuronal polarity have been detected by changes in cell orientation 
in the body of the worm, leading to the discovery of several mole-
cules in the Wnt/Frizzled and Netrin/DCC pathway that are critical 
for this process in vivo (Adler et al., 2006; Chang et al., 2006; Hilliard 
and Bargmann, 2006; Prasad and Clark, 2006; Quinn et al., 2008). In 
parallel, studies using cultured hippocampal neurons have provided 
insights into the molecules that specify neurite identity, thereby es-
tablishing whether a neuronal process develops into an axon or a 
dendrite (Polleux and Snider, 2010). Local destabilization of the ac-
tin network at the tip of a neurite has been shown to act as an early 
signal within the cell for axon specification (Bradke and Dotti, 1999; 
Witte and Bradke, 2008; Neukirchen and Bradke, 2011). However, 
several studies have identified molecules, such as collapsin re-
sponse–mediated protein 2 (CRMP2), synapses of amphids defec-
tive (SAD) kinases, and glycogen synthase kinase-3β (GSK3β), that 
trigger axon specification independently of actin through microtu-
bule dynamics (Jiang et al., 2005; Kishi et al., 2005; Yoshimura et al., 
2005; Maniar et al., 2012). Furthermore, growing evidence from 
in vitro experiments suggests that microtubules do not merely act 
as simple building blocks or cargo tracks in this process, but may 
provide instructive signals for axon specification (Baas, 2002; Witte 
et al., 2008; Hoogenraad and Bradke, 2009; Stiess and Bradke, 
2011). Interestingly, microtubule dynamics have also been impli-
cated in axonal regeneration, indicating microtubules are important 
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observed during development, we also 
demonstrate that axons of mec-7 animals 
display a reduced capacity for regeneration 
following laser-induced injury. Our results 
reveal that β-tubulin mutations can alter 
the number of axons generated in vivo 
and inhibit multiple stages of axonal 
regeneration.
RESULTS
Semidominant mutations in MEC-7/β-
tubulin induce neurite outgrowth 
in vivo
The C. elegans ALM mechanosensory neu-
ron is bilaterally symmetrical and has a sin-
gle process that extends anteriorly, with a 
ventral branch of this process forming syn-
aptic connections in the nerve ring (Figure 
1A). Occasionally, a short posterior neurite 
that is less than twice the length of the cell 
body is observed, although this is regarded 
as a protrusion, rather than a full process 
(White, 1986; Watari-Goshima et al., 2007). 
The ALM neuron was visualized using the 
zdIs5(Pmec-4::GFP) transgene, which ex-
presses green fluorescent protein (GFP) in 
the ALM, AVM, PVM, and PLM mechanosen-
sory neurons. In an unbiased, forward ge-
netic screen aimed at finding mutants 
with ectopic neurite outgrowth in the ALM 
neuron, we isolated a mutation, ky852, in 
which both the left and right ALM neurons 
extended a long posterior neurite, essen-
tially converting them into bipolar neurons 
(Figure 1, C and D). This phenotype was 
fully penetrant and semidominant, with 
heterozygotes (ky852/+) displaying a less 
severe phenotype with shorter posterior 
processes than those of homozygotes 
(Figure 1, B and D). Interestingly, we never 
observed a reversed ALM phenotype in 
which the anterior process was misrouted 
posteriorly, a common occurrence in other 
known ALM polarity mutants (Wolf et al., 1998; Hilliard and 
Bargmann, 2006; Prasad and Clark, 2006; Levy-Strumpf and Culotti, 
2007; Watari-Goshima et al., 2007; Pan et al., 2008). This suggests 
that the ky852 phenotype might result from disruption of a different 
molecular process that, rather than affecting orientation of a neuron 
within the animal, specifically regulates the number of neurites it 
develops. Moreover, unlike other polarity mutants, the ky852 mu-
tant also exhibited ectopic neurite formation in the mechanosen-
sory neurons AVM and PVM, and overextension of the posterior 
neurite in the PLM neuron (Figure S1). Behavioral analysis of ky852 
mutants with the light-touch assay (Chalfie and Sulston, 1981) 
revealed a mild touch insensitivity compared with wild-type animals, 
suggesting that the functional integrity of the mechanosensory 
neurons had been affected (Figure S2). To determine whether 
the mutation affected other classes of neurons, we visualized the 
D-type GABAergic motor neurons (Punc-25::GFP transgene) and 
the oxygen sensory neurons, AQR, PQR, and URX (Pgcy-36::GFP 
transgene) in the ky852 mutants. The morphology of these motor 
and oxygen sensory neurons appeared unaltered (unpublished 
not only during axon development but also for regrowth following 
injury (Erturk et al., 2007; Stone et al., 2010; Chen et al., 2011; Hellal 
et al., 2011; Sengottuvel and Fischer, 2011).
Although significant advances have been made in understand-
ing the molecular mechanisms of neuronal polarization governed by 
neuron orientation and neurite identity, we know much less about 
how a neuron is able to control the number of neurites it forms 
in vivo. Recent results have shown the planar cell polarity molecules 
VANG-1 and PRKL-1 are involved in this process (Sanchez-Alvarez 
et al., 2011).
In this study, we performed an unbiased genetic screen in 
C. elegans mechanosensory neurons to identify mutations affect-
ing the number of neurites that a neuron generates. We show that 
a mutation in mec-7, which encodes β-tubulin, causes ALM mecha-
nosensory neurons to develop long, ectopic neurites containing 
presynaptic loci, in addition to their normal axons. Time-lapse mor-
phological characterization suggests that this defect results from a 
disruption in the maintenance of neuronal polarity, with pharmaco-
logical experiments revealing that similar defects arise from 
hyperstable microtubules. Converse to the excessive axon growth 
FIGURE 1: Posterior neurite outgrowth defects in ALM neurons of ky852 mutants. Morphology 
of ALM in wild type (A), ky852 heterozygotes (B), and ky852 homozygotes (C). White 
arrowheads indicate the ectopic posterior process. (D) Quantification of ALM phenotypes, 
classified as normal (no posterior process), moderate (medium length posterior process), and 
severe (long posterior process). Each data set is based on an n of at least 100 animals. Scale bar: 
25 µm.
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animal at hatching. We reasoned that the 
ectopic ALM process in ky852 mutants 
could either emerge during early develop-
ment, which would suggest a disruption in 
the establishment of neuronal polarity, or 
arise after the development of the anterior 
neurite, which would indicate a defect in 
the maintenance of the neuronal polarity. 
To investigate this, we performed time-
lapse analysis of ALM development and 
found that the ectopic neurite emerged 
during the L1 stage, after the normal ante-
rior neurite had already extended to the 
head of the animal (Figure 2). This supports 
the notion that the ky852 phenotype dif-
fers from other neuronal polarity mutants, 
in which polarity defects are already seen in 
the embryo when the cell first begins to de-
velop asymmetry (Hilliard and Bargmann, 
2006), and therefore indicates the ky852 
mutation affects signaling processes occur-
ring later in development.
Using single-nucleotide polymorphism 
(SNP) analysis (Wicks et al., 2001; Davis 
et al., 2005; Davis and Hammarlund, 2006), 
we mapped the ky852 mutation to an inter-
val of chromosome X including the mec-7 
gene, which encodes a β-tubulin that is spe-
cifically expressed in the six mechanosen-
sory neurons of C. elegans and forms a com-
ponent of the 15 protofilament micro-
tubules unique to these neurons (Chalfie 
and Thomson, 1982). Several lines of evi-
dence indicated the ky852 phenotype was 
due to a mutation in the mec-7 gene. First, 
sequence analysis of the ky852 mutant re-
vealed a single base-pair change (ccg to tcg) 
in the mec-7 gene that generated a mis-
sense mutation (proline to serine at amino 
acid position 220) in the encoded protein 
(Figure 3A). Second, when we introduced a 
wild-type copy of mec-7 under the control 
of the mec-4 promoter (Pmec-4::mec-7) into 
ky852 mutant animals, we found that this 
transgene could partially rescue the ALM 
defect, with the length of the ectopic pro-
cess being reduced or returned to wild-type 
length in the majority of animals (Figure 3B). 
This partial rescue was consistent with the 
mutation being semidominant, as heterozy-
gous animals showed ectopic processes of 
intermediate lengths (Figure 1, B and D), 
due to the presence of both wild type and 
mutant copies of the gene. Third, expres-
sion of the mec-7(ky852) mutant allele in 
wild-type animals induced ectopic posterior 
outgrowth in some ALM neurons (Figure 
3C), further supporting the semidominant role of this gene. Finally, 
the mec-7 gene has been extensively characterized for mutations 
that affect the touch sensitivity of C. elegans, with more than 50 
alleles identified (Savage et al., 1989, 1994). Although visualization 
in these studies of MEC-7 with antibodies indicated that the vast 
data), suggesting that the ky852 mutation specifically affected the 
mechanosensory neurons.
The ALM mechanosensory neurons develop during embryo-
genesis, a time at which mec-7 also begins to be expressed 
(Hamelin et al., 1992), and are fully extended to the head of the 
FIGURE 2: Ectopic neurites in ky852 mutants develop following embryogenesis. Morphology of 
ALM neurons in wild type and ky852 mutants in the embryo (A and B), at hatching (C and D), 
and 5 h after hatching (E and F). (G) Quantification of ALM neurons with posterior neurite 
defects in ky852 mutants during developmental stages corresponding to the images in (A–F). 
Each data set is based on an n of at least 100 animals. Error bars represent the SE of proportion. 
Scale bars: 20 µm.
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mals with a microtubule-destabilizing agent, colchicine, or a micro-
tubule-stabilizing agent, paclitaxel. Colchicine is known to inhibit 
the assembly of microtubules by binding to tubulin, thereby disrupt-
ing microtubule dynamics (Fojo, 2008). Treatment of mec-7(ky852) 
animals with colchicine prevented outgrowth of the ectopic poste-
rior process in the ALM neuron, leaving the anterior process intact 
(Figure 4A). To determine the developmental period during which 
colchicine produces its effect, we restricted treatment to the first 
24 h after hatching (when the animals are largely in the L1/L2 stages) 
or to the following 24 h (during L3/L4). Approximately 70% of ALM 
neurons formed normally in mec-7(ky852) animals treated with 
colchicine during the first 24 h following hatching; in contrast, no 
rescue of the ALM posterior neurite was observed when the colchi-
cine treatment was started 24 h after hatching (Figure 4B). The abil-
ity to specifically block development of the ALM ectopic process 
during the early L1 stage supports our observation that the defect 
emerges later than the normal ALM process, which is formed during 
embryogenesis. Notably, concentrations of colchicine that blocked 
development of the ALM ectopic process also affected neurite 
majority of these alleles cause degenerative phenotypes in ALM, 
two alleles, u278 and u170, presented posterior outgrowth in ALM 
similar to that observed in the ky852 mutant animals (Savage et al., 
1994). We visualized and quantified the phenotypes of the mec-
7(u278) allele in the zdIs5(Pmec-4::GFP) background and found it 
had a qualitatively similar but less severe phenotype compared with 
the ky852 mutant, with a lower penetrance of the ALM defect 
(Figure 3D). Complementation analysis between the ky852 and 
mec-7(u278) alleles revealed a significant worsening of the defect in 
the double heterozygotes (noncomplementation) compared with 
either individual heterozygote (Figure 3D), confirming ky852 to be a 
novel allele of mec-7.
Ectopic neurite outgrowth is triggered by hyperstable 
microtubules
Local stabilization of microtubules in immature neurites of dissoci-
ated neurons is sufficient to trigger axon formation (Witte et al., 
2008). To investigate whether the ectopic processes in mec-7(ky852)
animals were a result of hyperstable microtubules, we treated ani-
FIGURE 3: The ky852 phenotype is caused by a mutation in the mec-7 gene. (A) Diagram of the mec-7 gene. Solid bars 
represent exons and connecting lines represent introns. The ky852 mutation and two other alleles that cause similar 
ALM neurite outgrowth phenotypes are indicated. (B) Rescue of ALM defects by insertion of wild-type mec-7 into 
mec-7(ky852) mutants. Two independent lines that were generated with different concentrations of injected transgene 
are shown. Phenotypic distributions between transgenics and nontransgenic controls were significantly different in both 
cases (chi-square test: p < 0.0001). (C) Induction of mec-7(ky852) phenotype by insertion of mutant mec-7 into wild-type 
animals. Two independent lines that were generated with different concentrations of injected transgene are shown. In 
both cases, transgenics had a reduced percentage of normal ALMs and an increased percentage of ALMs with 
intermediate length posterior process defects (Fisher’s exact test: p < 0.0001). (D) ALM phenotype of mec-7(u278) 
homozygotes, mec-7(u278) heterozygotes, and mec-7(u278)/mec-7(ky852) double heterozygotes. Data sets for (B–D) 
are based on an n of at least 100 animals.
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outgrowth of the AVM and PVM mechanosensory neurons in wild-
type animals, both of which develop within the first 24 h after hatch-
ing, suggesting that the microtubules in mec-7(ky852) animals have 
similar sensitivity to colchicine to those of wild-type animals (i.e., the 
mutation does not appear to affect the ability of colchicine to bind 
to β-tubulin).
We next tested the effect of a microtubule-stabilizing agent, 
paclitaxel, on development of the mechanosensory neurons. 
Paclitaxel binds to microtubule polymers, stabilizing them by sup-
pressing microtubule dynamics (Fojo, 2008). We hypothesized 
that pharmacological stabilization of microtubules would produce 
a similar phenotype to that of mec-7(ky852) mutants. bus-17(e2800) 
mutant animals were used for this experiment due to their thinner 
cuticles, which enhance the permeability of drugs (Bounoutas 
et al., 2009). In the absence of paclitaxel treatment, the mecha-
nosensory neurons were normal in these animals, as visualized us-
ing the Pmec-4::GFP transgene (zdIs5; bus-17). However, treat-
ment with paclitaxel during development induced the formation 
of ectopic processes, producing a phenotype that was similar to 
that of the mec-7(ky852) mutants, albeit to a lower penetrance 
(Figure 4C). This demonstrates that microtubule-stabilizing agents 
can induce ectopic neurite formation in vivo. Moreover, it sug-
gests that the mec-7(ky852) phenotype could arise from excessive 
stabilization of microtubules, providing a dosage effect of hyper-
stable β-tubulin consistent with the semidominant nature of the 
mutation.
Ectopic outgrowth in mec-7(ky852) is suppressed by unc-33 
and vab-8 mutations
Microtubule growth and stability is regulated by a variety of tubulin-
binding molecules. To investigate whether β-tubulin could interact 
with such molecules to produce ectopic neurite outgrowth, we 
searched for suppressors of the mec-7(ky852) ALM phenotype. We 
first investigated the ptl-1 gene, which is the sole C. elegans homo-
logue of the Tau/MAP2/MAP4 family of microtubule-associated pro-
teins (MAPs) and promotes microtubule assembly (Goedert et al., 
1996). A deletion mutation of the ptl-1 gene had no effect on 
the ALM outgrowth defects of mec-7(ky852) animals (Figure 5A 
and Table S1), suggesting that PTL-1 does not contribute to the 
mutant phenotype.
Next we analyzed the C. elegans member of the collapsin re-
sponse–mediated protein (CRMP) family, UNC-33. UNC-33 binds 
tubulin, promoting its assembly into microtubules, and has been 
shown to be necessary for axon outgrowth, microtubule structure, 
and polarized axonal transport (Hedgecock et al., 1985; Inagaki 
et al., 2001; Tsuboi et al., 2005; Maniar et al., 2012). We found that 
the unc-33(e204) mutation could partially suppress the mec-7(ky852) 
ALM outgrowth phenotype, as double mutants displayed a signifi-
cant number of normal ALMs (never seen in mec-7(ky852) single 
mutants) and a dramatic reduction in the length of the ectopic pro-
cess outgrowth (Figure 5A and Table S1). In contrast, the normal 
anterior process remained unaffected by the unc-33 mutation. This 
suggests that the ectopic outgrowth phenotype caused by the 
mutant MEC-7/β-tubulin could be caused by an enhanced or al-
tered interaction with UNC-33, which may contribute to excessive 
growth of microtubules in these mutants.
An intriguing question is how a single mutation in MEC-7/β-
tubulin can produce such precise, posterior outgrowth of a neuronal 
process. We hypothesized that this phenotype may be caused by 
interaction with VAB-8, a novel kinesin-like protein of C. elegans that 
is specifically required for posterior migration of both cells and growth 
FIGURE 4: Manipulation of microtubule stability using colchicine 
and paclitaxel affects development of ectopic ALM neurites. 
(A) Rescue of ALM posterior neurite defects in mec-7(ky852) animals 
grown on colchicine throughout development. The distribution of 
ALM phenotypes in mec-7(ky852) animals grown on colchicine was 
significantly different from that of control mec-7(ky852) animals 
(chi-square test: p < 0.0001). (B) Rescue of ALM defects in mec-
7(ky852) animals when treated with colchicine during the first 24 h 
but not the second 24 h after hatching. Animals treated with 
colchicine from 0 to 24 h were significantly different than controls 
(chi-square test: p < 0.0001). (C) Ectopic neurites generated in ALM 
neurons of wild-type (bus-17; zdIs5) animals grown on paclitaxel. 
ALM phenotypes of animals treated with paclitaxel were 
significantly different than controls (Fisher’s exact test: p < 0.03). 
Each data set is based on an n of at least 50 animals in (A) and (B) 
and 59 and 24 animals for paclitaxel-treated and control animals, 
respectively, in (C).
0
25
50
75
100
Pe
ne
tra
nc
e 
(%
)
normal
moderate
severe
wild-type wild-typemec-7
(ky852)
mec-7
(ky852)
control colchicine
A
0
25
50
75
100
Pe
ne
tra
nc
e 
(%
) normal
moderate
severe
control colchicine
(0-24hrs)
colchicine
(24-48hrs)
0
25
50
75
100
Pe
ne
tra
nc
e 
(%
)
B
C
normal
moderate
severe
control paclitaxel
  Colchicine treatment 
  (long incubation time)
  Colchicine treatment 
 (short incubation time)
  Paclitaxel treatment
24 | Chapter 2
290 | L. Kirszenblat et al. Molecular Biology of the Cell
single process extending posteriorly toward 
the tail. We asked whether the mec-7(ky852) 
mutation was able to transform a reversed 
unipolar ALM into a bipolar ALM, thus indi-
cating an independent mechanism of ac-
tion. We found that in triple mutants mec-
7(ky852) cwn-1 cwn-2, 100% of the reversed 
ALM neurons extended an ectopic anterior 
process (Figure 5B and Table S1), distin-
guishable from a normal ALM process, be-
cause it had not extended in the L1 and did 
not reach the nerve ring (unpublished data). 
This suggests that the function of mec-
7(ky852) is preserved regardless of the ori-
entation of the neuron, and is independent 
from this polarity effect of the Wnt 
mutations.
Mutant β-tubulin alters synaptic 
localization and axonal transport
Presynaptic loci are important elements 
that define the axonal identity of a neurite 
(Nonet, 1999; Hilliard and Bargmann, 
2006; Mahoney et al., 2006; Ou et al., 
2011). We investigated whether the ecto-
pic posterior neurite in the ALM neuron of 
mec-7(ky852) mutants had axon-like prop-
erties, and whether the mutation could al-
ter the normal distribution of presynaptic 
loci in the anterior process. In wild-type 
animals, ALM neurons have presynaptic 
sites located on a short branch of the ante-
rior process that enters the nerve ring 
(Figure 6, A and E). Presynaptic densities 
can be labeled by the vesicle-associated 
Ras GTPase, RAB-3 (Nonet et al., 1997; 
Nonet, 1999; Mahoney et al., 2006). We 
used a Pmec-4::mCherry::rab-3 transgene 
to visualize the presynaptic sites specifi-
cally in the mechanosensory neurons of 
wild type and mec-7(ky852) mutants. A 
high percentage of mec-7(ky852) animals 
displayed mCherry::RAB-3 expression on 
the ectopic posterior process of the ALM 
neurons (Figure 6, B and E). The presence 
of the presynaptic marker on the ectopic process indicates that it 
has acquired an axon-like identity, indicating that the ALM neuron 
in the mec-7(ky852) animals has been changed from a cell with a 
single axon to a cell with two axon-like neurites. However, among 
those animals that ectopically expressed mCherry::RAB-3 on the 
posterior ALM process, approximately half also showed a loss of 
synapses from the normal anterior process of ALM, suggesting 
that the ky852 mutation might compromise the normal transport 
of vesicles to the anterior neurite. To determine whether this 
could occur in other neurons, we investigated the presynaptic 
distribution in the bipolar PLM neuron of mec-7(ky852) mutants. 
Interestingly, we found that, similar to ALM, the transport of pre-
synaptic vesicles in PLM was altered in the mutants. In the PLM 
neurons of mutant animals, the RAB-3 presynaptic marker was 
mislocalized to the posterior neurite, with only a small percent-
age of selective localization on the anterior neurite, as in wild-
type animals (Figure S3).
cones (Wightman et al., 1996; Wolf et al., 1998; Lai and Garriga, 
2004). Indeed, mutations in vab-8 could partially suppress the 
mec-7(ky852) ALM phenotype (Figure 5A and Table S1). Further-
more, several molecules that have been proposed to act downstream 
of VAB-8 in axon outgrowth, such as UNC-40 and UNC-73 
(Levy-Strumpf and Culotti, 2007; Watari-Goshima et al., 2007) with its 
interacting partner CED-10/Rac (Steven et al., 1998; Spencer et al., 
2001), could also partially suppress the ALM outgrowth phenotype 
(Table S1). Together these results suggest that VAB-8 and other 
downstream molecules interact with mutant MEC-7/β-tubulin to 
coordinate posterior neurite outgrowth.
Finally, we examined interactions with Wnt molecules, which act 
redundantly in ALM polarity (Hilliard and Bargmann, 2006; Prasad 
and Clark, 2006). Loss of specific combinations of Wnt molecules, 
such as in cwn-1 cwn-2 double mutants, results in the development 
of bipolar and reversed ALMs. Reversed ALMs remain monopolar 
but have an opposite orientation within the animal’s body, with their 
FIGURE 5: Genetic interactions of mec-7(ky852) with MAPs and Wnts. (A) ALM phenotypes in 
double mutants of the microtubule-binding proteins, PTL-1/Tau and UNC-33/CRMP2, and the 
kinesin-like molecule VAB-8. mec-7(ky852); unc-33(e204) and mec-7(ky852); vab-8(e1017) double 
mutants have significantly more wild-type ALMs and less severe ALM defects compared with the 
mec-7(ky852) mutant (chi-square test: p < 0.001). (B) ALM phenotypes in mec-7(ky852); cwn-1; 
cwn-2 triple mutants. The mec-7(ky852) mutation converts the reversed unipolar neurons 
generated in cwn-1; cwn-2 double mutant animals into bipolar neurons. Each data set is based 
on an n of at least 100 animals.
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Anterograde transport of synaptic vesi-
cles along axonal microtubules is mediated 
by the UNC-104/KIF1A motor protein (Hall 
and Hedgecock, 1991). To investigate 
whether this machinery was compromised in 
the mec-7(ky852) animals, we examined its 
localization in the ALM mechanosensory 
neurons of wild-type animals and mec-
7(ky852) mutants using a Pmec-4::unc-
104::GFP transgene. In wild-type mecha-
nosensory neurons, UNC-104::GFP is 
expressed throughout the cell body and 
axon and is strongly localized to presynaptic 
sites (Kumar et al., 2011; Figure 6C). In mec-
7(ky852) mutants, UNC-104::GFP appeared 
to localize normally in the anterior ALM pro-
cess; however, it was also enriched in the 
terminals of the ectopic posterior processes 
(Figure 6, D and F), indicating a failure to 
restrict transport to the anterior process. As 
expected, the ectopic UNC-104::GFP ap-
peared to colocalize with RAB-3 (unpub-
lished data). Together these results suggest 
that mec-7(ky852) animals have mislocalized 
transport of synaptic vesicles into the ecto-
pic posterior processes, which gives them 
an axon-like identity.
Axonal regeneration is inhibited in 
mec-7(ky852) mutants
The likelihood that an axon will regrow fol-
lowing injury has been closely linked to the 
presence of presynaptic loci, as axons re-
generate poorly when they are severed dis-
tally from presynaptic sites (Wu et al., 2007). 
FIGURE 6: Distribution of RAB-3 and 
UNC-104/kinesin in ALM neurons of 
mec-7(ky852) mutants. (A) Normal 
localization of the RAB-3::mCherry 
presynaptic marker in ALM neurons of 
wild-type animals. White arrowheads indicate 
RAB-3 in the nerve ring branch of ALM. Gray 
dashed circles represent coelomocytes 
expressing GFP that were used as a 
transgenic marker. (B) RAB-3::mCherry 
localizes to the posterior processes of ALM 
neurons in mec-7(ky852) mutants. White 
arrowheads indicate RAB-3 in the nerve ring 
branch and ectopic posterior process of 
ALM. (C) UNC-104::GFP localization in ALM 
neurons of wild-type animals. Localization of 
UNC-104 is indicated (white arrowheads). 
(D) UNC-104::GFP localizes to the posterior 
processes of ALM neurons in mec-7(ky852) 
mutants. (E) Quantification of RAB-
3::mCherry localization on the anterior 
processes and on the posterior processes 
of ALM neurons. (F) Quantification of 
UNC-104::GFP localization on the anterior 
and posterior processes of ALM neurons. 
Each data set is based on an n of at least 
50 animals. Scale bar: 25 µm.
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these defects also extended to other neurons, we tested the regen-
erative capacity of PLM. Neurite regeneration was also altered in 
this cell, similar to ALM, with strongly reduced initiation of regrowth 
and reduced fusion (Figure S4). These results suggest that the 
mec-7(ky852) mutation causes defects in multiple aspects of axonal 
regeneration, including regrowth initiation and reconnection with 
separated distal fragments.
DISCUSSION
Studies in cultured neurons have demonstrated that regulation of 
microtubule dynamics plays a crucial role in determining whether an 
immature neurite develops into an axon. Nevertheless, evidence 
that this can occur in vivo has been lacking. Witte et al. (2008) re-
cently demonstrated that local stabilization of microtubules in cul-
tured hippocampal neurons is sufficient to induce axon formation, 
and suggested that microtubules play an active, instructive role in 
specifying axonal identity. Our study provides evidence that a single 
point mutation in the mec-7/β-tubulin gene can lead to outgrowth 
of secondary axon-like neurites. Interestingly, we find that the same 
Our observation that mec-7(ky852) animals displayed mislocaliza-
tion of the RAB-3 presynaptic marker suggested that this might in-
fluence their capacity for axonal regeneration. To test whether this 
was the case, we used laser axotomy to sever the axons of ALM 
neurons in wild-type and mutant animals and then quantified the 
level of regeneration. As previously shown by us and by others, ALM 
presents a high rate of regeneration following injury, with the re-
growing proximal axon extending toward the distal fragment and 
often reconnecting with it by means of axonal fusion, which restores 
the axonal tract (Yanik et al., 2006; Wu et al., 2007; Ghosh-Roy et al., 
2011; Neumann et al., 2011). Interestingly, regeneration of both the 
anterior and posterior neurites was reduced in mec-7(ky852) mu-
tants (Figure 7). mec-7(ky852) animals displayed a reduced capacity 
to initiate axon regrowth (Figure 7A); however, axon extension was 
normal, as the average length of regrowth in animals that could initi-
ate regeneration was similar to that of wild-type animals (Figure 7B). 
Furthermore, regrowing ALM neurites in mec-7(ky852) mutants dis-
played a reduced rate of axonal reconnection and fusion compared 
with wild-type animals (Figure 7, C and D). To determine whether 
FIGURE 7: Axonal regeneration defects in mec-7(ky852) mutants. Regeneration of the anterior ALM process in 
wild-type animals and both the anterior and posterior ALM processes in mutants is shown in each graph. (A) Percentage 
of ALM neurons showing regrowth following axotomy in wild-type and mec-7(ky852) animals. (B) Quantification of the 
average length of regrowth of regenerating axons shown in (A). (C and D) Percentage of ALM neurons showing 
reconnection of the regenerating process to the distal fragment, and of these reconnected axons, the percentage 
showing maintenance of the connection (fusion). (E and F) Images showing axonal regeneration in a wild-type animal (E) 
and defective axonal regeneration a mec-7(ky852) mutant (F). In wild-type animals, the regenerating axon regrows from 
the proximal fragment (closest to the cell body) to the distal fragment of the ALM neuron. n for each data set is 
indicated on the bars of the graph. Error bars represent the SE of proportion. *, significant difference between 
wild-type and mutant animals (Student’s t test: p < 0.05).
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Maniar et al., 2012), may contribute to excessive axon outgrowth, 
consistent with the results of overexpression studies in hippocampal 
neurons (Inagaki et al., 2001).
The ectopic localization of the RAB-3 presynaptic marker and the 
UNC-104/KIF1A motor protein in the posterior ALM processes of 
mec-7(ky852) animals suggests that the mutant microtubules affect 
normal intracellular transport. Notably, defects in synapse and axon 
outgrowth have recently been observed in C. elegans mutants of 
other tubulin subunits (Baran et al., 2010), further indicating that the 
nature of microtubules and their potential interactions with motor 
proteins is crucial for normal axonal transport. Intracellular transport 
of proteins is dependent on the intrinsic polarity of microtubules, 
which have dynamic plus ends that undergo rapid growth or col-
lapse, and more stable minus ends (Howard and Hyman, 2003). 
These polarized polymers serve as one-way conduits for intracellular 
trafficking by plus end–directed or minus end–directed motor pro-
teins (Baas and Lin, 2011) and are thus crucial for axon development 
and maintenance. Interestingly, UNC-33 is required for polarization 
of microtubule subunits and directed transport of synaptic proteins 
into the axon of PVD neurons (Maniar et al., 2012). Polarized trans-
port has also been shown to be essential for correct synapse localiza-
tion to the axon of the C. elegans DA9 motor neuron and for trans-
port of polarity proteins into the axon in cultured neurons (Nishimura 
et al., 2004; Shi et al., 2004; Ou et al., 2011). The plus end–directed 
kinesin-1 motor domain has been reported to selectively accumulate 
in a neurite prior to its specification as an axon (Jacobson et al., 
2006). Therefore it is possible that intrinsic microtubule polarity 
could provide an initial cue for axon formation by promoting move-
ment of cargo by axon-specific kinesins into the developing axon.
The altered transport of synaptic proteins in mec-7(ky852) mu-
tants may also be a cause of their axonal regeneration defects. Fol-
lowing injury, rapid signaling must occur between the site of injury 
and the cell body in order to initiate regeneration (Abe and Cavalli, 
2008). This is reliant on the transport of proteins, as impairment of 
axonal transport mechanisms has been found to affect regrowth of 
PLM in C. elegans (Chen et al., 2011). Therefore it is possible that 
mec-7(ky852) regeneration defects are partly due to a failure of ax-
onal transport following injury. Another possible explanation is that 
regeneration may be triggered only when the cell body detects a 
loss of synapses. This hypothesis is consistent with the findings of 
Wu et al. (2007), who showed that axons of C. elegans mechanosen-
sory neurons severed distally to the presynaptic sites (i.e., with pre-
synaptic sites still connected to the cell body) fail to regenerate 
and, furthermore, that regeneration can be rescued by severing 
the branch containing presynaptic sites. Thus, it is possible that in 
mec-7(ky852) mutants, which often lack presynaptic sites in the ax-
ons, the cell fails to detect a loss of synapses following severing of 
its axon and consequently fails to signal for regeneration to occur. 
Future studies are required to determine whether the defects in ax-
onal regeneration observed in these mutants are caused by impair-
ment of axonal transport or by alterations to the synaptic sites, or 
whether an alternative mechanism is in place.
Although emerging evidence suggests that the regulation of mi-
crotubule dynamics is a crucial determinant of axonal regenerative 
capacity (Erturk et al., 2007; Stone et al., 2010; Chen et al., 2011; 
Hellal et al., 2011; Sengottuvel and Fischer, 2011), a direct role for 
β-tubulin in regeneration has not been shown. Regeneration of an 
axon requires drastic remodeling of cell shape, which relies on dy-
namic instability of the cytoskeleton. An axon must first sprout a new 
process with a growth cone at its tip; this must then extend in the 
correct direction to reconnect with its target tissue. Interestingly, al-
though regrowth initiation and reconnection to the distal process 
mutation inhibits axonal regeneration in these neurons. Together 
our results indicate that the mutant form of β-tubulin affects multiple 
aspects of neuronal development and repair, and suggest that there 
are critical differences between axonal growth and regeneration.
We have identified a novel allele of mec-7/β-tubulin that causes 
an unusual polarity phenotype in the ALM mechanosensory neu-
rons, inducing the outgrowth of an additional neurite, which trans-
forms them into bipolar neurons. The precision of this phenotype 
is remarkable: the neurons in the mutant animals are consistently 
bipolar (rather than multipolar), and the long ectopic processes 
always grow in the posterior direction. Such precise ectopic neu-
rite outgrowth along the anterior–posterior axis has also been ob-
served in the six C. elegans VC motor neurons (VC1–6), suggesting 
the involvement of common factors (Sanchez-Alvarez et al., 2011). 
These phenotypes may be explained by the presence of extracel-
lular factors, or intrinsic cell signals, that bias the direction of out-
growth. A number of studies have identified mutations in guidance 
cues, receptors, and intracellular proteins that cause ALM polarity 
defects (Wolf et al., 1998; Hilliard and Bargmann, 2006; Levy-
Strumpf and Culotti, 2007; Watari-Goshima et al., 2007; Pan et al., 
2008). However, the phenotypes observed in these studies dif-
fered from those in the mec-7(ky852) animals, as they predomi-
nantly showed complete inversion of ALM polarity and were gen-
erated during the embryonic development of the ALM neuroblast 
(Hilliard and Bargmann, 2006), rather than postembryonically. Fi-
nally, our finding that inverted ALM neurons caused by Wnt muta-
tions were transformed into bipolar neurons in a mec-7(ky852) 
mutant background suggests that the outgrowth of the mec-
7(ky852) ectopic process is mediated by an intrinsic cell bias, which 
may operate independently of neuronal polarity established by 
Wnts. Our study suggests that the kinesin-like protein,VAB-8, re-
cruits molecules required for the posterior neurite outgrowth seen 
in the mec-7(ky852) mutants. Whether VAB-8 binds directly to tu-
bulin remains to be investigated.
In cultured cells, neuronal polarization is considered to occur 
when a preexisting immature neurite transforms into an axon (Polleux 
and Snider, 2010; Namba et al., 2011). In such cases, the number of 
potential axons and their directions of outgrowth are dependent on 
the location and number of immature neurites. In contrast, C. elegans 
ALM neurons usually lack secondary neurites, with only a small pro-
portion of animals presenting a short posterior protrusion, which may 
be indicative of a preexisting intrinsic cell bias. Thus the ALM ectopic 
posterior process observed in the mec-7(ky852) mutants usually 
emerges directly from the cell body. This suggests that mutations 
in mec-7/β-tubulin can alter the entire process of axon formation 
in vivo, from the initial emergence of the neurite to its full extension 
into an axon-like process containing presynaptic sites.
Our results suggest that microtubule stabilization contributes to 
the regulation of axon outgrowth in vivo. First, application of pacli-
taxel to wild-type animals was sufficient to trigger the outgrowth of 
ectopic processes. Second, colchicine treatment could rescue the 
ectopic ALM outgrowth in mec-7(ky852) mutants, suggesting that 
microtubules could mitigate the effect of the mutation. Whether the 
ky852 mutation can specifically confer microtubule hyperstability 
remains unclear. One possibility is that it might alter the structure of 
tubulin polymers, such that they interfere with normal microtubule 
dynamics, slowing or preventing microtubule breakdown. Alterna-
tively, the mutation may alter the binding or transport of molecules 
that regulate microtubule stability. Our finding that UNC-33/CRMP 
could suppress the mec-7(ky852) ALM phenotype suggests that the 
binding of this molecule, which has been shown to regulate micro-
tubule structure, dynamics, and transport (Fukata et al., 2002; 
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wild-type zdIs5 animals are usually monopolar, some have a small 
posterior protrusion that is less than two cell bodies in length. The 
ALM posterior process defect in mec-7(ky852) animals was consid-
ered to be moderate when the process was between 2 and 15 cell 
bodies in length, and severe when greater than 15 cell bodies in 
length. AVM, PVM, and PLM mechanosensory neurons were also 
analyzed for axon outgrowth and overextension phenotypes in L4 
and adult animals.
Developmental analysis of ALM morphology in the mec-7(ky852) 
mutant was performed in embryos and in synchronized populations 
of hatched animals. Animals were synchronized by collecting newly 
hatched larvae from a plate containing only eggs. Newly hatched L1 
animals were either scored immediately or transferred to new plates 
and grown on food for 5 h or until adulthood before scoring. In 
embryos and L1 animals, ALM neurons were scored as defective if a 
posterior process was observed (in wild-type animals, posterior pro-
cesses were never observed at these early stages).
Microscopy and laser axotomy
Animals were immobilized in 0.01–0.05% tetramisole hydrochloride 
on 4% agar pads and visualized using Zeiss Axioimager Z1 and Zeiss 
Axioimager A1 microscopes (Jena, Germany). Images were taken 
using a Photometrics camera (Cool Snap HQ2; Tucson, AZ) and ana-
lyzed with MetaMorph software (Molecular Devices, Sunnyvale, CA). 
Individual planes from Z-stacks were combined in Adobe Photoshop 
(San Jose, CA). Axotomies were performed as previously described 
(Neumann et al., 2011). A MicroPoint laser system basic unit (Andor, 
Belfast, UK) was used to perform axonal transection on L4 animals at 
a point ∼50 µm anterior to the ALM and PLM cell bodies. For analy-
sis of regeneration in the posterior ALM axon in mec-7(ky852) ani-
mals, axotomy was performed ∼50 µm posterior to the cell body. 
Axonal regrowth was quantified by measuring the length of the lon-
gest neurite beyond the cut site 24 h postaxotomy; neurons that 
underwent axonal fusion were excluded from these quantifications.
Colchicine and paclitaxel treatment
Animals were grown on nematode growth medium agar plates con-
taining colchicine (Sigma-Aldrich, St. Louis, MO) or paclitaxel 
(Sigma-Aldrich) with dimethyl sulfoxide, as previously described 
(Chalfie and Thomson, 1982).
Statistical analyses
Primer of Biostatistics 3.01 and GraphPad Prism (La Jolla, CA) were 
used for statistical analyses. Error of proportions was used to esti-
mate variation within a single population. The Student’s t test or 
Mann-Whitney rank sum test were used as indicated. The chi-square 
test was performed to estimate variance in the distribution of phe-
notypes between wild-type and mutant populations.
are inhibited in the mec-7(ky852) mutants, there are no apparent 
deficits in extension of regrowing axons. It is therefore likely that 
regrowth initiation and reconnection by axonal fusion require com-
paratively greater structural changes to the cytoskeleton than axon 
extension. Thus mec-7(ky852) mutations may differentially affect 
distinct stages of regeneration, depending on their specific require-
ments for dynamic microtubules.
This study of a C. elegans β-tubulin mutant has revealed a central 
role for microtubules in axon outgrowth and regeneration in vivo. 
Our findings contribute to growing evidence that precise microtu-
bule dynamics are essential for neuronal development, mainte-
nance, and repair. Mutations in human tubulin have been found to 
cause neurodevelopmental and neurodegenerative diseases 
(Kuijpers and Hoogenraad, 2011; Tischfield et al., 2011). As β-tubulin 
is highly conserved across species, understanding its function in 
model organisms has the potential to provide important insights 
into microtubule-related neuropathies in humans.
MATERIALS AND METHODS
Strains
Nematodes were cultured under standard conditions (Brenner, 1974). 
All experiments were performed at 22°C on hermaphrodite animals. 
The Hawaiian CB4856 strain was used for SNP mapping of the 
mec-7(ky852) mutation (Wicks et al., 2001; Davis et al., 2005; Davis 
and Hammarlund, 2006). The wild-type Bristol N2 strain and the fol-
lowing mutations were used: LGX: mec-7(ky852), mec-7(u278); LGI: 
unc-73(e936), mig-2(mu28), unc-40(e1430); LGII: cwn-1(ok546); LGIII: 
mig-10(ct41), ptl-1(ok621); LGIV: ced-10(n3246), unc-33(e204), cwn-
2(ok895); and LGV: vab-8(e1017). Transgenes used were: zdIs5[Pmec-
4::GFP]; juIs76[Punc-25::GFP]; vdEx262[Pmec-4::mCherry::rab-3 
(0.5 ng/µl), Punc-122::GFP (25 ng/µl)]; vdEx309[Pmec-4::mec-7 
(5 ng/µl), Podr-1::dsRed (30 ng/µl)]; vdEx312[Pmec-4::mec-7 
(10 ng/µl), Podr-1::dsRed (30 ng/µl)]; jsIs1111[Pmec-4::unc-104::GFP]; 
vdEx263[(Pmec-4::mCherry (5 ng/µl), Podr-1::dsRed (30 ng/µl)]; 
vdEx326 [Pmec-4::mec-7(ky852) (5 ng/µl), Podr-1::dsRed (30 ng/µl)]; 
vdEx329[Pmec-4::mec-7(ky852)(10 ng/µl), Podr-1::dsRed (30 ng/µl)]. 
The jsIs1111 strain was a kind gift from Sandhya Koushika (Tata 
Institute of Fundamental Research, Bangalore, India).
Molecular biology
Standard molecular biology techniques were used (Sambrook and 
Russell, 2001). The Pmec-4::mec-7::unc-54 3′UTR plasmid was gener-
ated through excision of the GFP coding sequences from the Pmec-
4::GFP plasmid and subsequent insertion of the entire mec-7 coding 
sequence (amplified from N2 DNA, with the following primers: for-
ward, 5′-tcagtgggatccaagcaacatgcgcgagatcg-3′; reverse, 5′-tcagtg-
ggatccatttactctccgtcgaacgc-3′). The Pmec-4::mec-7(ky852)::unc-54 
3′UTR plasmid was generated by QuikChange Site-Directed Muta-
genesis (Agilent, Santa Clara, CA) using the Pmec-4::mec-7::unc-54 
3′UTR as template DNA and the following primers to introduce 
the ky852 mutation: sense, 5′-cactctgaaactgacgacatcgacatatgga-
gacc-3′; antisense, 5′-ggtctccatatgtcgatgtcgtcagtttcagagtg-3′. The 
Pmec-4::mCherry::RAB-3::unc-54 3′UTR plasmid was created through 
modification of the Pmec-4::GFP plasmid. First, the coding sequence 
for GFP was excised and replaced with that of mCherry. Next 
the rab-3 coding sequence, which was amplified from the 
Prab-3::eGFP::RAB-3::rim-3 3′UTR plasmid (a kind gift from Michael 
Nonet, St. Louis, MO), was inserted downstream from mCherry.
Phenotypic analyses
ALM morphology was analyzed at the L4 or adult stage in 
a zdIs5(Pmec-4::GFP) background. Although ALM neurons in 
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Supplementary Figure 2.  ky852 mutants have reduced touch sensitivity.  Each data set is 
based on an n of 10 animals each tested 10 times.  Error bars represent the s.e. of the mean.  
Asterisks indicate a significant difference between wild-type and mutant (Mann-Whitney t-test: * 
p<0.05, *** p<0.0002). 
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Supplementary Figure 3.  Axonal regeneration defects in PLM neurons of mec-7(ky852) 
mutants.  Regeneration of the anterior PLM process in wild type and mec-7(ky852) animals is 
shown in each graph.  (A) Percentage of PLM neurons showing regrowth following axotomy.  (B) 
Quantification of the average length of regrowth of regenerating axons shown in (A).  (C, D) 
Percentage of PLM neurons showing reconnection of the regenerating process to the distal 
fragment, and of these reconnected axons, the percentage maintenance of the connection (fusion).  
n for each data set is indicated on the bars of the graph.  Error bars represent the s.e. of proportion.  
Asterisks indicate a significant difference between wild-type and mutant animals (Student’s t-test, 
p<0.05). 
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Supplementary Figure 4.  RAB-3 localization in PLM neurons of mec-7(ky852) mutants.  (A) 
Normal localization of the RAB-3::mCherry presynaptic marker to the synaptic branch in PLM 
neurons of wild-type animals.  Grey dashed circles represent coelomocytes.  (B) RAB-3::mCherry 
localizes to the posterior process of PLM neurons in mec-7(ky852) mutants.  (C) Quantification of 
RAB-3::mCherry localization on the anterior processes and on the posterior processes of PLM 
neurons. Each data set is based on an n of at least 50 animals.  Error bars represent the s.e. of 
proportion. Scale bar: 25 m  
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  2.4 Discussion and implications of findings 
 
The specification and outgrowth of the axonal process are critical events in the development of a 
mature neuron.  Recent studies have identified molecules that initiate axon specification through the 
regulation of microtubule dynamics (Jiang et al., 2005; Kishi et al., 2005; Maniar et al., 2012; 
Yoshimura et al., 2005).  In addition, it has been shown that pharmacological stabilization of 
microtubules in vitro is sufficient to induce axon formation (Witte et al., 2008).  The present study 
demonstrates that a mutation increasing the stabilization of microtubules is sufficient to induce 
ectopic axon formation in vivo, and that this effect can be recapitulated with pharmacological 
stabilizing agents.  Thus, our results in vivo provide strong support for the notion of a direct 
instructive role for microtubules in axon formation during neuronal development.  
 
Neurons are post-mitotic cells that form connections over large distances.  This requires efficient 
maintenance of axons and dendrites over the lifetime of the organism.  There are active mechanisms 
in place that protect the axonal process from degeneration over time, as well as regenerative 
programs that are initiated after injury (reviewed in chapter 1).  The present study reveals that 
microtubule dynamics are essential for axonal regeneration after injury induced by UV-laser 
axotomy.  The regulation of microtubule dynamics has been demonstrated to be important for a 
regenerative response following injury.  Our data confirm and extend these results, indicating that 
mutations in the gene mec-7/β-tubulin, which alter the microtubule dynamics, affect the 
regenerative capacity of the anterior axon of ALM.  Although the number of axons ALM formed in 
mec-7 mutants was altered, the developmental outgrowth and guidance of the anterior axon was 
unaffected.  Thus, our study provides an in vivo analysis that supports the existence of critical 
differences between axon outgrowth during development and regeneration.  Furthermore, we show 
that later stages of axonal regeneration, such as reconnection and fusion with the separated distal 
fragment (as reviewed in chapter 1), are severely reduced in animals with mutations in mec-7/β-
tubulin.  Growth cone formation involves large scale remodelling of the microtubule cytoskelelton, 
which is likely responsible for the regeneration defects seen in mec-7/β-tubulin mutants.  Similarly, 
axonal fusion during regeneration may also involve large-scale microtubule dynamics and as such is 
reduced in mec-7/β-tubulin mutants.  Regulation of axonal fusion during regeneration will be 
discussed further in chapters 5 and 6. 
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  2.5 Statement of contribution 
 
I performed the experiments presented in Figure 3c and Figure 4.  Of particular relevance are the 
experiments presented in Figure 4, which were performed using the microtubule affecting drugs 
Paclitaxel (Taxol) and Colchicine.  Both these drugs have been implicated in the development of 
peripheral neuropathy, and were initially tested to determine their efficacy in causing axonal 
damage as a means to induce regeneration.  My experiments indicated that this type of insult was 
unable to induce axonal regeneration (data not shown); instead, I used this paradigm to alter the 
stability of microtubules in vivo, in a set of critical experiments aimed at determining if this 
condition phenocopies the mec-7/β-tubulin mutant phenotype, causing ectopic neurite outgrowth.  
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Chapter 3:  
Designing an optogenetic method of axonal injury 
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  3.1 Introduction 
 
Chapter 2 outlined a basic mechanism by which a neuron establishes polarity and specifies axon 
identity, which has implications for maintenance and regeneration following injury.  Once axon 
identity is established and the axon has extended and formed connections with the correct distal 
targets (often over large distances), it must maintain these connections for the duration of the 
animal’s lifespan.  A large body of work has revealed that active mechanisms are in place to prevent 
degeneration of the axon during the lifetime of the animal (reviewed in chapter 1).  Different axonal 
injury models have been used to study axonal degeneration.  They include laser-induced or blade-
induced axotomy, axonal damage by toxic compounds, or the use of genetic mutations that cause 
spontaneous damage to axons.  Physical trauma (laser or blade) axotomy has the primary advantage 
of spatial and temporal resolution: it can target the desired axon at the desired time.  In contrast, the 
application of toxic compounds and genetic mutations lack the specificity of injury but have the 
significant advantage of being applicable to high throughput forward genetic screens.  In this study, 
together with colleagues, we combined the specificity of laser axotomy with the scalability of toxic 
compounds and genetic mutations, to create a C. elegans strain in which axonal damage can be 
induced in vivo.  
 
Optogenetic tools are genetically encoded proteins that are activated by light.  In C. elegans the 
optogenetic tools halorhodopsin (Zhang et al., 2007) and archaerhodopsin (Chow et al., 2010; 
Okazaki et al., 2012) have been successfully used to silence neurons in vivo.  The aim of this study 
was to use the optogenetic tool KillerRed to cause axonal damage in vivo, to facilitate forward 
genetic screens for molecules that regulate axonal degeneration.  KillerRed is a red fluorescent 
protein that produces ROS upon illumination with green light (540-580nm) (Bulina et al., 2006).  
Early results activating KillerRed in C. elegans neurons proved extremely efficient at inducing 
neuronal cell death in vivo (discussed in section 3.2).  As a result this study became more focused 
on a method to induce neuronal cell death in vivo using photoactivation of KillerRed as a means of 
irreversibly silencing neurons.   
 
This study was published in the peer-reviewed journal Cell Reports as part of an international 
collaboration with the laboratories of Marc Hammarlund (Yale University), Hang Lu (Georgia 
Institute of Technology) and Aravi Samuel (Harvard University).  A copy of this article is presented 
in section 3.2 of this thesis.  
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  3.2 Rapid and permanent neuronal inactivation in vivo via subcellular generation of reactive 
oxygen with the use of KillerRed 
  
Williams, D.C.*, El Bejjani, R.*, Mugno Ramirez, P.*, Coakley, S.* , Kim, SA., Lee, H., Wen, Q., 
Samuel, A., Lu, H., Hilliard, M.A. and Hammarlund, M. (2013) Rapid and permanent neuronal 
inactivation in vivo via subcellular generation of reactive oxygen with the use of KillerRed. Cell 
Reports 5, 552-563. 
*These authors contributed equally. 
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Inactivation of selected neurons in vivo can define
their contribution to specific developmental out-
comes, circuit functions, and behaviors. Here, we
show that the optogenetic tool KillerRed selec-
tively, rapidly, and permanently inactivates different
classes of neurons in C. elegans in response to a
single light stimulus, through the generation of reac-
tive oxygen species (ROS). Ablation scales from indi-
vidual neurons in single animals to multiple neurons
in populations and can be applied to freely behaving
animals. Using spatially restricted illumination, we
demonstrate that localized KillerRed activation in
either the cell body or the axon triggers neuronal
degeneration and death of the targeted cell. Finally,
targeting KillerRed to mitochondria results in organ-
elle fragmentation without killing the cell, in contrast
to the cell death observed when KillerRed is targeted
to the plasma membrane. We expect this genetic
tool to have wide-ranging applications in studies of
circuit function and subcellular responses to ROS.
INTRODUCTION
Optogenetic approaches to studying the function of specific
neurons in vivo generally involve the use of light to acutely acti-
vate or inactivate the cells of interest. In particular, inactivation
in Caenorhabditis elegans of specific neurons in vivo can be
used to investigate their contribution to specific network func-
tions and also to study compensation or homeostasis in the re-
maining cells. However, the best-described optogenetic tools
for silencing neurons in C. elegans, halorhodopsin (Zhang
et al., 2007) and archaerhodopsin (Chow et al., 2010; OkazakiC
41 | Chet al., 2012), are light-driven ion pumps (chloride and protons,
respectively) that require constant stimulation to keep neurons
inactive, andmay not be suitable for studying behavior, compen-
sation, or homeostasis over longer timescales.
An alternative way to acutely and permanently inactivate spe-
cific neurons in vivo is to kill them. Investigators have utilized this
approach extensively in C. elegans to define the function of a
wide variety of cells (especially neurons), using a laser micro-
beam to ablate the cells (Avery and Horvitz, 1987, 1989; Fang-
Yen et al., 2012). However, application of the laser-ablation
approach is limited because of the difficulty of ablating multiple
target cells without damaging surrounding cells or tissues, and
the extensive amount of time required to perform surgery on a
large number of animals. Thus, the development of optogenetic
ablation tools that can be spatially and temporally controlled is
highly desirable. An optimal optogenetic ablation tool should
kill cells rapidly, avoid collateral damage to neighboring cells
and tissues, and scale in application from single neurons to
groups of cells in single animals or populations.
KillerRed is a dimeric red fluorescent protein that produces
high levels of reactive oxygen species (ROS) upon illumination
with green light (540–580 nm), thereby inducing cell death (Bulina
et al., 2006). Structurally, KillerRed resembles other GFP-like
proteins, which comprise an 11-strand antiparallel b-barrel that
surrounds a centrally located chromophore (Carpentier et al.,
2009; Pletnev et al., 2009). However, KillerRed is 1,000 times
more toxic than other fluorescent proteins. This higher toxicity
is due to the presence of a long water-filled channel in
KillerRed that allows diffusion ofmolecular oxygen near the chro-
mophore, and is thought to provide a path for electron transfer
during the production of superoxide radicals (Roy et al., 2010;
Serebrovskaya et al., 2009). Similar to the generation of GFP
fluorescence, the phototoxic activity of KillerRed is effective
in vivo and can be induced in mammalian and zebrafish cells
without coexpression of other factors (Bulina et al., 2006; Teh
et al., 2010).ell Reports 5, 553–563, October 31, 2013 ª2013 The Authors 553
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Figure 1. KillerRed Activation Disrupts the Function and Morphology of Targeted Neurons and Results in Cell Death
(A) KillerRed activation induces behavioral defects. Animals were illuminated with white light and then scored 24 and 72 hr later for the shrinker phenotype caused
by GABAergic neuron dysfunction. n = 50 for KillerRed and GFP, and 100 for wild-type.
(legend continued on next page)
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Here, we demonstrate that KillerRed can efficiently kill a vari-
ety of neurons in C. elegans, including sensory neurons, inter-
neurons, and motor neurons. We show that the effect of
KillerRed is cell-autonomous and does not spread to nearby
neurons. Our results indicate that KillerRed disruption of
neuronal function is rapid and can be used to alter the circuits
and behavior of freely moving animals. In addition, the tool is
highlymodifiable, with ablation efficiency dependent upon illumi-
nation duration and intensity. We also demonstrate that certain
neurons are resistant to KillerRed damage, raising the intriguing
possibility that some cells possess increased intrinsic protection
mechanisms against ROS. We further show that subcellular
localization of KillerRed dramatically alters its function, with
mitochondria localization resulting in specific disruption of
organelle morphology. Finally, using selective illumination, we
show that exposure of individual neuronal compartments, such
as the cell body or the axon, is sufficient to induce neuronal
damage and death.
RESULTS
Expressing KillerRed in C. elegans GABA Neurons
Results in Light-Dependent Cell Death
We established the consequences of KillerRed activation in
different sets of C. elegans neurons, including motor neurons,
mechanosensory neurons, chemosensory neurons, and inter-
neurons (details of the KillerRed constructs and illumination
parameters can be found in Table S1 available online). We first
generated transgenic animals expressing cytosolic KillerRed
under the control of the GABAergic neuron-specific promoter
Punc-47, which drives expression in 26 motor neurons required
for coordinated movement (McIntire et al., 1997). Cytosolic
KillerRed activation in GABAergic neurons caused a ‘‘shrinker’’
phenotype (i.e., longitudinal shortening of the body upon head
touch) in the animals 24 hr after illumination, consistent with
loss of GABAergic neuronal function (Figure 1A; McIntire et al.,
1993). Furthermore, neuronal function remained disrupted
72 hr after KillerRed activation (Figure 1A), suggesting that the
affected neurons were dead rather than merely damaged. To
examine themorphology of KillerRed-expressing neurons before
and after KillerRed activation, we coexpressed GFP in the
targeted cells (Figure 1B). Twenty-four hours after KillerRed acti-
vation, we found that the morphology of the GABAergic neurons(B and B0) Confocal images of the GABAergic nervous system of GABA::KillerRe
(C) Nomarski image of affected GABAergic neuron cell bodies 24 hr after KillerR
(D and D0) CEPs before (D) and 24 hr after (D0) illumination. After illumination, the d
are smaller and rounded.
(E and E0) RIA interneuron before (E) and 24 hr after (E0) illumination, with the cel
(F and F0) Cholinergic nervous system before (F) and 24 hr after (F0) illumination.
smaller cell bodies.
(G–H’) Fluorescent images of axonal and neuronal damage in ALM and PLM bef
completely cleared (G0) and the PLM axon has disappeared (H’).
(I) Nomarski image of ablated ALM cell body 24 hr after illumination.
(J) Quantification of cell death 24 hr after illumination. n = 155 cells (CEP and AD
(K) Light touch response 24 hr after illumination in wild-type and KillerRed-expres
light touch in both the head and tail of the animal. n = 50 animals.
(L) Quantification of cell death in touch neurons 24 hr after illumination. n = 107 ce
neuron cell bodies, arrows mark processes, and arrowheads mark dorsal and ve
See also Table S1.
C
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mented and broken, often with large blebs, or missing altogether
(Figure 1B0). The cell bodies of the affected neurons were round
and swollen, and appeared smaller than those in nonilluminated
animals, consistent with neuronal death. To confirm that the
morphological changes observed based on GFP fluorescence
reflected cell death, we analyzed the GABAergic neurons by
differential interference contrast (DIC) microscopy and found
that the cell bodies of affected neurons displayed swelling, the
presence of vacuole-like structures, and nuclear changes (Fig-
ure 1C), all of which are phenotypes consistent with cell death.
The observed structural and behavioral defects were specific
and dependent on KillerRed expression and activation. Illumina-
tion of either wild-type animals or animals expressing only GFP in
GABAergic neurons did not elicit a shrinker phenotype (Fig-
ure 1A). Moreover, expression and illumination of the spectrally
similar fluorophore mCherry did not cause a detectable behav-
ioral defect (data not shown). Furthermore, prior to illumination,
neurons expressing KillerRed displayed no morphological or
functional deficits, indicating that neuronal deathwas dependent
upon KillerRed activation (Figures 1A and 1B). Thus, KillerRed
activation in GABAergic neurons permanently disrupts function
and results in cell death.
KillerRed Can Be Used to Efficiently Ablate Multiple
Classes of Neurons
Our experiments demonstrated that KillerRed can disrupt
neuronal function. Next, we asked whether we could improve
the efficiency of disruption. KillerRed is dimeric (Bulina et al.,
2006; Carpentier et al., 2009; Pletnev et al., 2009), and we
reasoned that increased efficiency might result from expression
as a tandem dimer, as previously reported for other multimeric
fluorescent proteins (Campbell et al., 2002; Shaner et al.,
2004). We generated a tandem-dimer version of KillerRed
(tdKillerRed) and found that it was significantly more effective
than monomeric KillerRed at disrupting GABA neuron function.
After illumination with green light (5.1 mW/mm2 for 5 min),
100% of tdKillerRed animals (n = 11) exhibited a shrinker pheno-
type, compared with only 14% for monomeric KillerRed (n = 14;
p < 0.0001). We also localized tdKillerRed to the plasma mem-
brane using a myristoylation tag (myr-tdKillerRed). Membrane-
targeted dimeric KillerRed had efficiency similar to that of
soluble dimeric KillerRed (92% shrinker, n = 13, p = 1.0). Wed (Punc-47::KillerRed) animals before (B) and 24 hr after (B0) illumination.
ed activation.
endrites of CEP neurons (arrows) are fragmented and the cell bodies (asterisks)
l body and axon degenerated in (E’).
Activation results in fragmentation of neuronal processes as well as fewer and
ore (G and H) and 24 hr after (G’ and H’) illumination. After illumination, ALM is
E), 48 cells (RIA), 74 cells (AWB), and 17 cells (AFD).
sing animals. After KillerRed activation, there is a reduction in the response to
lls (AVM and PVM) and 214 cells (ALM and PLM). In all figures, asterisks mark
ntral nerve cords. Error bars indicate 95% confidence intervals.
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Figure 2. KillerRed Activation Results in Immediate Disruption of
Neuronal Function
(A) Illumination of animals expressing KillerRed in cholinergic neurons results in
immediate and permanent disruption of movement. n = 50 for unilluminated,
n = 20 for immediate (just after the end of illumination) and 6 hr time points, and
n = 41 for 16 hr time point. Error bars indicate 95% confidence intervals.
(B) A freely swimming L1 larva before KillerRed activation in GABAergic motor
neurons (top panel). The same larva immediately following 5 min exposure to
green light illumination (40 mW/mm2) displays uncoordinated locomotion
(bottom panel).
See also Table S1.used myr-tdKillerRed for some of the subsequent experiments
(Table S1).
To determine whether other neurons could be targeted by
KillerRed, we generated different transgenic strains expressing
KillerRed in the dopaminergic neurons CEP, ADE, and PDE
(Pdat-1::myr-tdKillerRed); the interneuron RIA (Pglr-3::myr-
tdKillerRed); the cholinergic neurons (approximately 120
neurons; Punc-17::myr-tdKillerRed); the amphid sensory neu-
rons AWB (Pstr-1::myr-tdKillerRed) and AFD (Pgcy-8::myr-
tdKillerRed); and the mechanosensory neurons ALM (L/R),
PLM(L/R), AVM, and PVM (Pmec-4::KillerRed). Like the
GABAergic motor neurons, the dopaminergic neurons CEP
and ADE and the interneuron RIA were efficiently killed after
KillerRed activation (Figures 1D, 1E, and 1J). The cholinergic
neurons were also efficiently killed, although the maximum effi-
ciency could not be determined because the animals died (Fig-
ure 1F). This lethal phenotype is consistent with a requirement
for cholinergic neuron function for survival of animals in early
developmental stages (Alfonso et al., 1993). In comparison
with these cell types, the AWB and AFD amphid neurons were
killed with lower efficiency (Figure 1J). The dopaminergic PDE
neurons were also killed with lower efficiency (26 out of 60 cells),
even though the other dopaminergic neurons were efficiently
killed in the same animals. We also tested the efficiency of
KillerRed in the mechanosensory neurons, which mediate a spe-
cific behavior: response to light touch. We found that expression
and activation of KillerRed in the mechanosensory neurons
caused deficits in mechanosensation (Figure 1K). Consistent
with this loss of touch sensitivity, KillerRed activation also
caused efficient neuronal cell death in ALM and PLM neurons
(Figures 1G–1I and 1L). However, the AVM and PVM neurons
were refractory to axonal degeneration or cell death. Thus,
KillerRed can ablate many neuronal types in C. elegans, and is
effective at targeting single neurons as well as entire neuronal556 Cell Reports 5, 553–563, October 31, 2013 ª2013 The Authors
44 | Chapclasses, with selected neurons being specifically resistant to
disruption.
KillerRed Induces Immediate Inactivation of Illuminated
Neurons
Although the morphological effects of KillerRed activation in
neuronal cell bodies and processes are not apparent immedi-
ately after activation, it is possible that KillerRed disrupts
neuronal function more rapidly than it affects neuronal
morphology. To test this, we used two strategies. First, we
took advantage of the profound consequence of KillerRed acti-
vation in cholinergic neurons, which triggers paralysis in a coiled
posture, similar to what is observed in animals that lack cholin-
ergic neurotransmission (Rand, 1989). To determine the time
necessary for neuronal function to be disrupted byKillerRed acti-
vation, we quantified this uncoordinated behavior at various
times after illumination. This revealed that functional disruption
was both immediate and permanent (Figure 2A). Immediately
after completion of the 5 min illumination period, the animals
exhibited a robust, uncoordinated phenotype consistent with
loss of cholinergic neuron function. This functional deficit per-
sisted long after activation, suggesting that disruption was not
due to temporary inactivation, but rather to permanent disruption
of neuronal function followed by cell death.
Second, we used an optogenetic illumination system that
allowed us to expose single, freely swimming animals to intense
green laser light while monitoring their behavior before, during,
and after illumination (Leifer et al., 2011). When we used this sys-
tem to analyze the effect of KillerRed activation in GABAergic
motor neurons of freely swimming L1 larvae, we found that acti-
vation of KillerRed caused a severe deficit in locomotion, which
was observed immediately after the end of the illumination
period (Figure 2B; Movies S1 and S2). Together, these experi-
ments demonstrate that KillerRed activation can rapidly and
permanently disrupt neuronal function. In addition, our inactiva-
tion experiments in the GABAergic neurons of L1 animals sug-
gest that these neurons make a greater contribution to normal
locomotion of L1 animals than was previously appreciated.
KillerRed-Dependent Neuronal Death Is Caspase
Independent and Can Be Improved by Mutating
ROS-Detoxifying Enzymes
KillerRed is thought to act as a type II photosensitizer, producing
superoxide anion radicals rather than singlet oxygen (Pletnev
et al., 2009; Shu et al., 2011). Superoxide is scavenged by super-
oxide dismutases (SODs), which catalyze the conversion of
superoxide radicals to hydrogen peroxide and thus limit cellular
damage.C. elegans has a total of five SODs, two of which (sod-1
and sod-5) are cytoplasmic Cu/Zn SODs (the remaining three
SODs are mitochondrial Fe/Mn SODs [sod-2 and sod-3] and
an extracellular Cu/Zn SOD [sod-4]) (Landis and Tower, 2005).
We found that a sod-1 mutant background, which eliminates
one of the cytoplasmic SODs, increased the efficiency of abla-
tion in AWB, a neuron that normally is refractory to KillerRed
damage (Figure 3A). These data support a model in which
KillerRed exerts its effect via superoxide, and demonstrate that
the effect of KillerRed in normally resistant cells can be enhanced
by specific genetic mutations.ter 3
Figure 3. KillerRed Phototoxicity Is Enhanced in SOD Mutants and Does Not Require the Caspase CED-3
(A) Myr-tdKillerRed activation ablates AWB amphid neurons more effectively in sod-1(tm776) mutant animals. n = 74 cells (wild-type) and 38 cells (sod-1).
(B) Neuronal cell death induced byMyr-tdKillerRed activation in cholinergic neurons does not require ced-3(n717). The illumination protocol was adjusted to avoid
killing the animals (see Table S1). n = 132 cells (wild-type) and 79 cells (ced-3).
(C) Neuronal cell death induced by cytosolic KillerRed activation in mechanosensory neurons does not require ced-3(n717). For ced-3, n = 95 cells (AVM, PVM)
and 190 cells (ALM, PLM); for wild-type, n = 107 cells (AVM and PVM) and 214 cells (ALM and PLM; same data as Figure 1L). Phenotypes were determined 24 hr
after illumination. In all panels, error bars indicate 95% confidence intervals.
See also Table S1 and Movies S1 and S2.In C. elegans, apoptotic cell death requires the caspase CED-
3, whereas necrotic cell death does not (Ellis and Horvitz, 1986;
Hall et al., 1997). We tested whether KillerRed-mediated
neuronal cell death occurred through apoptosis by examining
the requirement for ced-3. Cell death, as well as the other
morphological and behavioral consequences of KillerRed activa-
tion, was as robust in ced-3mutants as in the wild-type for both
acetylcholinemotor neurons andmechanosensory neurons (Fig-
ures 3B and 3C). Further, the pathology of neuronal cell death
induced by KillerRed included cell swelling, vacuolation, and
nuclear changes (Figures 1C and 1I), which is similar to previous
observations of necrosis-like neuronal cell death (Hall et al.,
1997) but in contrast to the compact morphology of apoptotic
cells. These observations suggest that KillerRed does not act
via an apoptotic pathway and may instead kill neurons through
a necrotic, caspase-independent mechanism.
KillerRed’s Effects Are Cell Autonomous and Do Not
Spread to Adjacent Neurons
To test the cell autonomy of KillerRed’s cytotoxicity, we exam-
ined the morphology of neurons located adjacent to KillerRed-
targeted cells in three different experiments. First, we examined
AWA and AWB, which are sensory neurons located in the head.
The cell bodies of the AWA and AWB neurons are located next to
each other within the lateral ganglia; their axons project into the
nerve ring and their dendrites fasciculate with each other (White
et al., 1986). We found that activation of KillerRed in the AWB
neuron resulted in its structural disruption after illumination, butC
45 | Chhad no effect on the structure of AWA (Figures 4A and 4B).
Second, we examined cholinergic and GABAergic motor neu-
rons. These neurons are synaptic partners; their cell bodies are
located near the ventral nerve cord and their processes fascicu-
late together in the dorsal and ventral nerve cords (White et al.,
1986). We found that KillerRed activation in the GABAergic neu-
rons did not affect the morphology of the cholinergic neurons
(Figures 4C and 4D). Furthermore, KillerRed activation in
GABAergic neurons caused a GABAergic-specific functional
defect (Figure 1A) rather than the coiled-paralysis defect caused
by activation in cholinergic neurons (Figures 1F and 2). Similar
specificity was observedwhenGABA neuronswere imaged after
KillerRed activation in the cholinergic neurons, that is, activation
in cholinergic neurons did not affect the GABA neurons. Finally,
we tested whether KillerRed activation in the PLMmechanosen-
sory neuron had any effect on the morphology of the nearby PLN
neuron. Both PLM and PLN neurons have their cell bodies in the
lumbar ganglia, and their processes run adjacent to each other
for the entire posterior half of an animal’s body (White et al.,
1986). Activation of KillerRed in PLM had no effect on the axon
or cell body of PLN (Figures 4E–4G). Together, these results
indicate that KillerRed-mediated functional disruption and cell
damage is cell-autonomous and does not spread beyond the
targeted cell (or cells).
Selective Illumination Results in Neuronal Cell Death
We next investigated the effect of selective illumination on
different regions of the animal’s body or on defined regions ofell Reports 5, 553–563, October 31, 2013 ª2013 The Authors 557
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Figure 4. KillerRed Phototoxicity Does Not
Spread to Neighboring Neurons
(A) AWA neuron intact after illumination (green,
Podr-10::GFP).
(B) AWB degenerated neuron in the same animal
as in (A) (red, Pstr-1::myr-tdKillerRed).
(C) Cholinergic neurons after illumination (green,
Punc-17::GFP).
(D) Affected GABAergic neurons after illumination
in the same animal as in (C) (red, Punc-47::myr-
tdKillerRed).
(E) PLN neuron after illumination (red, Plad-
2::mCherry).
(F) PLM neurons expressing KillerRed after illumi-
nation in the same animal as in (E) (green, Pmec-
4::GFP). In all panels, asterisks mark cell bodies,
arrows mark processes, and arrowheads mark
dorsal (top) and ventral (bottom) nerve cords.
(G) Quantification of cell death in PLM and PLN
neurons in animals expressing KillerRed in PLM
only. Animals were scored for PLN death only if
PLM had died; thus, PLM death is 100%. n = 25
animals in which both PLM and PLN were scored.
In all panels, phenotypes were determined 24 hr
after illumination.
See also Table S1.individual neurons. For these experiments, we chose themecha-
nosensory neurons ALM and PLM and used a spatially restricted
illumination scheme similar to that used previously for optoge-
netic stimulation and inhibition of neurons (Stirman et al.,
2011). Specifically, we first imaged animals for GFP to locate
the neurons expressing KillerRed without inducing cell damage.
Then, using an LCD projector controlled by a LabVIEW program,
we illuminated selected regions (such as the anterior half or pos-
terior half of the animal’s body, or the cell body or axon of a single
neuron; Figure 5). Using high-magnification lenses with a small
focal depth (e.g., 1003), we were able to confine illumination
with precision and reproducibility. Targeting the anterior or pos-
terior half of the animal induced cell death of specific neurons
included in the respective illuminated regions (Figures 5A–5C).
As was the case with the nontargeted illumination, AVM and
PVM were resistant to KillerRed-induced damage. When
activation was confined to a limited portion of a single neuron,
we found that targeting only the cell body of the ALM
mechanosensory neuron resulted in cell damage and death (Fig-
ures 5D and 5E). Similarly, when the illumination was directed
selectively to the axon, we observed robust cell death (>40%
of cases), with the remaining animals presenting axonal
degeneration in regions beyond the irradiated sections. Thus,
even though expression of KillerRed was not spatially limited,558 Cell Reports 5, 553–563, October 31, 2013 ª2013 The Authors
46 | Chapter 3regional illumination was enough to
produce KillerRed-mediated cell damage
and death.
Mitochondrial Targeting Results in
Organelle-Specific Effects
The experiments described above show
that both membrane-targeted and cyto-plasmic KillerRed can disrupt neuronal function and kill neurons.
To test whether KillerRed function is dependent on subcellular
localization, we targeted tandem dimeric KillerRed to mitochon-
dria using the tom-20 targeting sequence, which results in local-
ization of KillerRed to the outer surface of the mitochondrion
(Ichishita et al., 2008; Kanaji et al., 2000). We performed these
experiments in body wall muscles because the mitochondria in
these cells have a well-defined morphology, which enabled us
to assess the effect of KillerRed on cell structure and function
and on the mitochondria themselves. We found that KillerRed
was efficiently targeted to mitochondria, and that mitochondria
labeled with KillerRed (without activation) had normal mor-
phology consisting of a reticulated network (Figure 6A).
Further, animals that expressedmitochondria-targeted KillerRed
(mt-tdKillerRed) in all of their body wall muscles displayed
normal movement in the absence of light activation, demon-
strating that muscle function was not disrupted by mt-
tdKillerRed expression (data not shown). By contrast, when
mt-tdKillerRed-expressing animals were exposed to green light,
we observed an immediate and dramatic change in mitochon-
dria morphology in muscle. mt-tdKillerRed activation disrupted
the reticulated network of mitochondria and resulted in small,
spherical mitochondria of various sizes (Figure 6B). Surprisingly,
we did not observe behavioral deficits in these animals,
Figure 5. Selected Region Illumination Can
Be Used in Combination with KillerRed to
Induce Cell-Specific Killing
(A and C) Illumination of the anterior half body of
the animal causes selective ablation of ALM
neurons, whereas PLM neurons are intact. n = 25
animals.
(B and C) Illumination of the posterior half of the
animal’s body ablated PLM neurons, leaving intact
ALMs. n = 24 animals.
(D and E) Selective illumination of either the soma
or axon of ALM neurons can cause damage and
neuronal ablation. n = 25 animals for soma and 19
animals for axon illumination. In all of the images,
the green arrowhead points to the targeted neuron
or axon before illumination, asterisks indicate the
same cell 24 hr after illumination, and white
arrowheads point to different neuronal cell bodies
in the animal.
See also Table S1.suggesting that activation of mt-tdKillerRed did not kill muscle
cells (Figure 6G). By contrast, expression of plasma mem-
brane-targeted KillerRed (myr-tdKillerRed) in the same muscle
cells resulted in cell death and immediate behavioral deficits
after activation (Figures 6E and 6F). Since mt-tdKillerRed did
not kill muscles, we performed studies to test whether mito-
chondrial morphology could recover after KillerRed-mediated
disruption.We found that by 48 hr after disruption, themitochon-
dria had recovered normal morphology (Figures 6C and 6D).
Together, these results demonstrate that subcellular targeting
of KillerRed enables the generation of local and specific cell-
biological phenotypes.
Use of KillerRed with Other Optical Tools
A number of optical tools are currently being used in C. elegans,
including the optogenetic tool channelrhodopsin (Nagel et al.,
2005) and the reactive oxygen generator miniSOG (Qi et al.,
2012). Because KillerRed is excited by green light, whereas these
other tools are excited by blue light, we considered that it might
be possible to address them separately in a single animal byCell Reports 5, 553–563,
47 | Chapter 3using different illumination wavelengths.
To determine the feasibility of this idea,
we compared the requirements for acti-
vation of KillerRed, channelrhodopsin,
and miniSOG in the cholinergic motor
neurons. The activity of all three tools
has been described in these cells (Figures
1F and 2; Liu et al., 2009; Qi et al., 2012;
Zhang et al., 2007). First, we determined
the feasibility of using KillerRed in
combination with miniSOG.We irradiated
animals expressing miniSOG in cholin-
ergic motor neurons (CZ14527) using
0.57 mW/mm2 of blue light for 30 min as
previously described (Qi et al., 2012;
Table S1). This treatment affected 100%
of the animals: 42% were paralyzed andthe remaining animals could move but were sluggish. Similarly,
we irradiated animals expressing KillerRed in cholinergic
neurons with the same intensity (0.57 mW/mm2) and time of
green light, and again observed 100% affected animals, with
76% paralysis and 24% sluggish movement (Figure 7A). Next,
we swapped the illumination conditions, that is, we illuminated
miniSOG animals with 0.57 mW/mm2 of green light and
KillerRed animals with 0.57 mW/mm2 of blue. This treatment
had little to no effect, although approximately 6% of the
KillerRed animals did react to blue light illumination (Figure 7A).
Finally, we asked whether higher-intensity activation could be
used for miniSOG. We had previously observed that C. elegans
can tolerate green light at 46mW/mm2 for 15minwith no adverse
effects (other than KillerRed activation; Figure 1). However,
exposing wild-type worms (n = 20) to blue light at 8 mW/mm2
for 10 min resulted in 100% lethality, consistent with previous
results (Edwards et al., 2008). Together, these data suggest
that KillerRed andminiSOG can be separately addressed in vivo.
Next, we determined the feasibility of using KillerRed in
conjunction with channelrhodopsin. Again, we focused on theOctober 31, 2013 ª2013 The Authors 559
Figure 6. KillerRed Activation at Mito-
chondria Results in Organelle Damage but
Cell Survival
(A–D) Mitochondria in body wall muscles express
mt-tdKillerRed and were imaged before (A) or at
various times after (B–D) illumination.
(E and F) Body wall muscles express plasma
membrane KillerRed and were imaged before (E)
and 16 hr after (F) illumination. GABA neurons
express GFP.
(G) Average thrash rate in liquid of animals
expressing mitochondria KillerRed in muscles
before and after illumination, corresponding to (A)
and (B). n = 9 for before illumination and 10 for after
illumination; error bars indicate SEM.
(H) Phenotype distribution of animals expressing
plasma membrane KillerRed in muscles after
illumination, corresponding to (F). n = 41; error
bars indicate 95% confidence intervals.
See also Table S1.cholinergic motor neurons, which are a well-described site for
channelrhodopsin activation (Liu et al., 2009; Zhang et al.,
2007). We tested whether activation of channelrhodopsin could
be performed independently of KillerRed activation. We acti-
vated channelrhodopsin in cholinergic motor neurons using
0.47 mW/mm2 of blue light, which caused 100% of the animals
to stop moving (n = 23). By contrast, 2.2 mW/mm2 of green light
had no effect on these animals (n = 22). As we previously deter-
mined that an even lower intensity of green light could be used to
activate KillerRed, and a higher intensity of blue light could
be used without activating KillerRed (Figure 7A), these experi-
ments indicate that KillerRed can be used in multimodal
experiments with channelrhodopsin. Finally, we confirmed
these experiments in mechanosensory neurons. As in the cholin-
ergic neurons, we found that prolonged illumination of KillerRed
strains at the appropriate wavelength and intensity to activate
channelrhodopsin had very little effect, although axon damage
was observed in a small percentage of animals (Figures 7B
and 7C). These data confirm that KillerRed can be used in con-
junction with channelrhodopsin in C. elegans, as well as in
conjunction with other fluorescent tools that are excited by
blue or cyan light.
DISCUSSION
KillerRed is a new tool in the C. elegans optogenetic toolkit that
can kill and inactivate cells in populations of animals with
extremely high temporal and spatial control. The effect of
KillerRed is immediate and cell-autonomous, with no spreading
of killing, or even damage, to surrounding cells or tissues. This
critical property makes KillerRed a powerful biological tool that560 Cell Reports 5, 553–563, October 31, 2013 ª2013 The Authors
48 | Chapter 3can be applied in a wide variety of cell-
perturbation studies in vivo, at scales
ranging from single to multiple cells in
both single animals and populations. For
example, the rapidity and efficacy of this
genetically encoded cell-ablation reagent
will now allow investigators to examinethe acute effects of disrupting specific neurons during behavioral
performance. KillerRed can also be used for longer behavioral
studies, since ablated neurons never recover function. For
example, our data indicate that GABA neurons have an essential
function in the locomotion of L1 larvae. Similarly, our data indi-
cate that ablation of acetylcholine neurons in L4 stage animals
results in relatively rapid lethality (within 24 hr of ablation), sug-
gesting that C. elegans has an acute requirement for cholinergic
neurotransmission for viability. One potential concern for such
behavioral studies is the fact that because KillerRed damages
and kills neurons, rather thanmerely silencing them, it is possible
that secondary effects on the remaining cells in the network
might complicate analysis. However, our data demonstrate
that, at least for the neurons assessed here, the effects of
ablation are restricted to the cells that express KillerRed.
Further, because KillerRed is excited by green light, it can be
used in combination with other optogenetic tools that are excited
by blue light, such as GFP, GCaMP, channelrhodopsin, and
miniSOG. The green light activation of KillerRed may have
some additional practical advantages in C. elegans, as worms
tolerate high levels of green light, but actively avoid—and can
be killed by—equivalent amounts of blue light (Edwards et al.,
2008). The selective-illumination method we describe here may
also have additional applications, such as ablating a neuron
from a distance by targeting a region of its axon (this is particu-
larly important when using KillerRed expressed in cells whose
cell bodies are in very close proximity and therefore are more
difficult to target individually), and investigating ROS effects in
axonal sections.
Our results also indicate that subcellular localization of
KillerRed can be exploited to study specific cell-biological
Figure 7. KillerRed Can Be Used in Multimodal Optical Experiments
(A) Comparison of the effects of KillerRed and miniSOG in acetylcholine
neurons illuminated with either blue or green light. n = 33 for miniSOG/blue,
n = 21 for miniSOG/green, n = 32 for KillerRed/blue, and n = 21 for KillerRed/
green. Error bars show 95% confidence interval for the paralyzed phenotype.
Phenotypes were determined 10 min after illumination.
(B and C) Effect of KillerRed in mechanosensory neurons illuminated with
either blue (b) or cyan (c) light. n = 102 for blue light and n = 64 for cyan light.
Phenotypes were determined 24 hr after illumination.
See also Table S1.functions. Targeting and activating KillerRed at the plasmamem-
brane is sufficient to inactivate and kill cells. This rapid and lethal
effect could be due to the susceptibility of membrane lipids to
oxidation. For example, unsaturated lipids are highly susceptible
to oxidative stress, resulting in the generation of toxic com-
pounds such as hydroxynonenal and acrolein (Catala´, 2010;
Fatokun et al., 2008). In addition to causing loss of membrane
fluidity and destruction of the plasma membrane barrier, these
toxic compounds react with membrane proteins, resulting in
inactivation of critical proteins such as the neuronal glucose
transporter, the glutamate transporter, and Na+/K+ ATPases
(Barnham et al., 2004; Keller et al., 1997; Mark et al., 1995; SmithC
49 | Chet al., 2009). In contrast, targeting and activating KillerRed at
mitochondria results in the specific disruption (and eventual re-
covery) of organelle morphology, without killing cells. A potential
explanation for the local effect of KillerRed on mitochondria is
that ROS are quenched rapidly and thus the effective diffusion
rate is very low. Alternatively, it is possible that the TOM20 tag
affects KillerRed function, allowing for mitochondrial damage
but preventing cell killing. Interestingly, another optogenetic
reactive oxygen generator, miniSOG, requires mitochondrial
targeting to kill neurons (Qi et al., 2012). miniSOG generates
mainly singlet oxygen, whereas KillerRed generates mainly
superoxide (Pletnev et al., 2009; Shu et al., 2011; this work).
These data suggest that different ROS may affect mitochondria
and cell function in different ways. KillerRed thus enables the
dissection of local effects of ROS.
ROS are toxic cellular molecules that need to be kept in check
for a neuron to function over a long period of time, and ROS
accumulation correlates with a variety of neurodegenerative dis-
eases (DiMauro and Schon, 2008; Uttara et al., 2009). Therefore,
defining the nature of the cytotoxicity of KillerRed, a generator of
ROS, offers a significant opportunity to genetically investigate
the mechanisms that regulate cellular responses to ROS. Our
findings show that selective neurons, such as AVM, PVM, and
AWB, are resistant to damage caused by KillerRed activation
and ROS. KillerRed expression is weaker in PVM than in other
neurons, so the reduced killing effect could be due to the pres-
ence of fewer molecules in the cell. However, AVM and AWB
express KillerRed at levels comparable to those observed in
other neurons, suggesting that they might have a higher intrinsic
capacity to buffer ROS. One such mechanism could be a higher
expression of molecules, such as SOD-1, that are able to catab-
olize ROS into nontoxic elements. Our data demonstrating that a
mutation in SOD-1 is able to increase the cytotoxic effect of
KillerRed activation in AWB provide support for this idea,
although additional mechanisms might also be in place. We
expect that the application of KillerRed shown here will provide
greater flexibility and control for genetic studies of both neuronal
function and ROS-induced neuronal damage in vivo.EXPERIMENTAL PROCEDURES
Strains and Molecular Biology
Nematodes were cultured using standard methods. All experiments were
performed at 22C except when otherwise noted. A C. elegans version of
the KillerRed coding sequence was synthesized (GenScript) using worm-
optimized codons and synthetic introns (Fire et al., 1990; Stenico et al.,
1994). Flanking regions for Multisite Gateway (Invitrogen) were included and
the KillerRed construct was placed in pDONR221. tdKillerRed was generated
from this monomeric construct using the same linker sequences as tdTomato
(Serebrovskaya et al., 2009; Shaner et al., 2004). tdKillerRed was targeted to
the plasma membrane through the addition of a myristoylation tag to generate
myr-tdKillerRed (Gitai et al., 2003). Promoters were cloned into the [4-1] slot of
Multisite Gateway. Final expression constructs were generated with LR
clonase into the destination vector pCFJ150 (Frøkjaer-Jensen et al., 2010).
For experiments with the mechanosensory neurons, we used the following
transgenes and mutations: zdIs5(Pmec-4::GFP), vdEx405[Pmec-4::KillerRed
(20 ng/ml) + odr-1::DsRED (30 ng/ml)], LGIV ced-3(n717), and vdEx167[Plad-
2::mCherry (25 ng/ml) + Podr-1::dsRED (30 ng/ml)]; Neumann et al., 2011).
Standard molecular-biology methods were used. The Pmec-4::KR construct
was generated by cloning a KillerRed cDNA (Evrogen) into a pSM vectorell Reports 5, 553–563, October 31, 2013 ª2013 The Authors 561
apter 3
(a derivative of pPD49.26 [Fire et al., 1990], a kind gift from Steve McCarroll
and Cori Bargmann) containing Pmec-4. KillerRed was amplified with primers
containing BamHI restrictions sites and inserted into pSM Pmec-4 digested
with the same enzyme.
DNA constructs were injected into the germline using standard methods
(Mello et al., 1991). Expression of KillerRed in the correct cells was verified
by fluorescence microscopy.
KillerRed Activation and Imaging
Light from a 200 W mercury bulb (PhotoFluor II; 89 North) was filtered with a
562/20 nm filter. The resulting green light was trained into a 5 mm liquid-light
guide. The output from the liquid-light guidewas directed through a collimating
lens (LA1951-A; Thorlabs) and a focusing lens (LA1027-A). Light intensity was
measured with a power meter (PM100A; Thorlabs). Illuminations were done in
upside-down PCR tube caps in 30 ml of M9 medium on ice to minimize sample
heating. L4 stage transgenic worms were used in all experiments. The animals
were allowed to crawl on unseeded plates prior to the experiment to remove
excess bacteria. Different neuronal cell types required different illumination
protocols to result in optimal killing. Illumination times, light intensities, and
transgenic lines carrying myr-tdKillerRed are shown in Table S1. An UltraVIEW
VoX (PerkinElmer) spinning disc mounted on a Nikon Ti-E Eclipse inverted
microscope and a 603CFI Plan Apo, NA 1.0 oil objective were used to capture
z stacks of nonilluminated and illuminated neurons. Cellular damage in illumi-
nated neurons was documented 18–24 hr after illumination.
Illumination ofmechanosensory neuronswasperformedon animals immobi-
lized onNGMagar plates with tetramisole hydrochloride (0.03%), using a Leica
MZ10F fluorescence dissecting microscope with an EtDsRed filter (green light
530–560 nm) and 803 magnification (intensity 3.8 mW/mm2). Twenty-four
hours after irradiation, the animals were mounted on 4% agar pads and visual-
ized byepifluorescenceusing aZeissAxioimagerZ1andaZeissAxioimagerA1
microscope. A CoolSNAP HQ2 camera (Photometrics) was used for imaging.
Metamorph software was used to analyze the collected images.
Selective illumination was performed using the LCD projector system as
previously described (Stirman et al., 2011). GFP fluorescence was used to
image the cells and define the location of the soma and axon. A green filter
(543–593 nm) was used to activate KR in regions of interest selected after
imaging. Typical power densities were 2–3 mW/mm2. In all experiments
performed using this system, the illumination time was 1 hr. The length of
the axonal processes that were selectively illuminated was 80 mm in all cases.
Extensive degeneration was defined as damage that extended beyond 10%of
the illuminated length along the axon.
Acute KillerRed activation using freely swimmingwormswas performed on a
modified version of the COLBERT system (Leifer et al., 2011). Briefly, a freely
moving L1 larva was imaged with a 203 microscope objective on an inverted
Nikon microscope (TE2000). The fluorescence video was taken with a
CoolSNAP CCD camera (Photometrics). A digital micromirror device was
used to reflect green laser light to illuminate targeted regions of the worm,
inducing KillerRed activation in GABAergic motor neurons.
Activation of miniSOG was performed using the same Photofluor II system
employed forKillerRed,butwithafilter at theappropriatewavelength (TableS1).
Statistics
Statistical comparisons were made using the two-tailed Fisher’s exact test
(http://www.graphpad.com/quickcalcs/contingency1/), and 95% confi-
dence intervals were calculated using http://www.graphpad.com/quickcalcs/
confInterval1/.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one table and two movies and can be
foundwith this article online at http://dx.doi.org/10.1016/j.celrep.2013.09.023.
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Supplemental Table S1. Details of KillerRed transgenes and illumination 
conditions, related to all Figures. 
Figure Neuron type Transgene/injection 
concentration 
Intensity Wavelength Illumination 
time
1 GABA Punc -47KillerRed 1mW/mm2 white 2 hours 
1 Dopamine
(CEP, ADE,
PDE)
Pdat -1::myr-tdKillerRed 
(20ng/μl)
46mW/mm2 542-582 
nm. 
15 min.
1 RIA Pglr -3::myr -tdKillerRed
linearized construct (3ng/μl)
46mW/mm2 542-582 
nm. 
10 min.
1 Acetylcholine Punc -17::myr -tdKillerRed
(20ng/μl)
46mW/mm2 542-582 
nm. 
5 min.
1 Mechanosensory
(ALM, PLM, 
AVM, PVM)
Pmec -4::KillerRed (20ng/μl)  3.8 mW/mm2 530-560 nm. 30 min.
1 AFD Pgcy -8::myr -tdKillerRed
(50ng/μl)
46mW/mm2 542-582 
nm. 
15 min.
1 AWB Pstr -1::myr -tdKillerRed
(30ng/μl)
46mW/mm2 542-582 
nm. 
10 min.
2 Acetylcholine Punc -17::myr -tdKillerRed
(20ng/μl)
46mW/mm2 542-582 
nm. 
5 min.
2 GABA Punc -47 KillerRed 40mW/mm2 542-582 
nm. 
5 min.
3 AWB Pstr -1::myr -tdKillerRed
(30ng/μl)
46mW/mm2 542-582 
nm. 
10 min.
3 Acetylcholine Punc -17::myr -tdKillerRed
(20ng/μl)
46mW/mm2 542-582 
nm. 
2 min.
3 Mechanosensory
(ALM, PLM, 
Pmec -4::KillerRed (20ng/μl)  3.8 mW/mm2 530-560 nm. 30 min.
3.3 Supplementary data
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AVM, PVM) 
4 AWB Pstr-1::myr-tdKillerRed 
(30ng/μl) 
46mW/mm
2
 542-582 
nm. 
 
10 min. 
4 GABA Punc-47::myr-tdKillerRed 
(20ng/μl)  
46mW/mm
2
 542-582 
nm. 
 
5 min.  
5 Mechanosensory 
(ALM, PLM, 
AVM, PVM) 
Pmec-4::KillerRed (20ng/μl) 3.8 mW/mm2 530-560 nm. 30 min. 
 
5 Mechanosensory 
(ALM, PLM, 
AVM, PVM) 
Pmec-4::KillerRed (20ng/μl) 
(anterior or posterior 
illumination) 
5.8 mW/mm
2 
 543-593 
nm. 
30 min. 
5 Mechanosensory 
(ALM, PLM, 
AVM, PVM) 
Pmec-4::KillerRed (20ng/μl) 
(axon or soma illumination) 
52 mW/mm
2 
 543-593 
nm. 
1h  
6 Muscle 
(mitochondria) 
Pmyo-3::mito-tdKillerRed 
(20ng/μl) 
46mW/mm
2
 542-582 
nm. 
 
5 min. 
6 Muscle (plasma 
membrane) 
Pmyo-3::myr-tdKillerRed 
(20ng/μl) 
46mW/mm
2
 542-582 
nm. 
 
5 min. 
7 Acetylcholine miniSOG 
CZ14527  Punc-17(beta)- 
tomm-20-
N'55AA::miniSOG(juEx3790) 
(Qi et al., 2012) 
0.57mW/mm2 
 
461-489 30 min. 
7 Acetylcholine Punc-17::myr-tdKillerRed 
(20ng/μl) 
0.57mW/mm2 
 
542-582 
nm. 
 
30 min. 
7 Acetylcholine miniSOG 
CZ14527  Punc-17(beta)- 
tomm-20-
N'55AA::miniSOG(juEx3790) 
(Qi et al., 2012) 
0.57mW/mm2 
 
542-582 
nm. 
 
30 min. 
7 Acetylcholine Punc-17::myr-tdKillerRed 
(20ng/μl) 
0.57mW/mm2 
 
461-489 30 min. 
7  
Mechanosensory 
(ALM, PLM, 
AVM, PVM) 
 
Pmec-4::KillerRed (20ng/μl) 0.57mW/mm2 
 
 
 
460-500 nm 20 min. 
7 Mechanosensory 
(ALM, PLM, 
AVM, PVM) 
Pmec-4::KillerRed (20ng/μl) 0.82mW/mm2 
 
426 -446 nm 
 
20 min. 
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  3.4 Discussion and implications of findings 
 
As demonstrated by the present study (and reviewed in chapter 1), neurons are particularly sensitive 
to ROS.  The generation of ROS is a normal byproduct of mitochondrial respiration, and specific 
cellular mechanisms of detoxification are in place to protect cells from damage.  In the present 
study ROS were generated cell-specifically in subsets of neurons using the phototoxic molecule 
KillerRed.  The result of this ROS generation was rapid and irreversible neuronal cell death.  As an 
optogenetic tool in C. elegans KillerRed has two main applications.  The first is as an optogentic 
method of neuronal ablation; such methods are essential to determine the function of a cell or group 
of cells.  Indeed, until now the simplest method of determining the function of a neuron has been to 
ablate it with a laser and observe the resulting defect.  Although used with great effect in C. 
elegans, this approach carries the intrinsic limitation imposed by the single-cell surgery procedure, 
which enormously limits the efficiency when a larger number of cells must be eliminated 
simultaneously.  The second application is as a method of subcellular ROS generation to study the 
effect of ROS accumulation in neurons.  ROS accumulation and oxidative damage have been linked 
to many neurodegenerative diseases, and an increase in ROS has been shown to induce axonal 
degeneration (reviewed in chapter 1).  The present study demonstrates that the activation of 
KillerRed in specific regions of the axon is sufficient to induce localized axonal degeneration.  
Although ROS accumulation has been identified as a key risk factor for axonal degeneration, the 
precise mechanism by which ROS induce axonal degeneration is not known.  Therefore, the 
application of this tool as a method of inducing ROS generation in neurons provides a way to study 
the mechanisms of ROS-induced neurodegeneration in vivo.  Chapter 4 examines the mechanisms 
of protection against ROS-induced neurodegeneration, using KillerRed to induce ROS production.  
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  3.5 Statement of contribution 
 
I performed the experiments presented in Figure 1g, h, i, k, l, Figure 3c, Figure 4e-g.  In addition, I 
contributed substantially to the design and planning of experiments and in the writing of the 
manuscript.  The strategy of using KillerRed to damage neurons was initially developed as an 
approach for the study of axonal regeneration and degeneration.  In this context, this paper 
represents a novel method of inducing neurodegeneration in vivo to identify and study the molecular 
mechanisms involved.  
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Chapter 4:  
Discovery of molecular mechanisms regulating  
neuronal degeneration induced by ROS 
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  4.1 Introduction 
 
The study presented in chapter 3 demonstrated that the optogenetic tool KillerRed is able to 
specifically and rapidly induce neurodegeneration in several classes of C. elegans neurons, via the 
generation of ROS in response to specific light illumination.  Neurons are particularly susceptible to 
ROS, and as such oxidative damage has been linked to many neurodegenerative diseases including 
Alzheimer’s and Parkinson’s diseases, ALS and MS (Uttara et al., 2009).  Mitochondria have been 
identified as the primary source of cellular ROS, and mitochondrial dysfunction is a common 
pathology in many neurodegenerative disorders (Lin and Beal, 2006).  However, the molecular 
mechanisms that link ROS accumulation to neurodegeneration remain mostly unknown.   
 
In the study presented in this chapter, KillerRed is used as a tool to discover the cellular and 
molecular mechanisms of neurodegeneration induced by ROS in the C. elegans mechanosensory 
neurons.  First, ROS is shown to induce neuronal death through a necrotic mechanism rather than 
apoptosis.  Second, KillerRed activation in different neuronal regions (such as the axon, cell body, 
or specific regions within the axon) is demonstrated to differentially induce neurodegeneration, 
suggesting that specific regions within a neuron have diverse sensitivities to ROS.  Finally, the 
axonal guidance molecule UNC-6/Netrin is identified as a novel axonal protective molecule against 
ROS-induced neurodegeneration.  
 
Together these data further characterize ROS-induced neuronal cell death and serve to demonstrate 
that KillerRed can be used as a tool to discover novel mechanisms of neuronal protection against 
such degeneration.  This work is part of an ongoing international collaboration with the laboratory 
of Prof. Hang Lu, at the Georgia Institute of Technology, Atlanta, and is being prepared for 
submission in early 2015.
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  4.2 Results 
 
KillerRed induces necrosis in neurons 
KillerRed can efficiently kill a variety of neurons in C. elegans, including sensory neurons, 
interneurons, and motor neurons (section 3.2).  This inducible neuronal ablation approach is strictly 
cell-autonomous and highly specific.  Furthermore KillerRed-induced neuronal damage is 
independent of the canonical apoptosis pathway, given that animals lacking the CED-3 caspase 
have a rate of neuronal death upon illumination that is indistinguishable from that of wild-type 
animals (section 3.2).  These results combined with the swollen and vacuolated appearance of the 
cell bodies in ablated neurons, led to the hypothesis that KillerRed-generated ROS trigger a necrotic 
cell death pathway.  In C. elegans, neurodegeneration that proceeds through necrotic cell death has 
been shown to require the calpain proteases CLP-1 and TRA-3 (Syntichaki et al., 2002).  To 
conclusively determine that a necrotic pathway mediates KillerRed-induced neuronal death, we 
tested the effect of KillerRed irradiation in animals lacking either the CLP-1 or TRA-3 calpain 
proteases.  A transgenic C. elegans strain expressing cytosolic monomeric KillerRed, as well as 
GFP, specifically in the six mechanosensory neurons using the promoter of the gene mec-4 (Pmec-
4::KR; Pmec-4::GFP), was crossed with individual mutants in either clp-1 or tra-3.  In wild-type 
animals KillerRed activation caused robust cell death in the ALM and PLM neurons, whereas AVM 
and PVM were largely refractory to KillerRed-induced damage (Fig 4.1; section 3.2).  A strong 
suppression of KillerRed-induced cell death was observed in both the ALM and PLM neurons of 
clp-1 and tra-3 mutants (Fig 4.1).  The requirement of CLP-1 and TRA-3 for efficient KillerRed-
induced neuronal death strongly supports the hypothesis that ROS-induced neurodegeneration 
proceeds through a necrotic cell death mechanism. 
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Figure 4.1.  KillerRed-induced ROS triggers a necrotic mechanism in mechanosensory neurons. 
Wild-type, clp-1(tm0858), and tra-3(e1107) animals expressing KillerRed in the mechanosensory 
neurons ALM and PLM were observed 24hr following a 30min illumination with green light 
(530-560nm).  clp-1(tm0858) and tra-3(e1107) mutants show a significant reduction in cell death.  n> 
98 neurons.  ***= P-value<0.001.
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  ROS activation in specific axonal regions is sufficient to induce neuronal ablation 
Selective illumination of the cell soma or axon of ALM neurons expressing KillerRed is sufficient 
to induce cell death (section 3.2).  To determine if individual axonal regions display selective 
vulnerability to ROS-induced damage this illumination was further restricted to three regions within 
the axon of ALM: a proximal region close to the soma, a region in the middle of the axon posterior 
to the synaptic branch, and a distal region at the synaptic branch point (Fig 4.2a).  Remarkably, 
illumination of the proximal or distal region was sufficient to induce cell death in ALM, whereas 
illumination of the middle region of the ALM axon was unable to kill the neuron (Fig 4.2c).  To 
further examine the spatial requirement of selective illumination of the distal region of the axon, 
illumination was restricted even further to three regions surrounding the synaptic branch of ALM: 
one posterior to the branch site, one at the branch site, and one anterior to the branch site (Fig 4.2b).  
Illumination of the branch point of ALM or the region posterior to it was sufficient to induce cell 
death, whereas illuminating the region anterior to the synaptic branch was unable to induce cell 
death (Fig 4.2d).  Taken together these results suggest that specific regions within individual 
neurons exhibit a selective vulnerability to KillerRed-induced ROS damage.  Strikingly, this 
damage is not proportional to the distance from the cell body.  In both selective illumination 
paradigms there were regions that were unable to induce cell death after illumination which were 
closer to the soma than those capable of inducing cell death.  This raises the possibility that distinct 
subcellular compartments, comprising different distributions of organelles and molecules, are able 
to provide either increased protection or sensitivity to ROS, in a region-specific manner. 
 
UNC-6/Netrin protects against KR induced neurodegeneration 
The ventral mechanosensory neurons AVM and PVM are resistant to KillerRed-induced damage 
(section 3.2).  The increased resistance to ROS-induced damage of these neurons may be mediated 
by extrinsic or intrinsic factors.  Animals lacking UNC-6/Netrin or SLT-1/Slit have anteriorly 
misrouted AVM and PVM axons that fail to initiate growth towards the ventral nerve cord (Hao et 
al., 2001).  To determine if the local environment surrounding AVM and PVM mediates this 
protection, we tested the effect of KillerRed illumination in mutants where guidance of the AVM 
and PVM axon was disrupted was tested (Fig 4.3a).  KillerRed irradiation in populations of animals 
lacking UNC-6 resulted in a strong increase in cell death in the AVM neuron (Fig 4.3b).  
Conversely, populations of animals lacking SLT-1 were no more sensitive to KillerRed illumination 
than wild-type controls (Fig 4.3b).  Both unc-6 and slt-1 mutants have a similar penetrance of 
misrouted AVM neurons (Hao et al., 2001; Hedgecock et al., 1990).  Thus, these data clearly 
indicate an effect of UNC-6 in protecting the AVM axon from ROS-induced damage; however they 
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Figure 4.2.  Subcellular ROS activation triggers cell death in the ALM neurons.  a, ALM 
neurons expressing KillerRed were illuminated with green light (543-593nm) using a selective 
illumination system in three axonal regions: proximal, middle, and distal.  b, illumination was 
reduced to three regions surrounding the synaptic branch of ALM: anterior to, posterior to, and at 
the synaptic branch point.  c, phenotype of the ALM neuron 24hr following a 1hr illumination of the 
regions shown in a.  Illumination of distal and proximal regions of the ALM axon were sufficient to 
induce cell death.  n> 6 neurons.  d, phenotype of the ALM neuron 24hr after a 1hr illumination of 
the regions shown in b.  Illumination of the synaptic branch or a region posterior to the synaptic 
branch was sufficient to induce cell death.  n> 17 neurons.
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  also reveal that this effect is not due to the simple aberrant trajectory of the axon but rather to 
another mechanism.  
 
UNC-6/Netrin acts via UNC-40/DCC and SAX-3/Robo independently of SLT-1/Slit 
In C. elegans the attractive guidance cue UNC-6 is expressed in ventral regions and acts through its 
receptor UNC-40 to attract the AVM axon to the ventral nerve cord (Chan et al., 1996; Wadsworth 
et al., 1996).  In parallel, the repulsive guidance cue SLT-1, expressed in dorsal regions, acts 
through its receptor SAX-3 to repel the AVM axon towards the ventral nerve cord (Hao et al., 
2001).  To determine the mechanism of UNC-6 protection we performed KillerRed illumination in 
animals lacking either UNC-40 or SAX-3.  As in unc-6 mutants, unc-40 mutants had a strong 
increase in the incidence of AVM cell death following illumination (Fig 4.3b).  Animals lacking the 
repulsive guidance molecule SLT-1 showed no change in their sensitivity to ROS-induced damage.  
However, in sax-3 mutants we observed a strong increase in AVM cell death following illumination 
of KillerRed (Fig 4.3b).  These data suggest that UNC-6 acts through its receptor UNC-40 to 
mediate neuronal protection against ROS and that this pathway may involve a SLT-1-independent 
role for the receptor SAX-3.  A full genetic analysis of these pathways is needed to confirm this 
hypothesis. 
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Figure 4.3.  UNC-6 protects against KillerRed-induced cell death in the AVM neuron.  
a, Schematic examples of normally routed (top) and mis-routed (bottom) AVM axons.  b, cell death 
was scored in the AVM neuron 24hr after a 30min illumination with green light (530-560nm) in 
wild-type and mutant animals lacking molecules required for the correct guidance of the AVM axon.  
A significant increase in AVM cell death was observed in unc-6(ev400), sax-3(ky123), and unc-
40(e1430) mutants.  n> 17 neurons.  **= P-value < 0.01, ***= P-value<0.001.
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  4.3 Discussion and implications of findings 
 
The present study together with that presented in chapter 3 demonstrates that KillerRed can be used 
as an optogenetic method of inducing both axonal and neuronal degeneration.  This method is 
suitable for use in both forward and reverse genetic approaches to discover the mechanisms that 
regulate axonal and neuronal degeneration induced by ROS.  As demonstrated in chapter 3, most 
neuronal classes tested displayed a differential sensitivity to KillerRed-induced death.  Selective 
vulnerability is a common theme in neurodegenerative disorders, whereby specific populations of 
neurons degenerate while others are spared in response to the same stimulus (Mattson and Magnus, 
2006).  In this manner, neurons refractory to KillerRed activation provide an excellent model in 
which to study the mechanisms underlying this selective vulnerability.  The present study 
demonstrates that not only are individual neurons differentially sensitive to ROS, but that regions 
within the same neuron exhibit differential sensitivity.  Synaptic regions of the ALM axon were 
more sensitive to KillerRed activation than non-synaptic regions.  It is not clear from these data if 
the synapse is more sensitive to ROS, or if the distribution and/or function of organelles, such as 
mitochondria, within these regions are different.   
 
This study also identified UNC-6/Netrin as a protective factor against KillerRed-induced ROS.  
Loss of UNC-6/Netrin resulted in a dramatic increase in the rate of neuronal cell death following 
KillerRed activation in the AVM neuron (a neuron normally resistant to KillerRed-induced 
damage).  Loss of the UNC-6/Netrin receptor, UNC-40/DCC, also increased the rate of KillerRed-
induced neuronal degeneration.  However, SAX-3/Robo, the receptor for the repulsive guidance cue 
SLT-1/Slit, protected against neurodegeneration independently of its canonical ligand.  A full 
genetic analysis is needed to determine if these molecules function in the same pathway to protect 
neurons from ROS-induced degeneration.  One potential mechanism of neuronal protection is 
through the regulation of mitochondria.  SAX-3 has been demonstrated to function independently of 
SLT-1 in regulating the localization, morphology, and function of mitochondria in C. elegans 
muscle (Han et al., 2012).  It is possible that, together or in parallel with the UNC-6/UNC-40 
pathway, SAX-3 has a similar function in neurons.  In addition to its role in guidance, Netrin-DCC 
signalling has been demonstrated to function as a cellular dependence signal in the nervous system 
(Furne et al., 2008; Llambi et al., 2001).  In this context DCC amplifies caspase-mediated apoptosis 
in the absence of its ligand Netrin.  There is no known role for SAX-3/Robo in this system and it is 
not known if the increased neuronal cell death observed in unc-6, unc-40, and sax-3 mutants, occurs 
via a necrotic or an apoptotic mechanism.   
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  Taken together the data presented in this chapter provide strong evidence that KillerRed can be used 
to study the molecular mechanisms of ROS-induced axonal and neuronal degeneration.  
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  4.4 Materials and methods 
 
Strains and molecular biology 
Nematodes were cultured using standard methods.  All experiments were performed at 20°C.  The 
Pmec-4::KillerRed construct was as used in chapter 3.  
 
KillerRed activation and imaging 
Animals were immobilized on NGM agar plates using tetramisole hydrochloride (0.03%), and 
irradiated using a Leica MZ10F fluorescence dissecting microscope with an EtDsRed filter (green 
light 530-560 nm) with an 80X magnification (intensity 3.8mW/mm2).  24 hr after irradiation 
animals were mounted on 4% agar pads, and epifluorescence was used to visualize animals either 
with a Zeiss Axioimager Z1 or with a Zeiss Axioimager A1 microscope.  A Photometrics camera, 
Cool snap HQ2, was used for image acquisition, and Metamorph software was used for image 
analysis.  The selective illumination using the LCD projector system is as described in Stirman et 
al. (2011).  GFP fluorescence was used to image the cells and define the location of the soma and 
axon.  A green filter (543-593 nm) was used to activate KillerRed in regions of interest selected 
after imaging.  Typical power intensities were 2-3 mW/mm2.  In all experiments performed using 
this system illumination time was 1 hr.  The length of the axonal processes that were selectively 
illuminated was 80µm in all cases.  Extensive degeneration was defined as damage that extended 
beyond 10% of the illuminated length along the axon.   
 
Statistical analyses 
Statistical analyses were performed using Primer of Biostatistics 3.01.  The error of proportions was 
used to estimate variation within a single population.  The Student’s t-test was used in all cases.
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  4.5 Statement of contribution 
 
I performed the experiments presented in Figure 4.1 and Figure 4.3.  Together with the principal 
advisor Dr. Massimo Hilliard, I significantly contributed to this project in designing and planning 
experiments, which are ongoing in collaboration with the lab of Prof. Hang Lu at the Georgia 
Institute of Technology, Atlanta. 
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Chapter 5:  
Discovery of molecular mechanisms of  
axonal fusion following regeneration 
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  5.1 Introduction 
 
Chapters 3 and 4 outlined an approach to study axonal degeneration in response to axonal injury in 
the form of ROS induced by KillerRed.  A complementary response to axonal degeneration after 
injury is that of axonal regeneration (as reviewed in chapter 1).  The C. elegans mechanosensory 
neuron PLM is capable of robust axonal regeneration following laser axotomy (Wu et al., 2007).  
Following formation of a growth cone and axon extension during regeneration, a proportion of 
regrowing PLM axons reconnect with their separated distal fragment and undergo a membrane 
fusion event.  This protects the distal fragment from degeneration and restores both membrane and 
cytoplasmic continuity in a process known as axonal fusion (reviewed in chapter 1).  This process is 
highly specific, supporting the notion that there are molecular mechanisms in place that mediate the 
recognition of the distal axonal fragment by the regrowing proximal fragment. 
 
The study presented in this chapter, identifies a molecular pathway that acts as a ‘save-me’ signal 
on the distal axonal fragment and signals via receptors on the regrowing proximal axon to mediate 
recognition and axonal fusion.  This signalling pathway utilizes components of the apoptotic 
recognition and engulfment pathway and is activated by both laser axotomy and genetically induced 
axonal damage.   
 
This work is an international collaboration with the laboratory of Ding Xue (University of 
Colorado), and is currently in revision at the peer-reviewed journal Nature.  A copy of the reviewed 
manuscript is presented as section 5.2 of this thesis. 
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  5.2 Axonal fusion during regeneration requires conserved components of the apoptotic 
pathway 
 
Neumann, B., Coakley, S., Giordano-Santini, R., Linton, C., Zhang, Y., Yang, H., Xue, D. and 
Hilliard, M.A. (2014) Axonal fusion during regeneration requires conserved components of the 
apoptotic pathway. In revision at Nature. 
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  Complete, functional regeneration after nervous system injury requires transected axons to 
reconnect with their original target tissue; however, how this occurs remains poorly 
understood.  Axonal fusion, a spontaneous regenerative mechanism identified in several 
different species, provides an efficient means of achieving target reconnection as a regrowing 
axon is able to contact and fuse with its own separated axon fragment, thereby re-establishing 
the original axonal tract.  Here we report a molecular characterization of this process in 
Caenorhabditis elegans, identifying phosphatidylserine (PS) and the PS receptor (PSR-1) as 
critical components for successful axonal fusion.  PSR-1 functions cell-autonomously in the 
regrowing neuron and requires both its PS-binding and catalytic domains.  Interestingly, 
instead of acting in the CED-2, CED-5, CED-12 phagocytosis pathway, PSR-1 functions in a 
parallel phagocytic pathway that is mediated by the transthyretin protein TTR-52, and 
includes CED-1, CED-7, NRF-5 and CED-6.  We show that TTR-52 binds to PS exposed on 
the injured axon and that its function is sufficient to restore fusion several hours following 
injury.  Thus, conserved components of the apoptotic cell clearance machinery play an 
unexpected role in mediating reconnection between axon fragments during regeneration of 
the nervous system.  We propose that PS functions in this context as a ‘save me’ signal for the 
distal fragment.   
 
Axonal regeneration occurs with the primary objective of re-establishing lost connection between 
an injured neuron and its original target tissue.  Although extensive knowledge has been gained 
regarding the intrinsic and extrinsic modifiers of axonal regeneration, insight into how a neuron can 
rejoin with its target is lacking.  A highly efficient means to re-establish the connection between an 
injured neuron and its target tissue occurs spontaneously in several invertebrate species 1-7.  This 
process, referred to as axonal fusion, occurs when the proximal axon that is still attached to the cell 
body regrows towards, then reconnects and fuses with its separated distal fragment.  Previously, we 
and others have demonstrated that axonal fusion in the C. elegans mechanosensory neurons is a 
highly specific process that occurs through a fusion event, with both membrane and cytoplasmic 
continuity re-established 4,7.  However, the genetic components that mediate axonal fusion remain 
largely unknown, with the nematode-specific fusogen, Epithelial Fusion Failure 1 (EFF-1), the only 
protein previously found to be involved 4. 
 We speculated that the process of axonal fusion might resemble that of apoptosis 7, in which the 
dying cell exposes “eat-me” signals that mediate recognition and engulfment by surrounding 
phagocytes.  During apoptosis, plasma membrane phospholipid asymmetry is lost, causing 
phosphatidylserine (PS), which is normally restricted to the cytoplasmic leaflet, to be externalized 
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  to the exoplasmic leaflet where it enables recognition by phagocytic cells 8-11.  Two partially 
redundant genetic pathways regulate the removal of apoptotic cells in C. elegans, the first of which 
is mediated by the PS receptor (PSR-1/jmjd6) that directly binds exposed PS 12,13 and signals 
through the CED-2/CrkII, CED-5/Dock180, CED-12/ELMO and CED-10/RAC1 GTPase 
engulfment pathway 14-17.  In the second pathway, the secreted transthyretin-like protein TTR-52 
bridges exposed PS on apoptotic cells with the CED-1/LRP1/MEGF10 transmembrane receptor 18,19 
in a pathway that includes the LPS-binding/lipid transfer protein NRF-5, CED-7/ABC transporter, 
and CED-6/GULP 20-23.  These two pathways converge with the downstream activation of CED-
10/RAC1 GTPase that triggers the cytoskeleton rearrangements necessary for engulfment 24.  Here 
we demonstrate that the function of these conserved apoptotic molecules is largely shared between 
apoptotic cell clearance and axon fusion during regeneration, and suggest that in the context of 
axonal regeneration PS functions as a ‘save me’ signal for the distal axonal fragment.   
 To study axonal fusion we expressed GFP specifically within the six mechanosensory neurons 
of C. elegans (Fig. 1a) and performed laser axotomy of the posterior-lateral mechanosensory (PLM) 
neurons (Fig. 1b).  To specifically study the process of axonal fusion, we analyzed only severed 
axons that re-established a connection between the regrowing proximal axon and its separated distal 
fragment.  Maintenance, or inhibition of degeneration, was used as evidence of a successful fusion 
event, while degeneration of the distal axonal fragment after reconnection had occurred was 
considered proof of an unsuccessful fusion event.  In wild-type (WT) animals, 80% of axons that 
displayed proximal-distal reconnection underwent successful fusion (Fig. 1b, d).  EFF-1, which 
mediates a vast array of fusion events in C. elegans 25, was previously found to function in axonal 
fusion 4.  Animals lacking EFF-1 displayed a strong suppression in the rate of axonal fusion (Fig. 1d 
and Extended Data Fig. 1a, b).  To determine where EFF-1 is required for this process, we 
expressed a GFP-tagged version of the protein specifically in the mechanosensory neurons.  This 
transgene could rescue the defect in eff-1 null animals, indicating that EFF-1 functions cell-
autonomously for the PLM axonal fusion event (Extended Data Fig. 1b).  Following axotomy, we 
consistently observed EFF-1::GFP on the membrane of regrowing axons (Extended Data Fig. 1c, 
d).  These findings suggest that EFF-1, localized on the membrane of the regenerative growth cone, 
mediates fusion once contact is re-established with the separated axon fragment.   
 While axon fusion is conserved across a range of species 1-7, EFF-1 is not 26.  In order to identify 
other conserved components required for this process, we undertook a candidate screen on 
molecules previously identified to mediate biological events that we predicted might share 
components with, or employ similar means as, axonal fusion.  From this screen we identified PSR-1 
as an important component for axonal fusion.  Two different loss-of-function deletions in psr-1 
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bar 25 μm.  d, Quantification of successful fusion events in WT (black bar) and mutant animals 
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  caused a strong suppression in the rate of axonal fusion (Fig. 1c, d).  Furthermore, double mutants 
between eff-1 and psr-1 displayed only a slight decrease (not statistically significant) in the rate of 
fusion compared with either of the single mutants (Fig. 1d), which may suggest that psr-1 and eff-1 
function in the same genetic pathway.   
 PSR-1 contains two highly conserved functional domains, an extracellular lysine-rich PS 
binding domain, and an intracellular JmjC domain that contains various biochemical activities, 
including histone arginine demethylase activity, lysyl hydroxylase activity, and single-stranded 
RNA binding activity 27-29.  To investigate the requirement of these domains for axonal fusion, we 
expressed different versions of the full-length psr-1 cDNA selectively in the mechanosensory 
neurons of psr-1 mutant animals.  Expression of WT cDNA restored the rate of axonal fusion to 
that of WT animals (Fig. 1e), demonstrating that PSR-1 functions cell-autonomously within PLM.  
Next we expressed psr-1 cDNA carrying mutations that disrupt its PS binding activity 
(K308/K315E; unpublished data) and found that it could no longer rescue the defect (Fig. 1e).  
Similarly, expression of psr-1 cDNA carrying mutations at the Fe(II) binding site (H192A/D194A) 
in the JmjC domain failed to rescue the defect caused by loss of PSR-1 (Fig. 1e).  Mutation of either 
of these two sites did not alter the stability of the PSR-1 protein (unpublished data).  Thus, these 
results demonstrate that PSR-1 requires both the extracellular PS binding domain and the 
intracellular JmjC domain for its cell-autonomous activity in axonal fusion. 
 PSR-1 functions in a known pathway that includes CED-2/CrkII, CED-5/Dock180, CED-
12/ELMO and CED-10/RAC1 to mediate the recognition and removal of apoptotic cells (Fig. 2a).  
Interestingly, we found that components of this cell corpse engulfment pathway are not required for 
axonal fusion, as animals carrying mutations in ced-2, ced-5, or ced-10 presented a normal rate of 
axonal fusion (Fig. 2b).  Next, we analyzed components of a second, partly redundant cell corpse 
engulfment pathway, which includes the secreted transthyretin PS binding protein TTR-
52/Transthyretin and the lipid binding protein NRF-5, the membrane transporter CED-7/ABC 
transporter, the transmembrane receptor CED-1/LRP1/MEGF10, and the intracellular adapter CED-
6/GULP.  Remarkably, we found that TTR-52 was critical for successful axonal fusion (Fig. 2c and 
Extended Data Fig. 2a).  As TTR-52 is normally expressed in and secreted from the intestinal cells 
to bind PS exposed by apoptotic cells during embryogenesis 19, we asked whether this was also true 
during axonal fusion.  As shown in Figure 2c, WT TTR-52 tagged with mCherry and expressed 
from a heat-shock promoter completely rescued the axonal fusion defect when induced either at the 
time of injury, or up to 6 hours after injury.  Heat-shock treatment applied to WT animals, or to ttr-
52 mutants not carrying the rescue transgene, did not significantly increase the rate of axonal fusion 
and did not cause a consistent alteration in the length of regrowth (Extended Data Fig. 2b-f).  Thus, 
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Figure 2.  PSR-1 functions in the TTR-52-mediated cell corpse engulfment pathway during 
axonal fusion.  a, Recognition and engulfment of apoptotic cells is mediated by two partially 
redundant parallel pathways.  b, Animals deficient in ced-2, ced-5 or ced-10 have normal axonal 
fusion as in WT animals; n ≥ 19.  c, TTR-52 is required for successful axonal fusion.  Expression of 
TTR-52::mCherry fully rescues the defect when induced from a heat-shock (HS) promoter immedi-
ately after axotomy (0 hr) and up to 6 hr post-axotomy; n ≥ 20.  d, Loss-of-function mutations in 
genes acting in the TTR-52 pathway reduce axonal fusion, and the axonal fusion defect in the 
double mutants with psr-1 is not worse than that of single mutants; n ≥ 18.  Error bars indicate 
standard error of proportion; p-values: * < 0.05; ** < 0.01; *** < 0.001 compared to WT unless 
marked on graph.
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  these findings identify the secreted TTR-52 molecule as functioning after the time of injury to 
regulate fusion between two axon segments.   
 We utilized the same transgene to visualize the localization of TTR-52 following axotomy of 
PLM.  Animals were analyzed prior to surgery, and at several time points after surgery.  Although 
we could not detect any localization of TTR-52::mCherry to PLM in WT animals, ttr-52 mutant 
animals lacking TTR-52 expression from the endogenous ttr-52 gene displayed low levels of TTR-
52::mCherry binding to PLM (Fig. 3a, b and data not shown).  These findings indicate that the 
endogenous protein was competing with the tagged version for a low level of PS on the surface of 
the PLM axon.  Interestingly, in non-operated adult animals, we observed TTR-52::mCherry 
localizing to the axon of PLM, as well as that of other neurons; this also occurred in larval stages 
(Extended Data Fig. 3a-c), but to a lesser extent, suggesting that the neuron’s ability to maintain 
membrane PS asymmetry may decline with aging.  Following axotomy, TTR-52 rapidly localized 
to both the distal and proximal axon segments, with slightly stronger binding observed on the distal 
axon fragment (Fig. 3a).  This localization pattern was maintained for approximately one hour, and 
then gradually declined to background levels over the four hours following transection (Fig. 3a, b).  
These results suggest that TTR-52 likely functions as a secreted molecule that binds to the injured 
neuron and plays an important role in mediating the fusion of the proximal axon with its separated 
distal counterpart.  To further confirm that TTR-52 was indeed binding to PS in this context, we 
analyzed the localization of a secreted version of Annexin V (sAnxV), a highly efficient and 
specific calcium-dependent PS binding protein 30-32.  PS was rapidly exposed on the proximal and 
distal PLM axon segments following axotomy, with sAnxV binding to both segments within 15 
minutes after transection (Fig. 3c).  Binding of sAnxV::mRFP was strongest to the distal segment, 
but similar patterns were observed for both the proximal and distal axons, with rapid localization 
that peaked one hour after axotomy, before gradually declining (Fig. 3d).  This localization pattern 
of sAnxV::mRFP closely matches that of TTR-52::mCherry (Fig. 3a, b), supporting a model in 
which PS is exposed on the axonal membrane after injury and acts as a ‘save-me’ signal for TTR-52 
to bind and initiate the reconnection and fusion needed to repair the damage.  Similar to the 
localization of TTR-52, we observed more sAnxV binding to the intact PLM axon in adult animals 
than in larvae (Extended Data Fig. 3d,e), again implying that the preservation of membrane PS 
asymmetry diminishes with age.  
 Next we examined the involvement of the other components of the TTR-52 engulfment pathway 
in axonal fusion.  Inactivation of ced-1 caused a modest deficit in axonal fusion that was not 
significantly different from that in WT animals (Fig. 2d and Extended Data Table 1).  However, 
animals lacking NRF-5, CED-7 or CED-6 displayed strong reductions in axonal fusion (Fig. 2d and 
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Figure 3.  TTR-52 binds to PS exposed on the PLM axon after axotomy.  a, Localization of 
TTR-52::mCherry in ttr-52(sm211); smIs119; zdIs5 animals to the PLM axon prior to axotomy and 
at several time points after transection.  Overlay image is shown for the 60 min time-point; the filled 
arrowheads point to the site of axotomy; asterisk highlights accumulation of TTR-52::mCherry at 
the site of injury; scale bar 10 μm.  b, Quantification of the relative fluorescence levels of TTR-
52::mCherry on the PLM distal and proximal axons after axotomy compared to mock surgery 
conditions.  The intensity of TTR-52::mCherry on the distal axon is not significantly different from 
that on the proximal axon.  c, Localization of the PS sensor, sAnxV::mRFP, to the axon of PLM 
prior to axotomy and at several time points after transection.  Overlay image is shown for the 60 
min time-point; filled arrowhead points to the site of axotomy; asterisks highlight accumulation of 
sAnxV::mRFP at the site of injury; scale bar 10 μm.  d, Quantification of the relative fluorescence 
levels of sAnxV::mRFP on the PLM distal and proximal axon segments after axotomy compared to 
mock surgery conditions.  The intensity of sAnxV::mRFP on the distal axon is significantly stronger 
than that on the proximal axon at the 15 min and 60 min time-points (p < 0.05).  Error bars indicate 
standard error; n ≥ 21; p-values: ** < 0.01; *** < 0.001 compared to mock surgery.
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  Extended Data Table 1).  Furthermore, we found that double mutants between psr-1 and either ttr-
52, ced-1, nrf-5, ced-7, or ced-6 were no worse than single mutant animals (Fig. 2d and Extended 
Data Table 1), indicating that unlike apoptosis, PSR-1 functions within this TTR-52-mediated 
pathway during axonal fusion.  Similarly to that seen in psr-1; eff-1 double mutant animals (Fig. 
1d), ttr-52; eff-1 double mutants did not display a significantly worse defect in axonal fusion than 
single mutant animals (Extended Data Fig. 2g), indicating that both psr-1 and ttr-52 might function 
in the same genetic pathway as eff-1.   
 To determine if the loss of any of the genes analyzed caused a reduction in the regenerative 
potential of PLM, we calculated the average length of regrowth 24 hours post-axotomy.  Mutations 
in psr-1, ttr-52, ced-7, ced-10 and nrf-5 all caused significantly less regrowth in PLM (Extended 
Data Table 2 and Extended Data Fig. 4a, b).  However, although a reduction in regrowth was 
evident for several genes, we found no correlation between the average length of regrowth and the 
rate of axonal fusion.  For instance, ced-10 mutants displayed reduced regrowth, but presented no 
defect in axonal fusion, while animals that lacked eff-1 had the strongest defect in axonal fusion, but 
their regenerative growth was not different from that of WT animals.  Moreover, neither the actual 
percentage of animals displaying regrowth nor the proportion of axons able to extend across the 
damage site was consistently different from that observed for WT animals (Extended Data Fig. 4c-
e).   
 Previously we demonstrated that, although axonal fusion is a highly specific process, instances 
of aspecific fusion do occur when a second axon in close proximity to PLM is also severed 7.  The 
axon of each bilateral PLN neuron fasciculates for much of its length with the axon of the PLM 
neuron of the ipsilateral side 33 (Fig. 4a).  When both fasciculating axons are simultaneously 
transected, approximately 10% of animals undergo aspecific fusion between these two neurons 7.  
Interestingly, we observed a similar phenotype in animals deficient in the unc-70/β-spectrin gene, a 
genetic background in which the axons of C. elegans motor neurons lose the capacity to resist 
physical strain and undergo spontaneous cycles of breaks followed by regeneration 34.  We observed 
that unc-70 mutant animals display aberrant morphology of the PLM axons comprising breaks, loop 
structures, and branching (Extended Data Fig. 5a, b), as well as spontaneous fusion between PLM 
and PLN neurons visualized through transfer of the GFP fluorophore (Fig. 4b, c).  These fusion 
events were found to be dependent on the EFF-1 fusogen and required DLK-1, a mitogen-activated 
triple kinase molecule essential for regeneration 35,36 (Extended Data Fig. 5c).  Remarkably, we 
found that loss of psr-1, ttr-52 or ced-6 caused a strong reduction in the rate of unc-70-induced 
PLM-PLN fusion (Fig. 4c).  Similar to our findings for axotomy-induced PLM axonal fusion, loss 
of ced-1 led to a modest decrease in the incidence of PLM-PLN fusion (Fig. 4c).  Thus, these data 
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200; p-values: *** < 0.001 compared to unc-70(s1502).  d, Proposed schematic model for the role 
of the apoptotic pathway in axonal fusion.  Following injury, PS is exposed on the distal fragment 
where it acts as a ‘save me’ signal, and this might be enhanced by CED-7-facilitated secretion of PS 
coated vesicles.  PS is recognized by secreted extracellular bridging protein TTR-52 and by the 
transmembrane PSR-1 on the proximal axon.  The ‘save me’ signal is transduced intracellularly via 
CED-6, and possibly also through activation of the TTR-52-interacting CED-1 receptor.   
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  indicate that the conserved molecules involved in apoptotic cell clearance are also required for 
axonal fusion in a genetic model of neuronal injury. 
 We have identified a genetic pathway that controls axonal fusion during regeneration.  Our data 
uncover a new role for PSR-1, a molecule previously shown to function as a phagocytic receptor 
12,13, a histone arginine demethylase 27, a lysyl hydroxylase 29, a single-stranded RNA binding 
protein 28, and now a protein required for efficient axonal regeneration.  Our study demonstrates 
that both the extracellular PS-binding domain and the intracellular JmjC domain of PSR-1 are 
important for its function in mediating axonal fusion after neuronal injuries; our results indicate that 
PS is exposed on the surface of severed axonal segments, which may underlie the action of PS-
binding PSR-1 and the PS-binding extracellular protein TTR-52 by facilitating the interaction and 
fusion of two separated axonal segments.  Thus, exposure of PS might function as a ‘save me’ 
signal for the severed distal axon.  PSR-1 acts in the same pathway as TTR-52 as well as its partners 
in cell corpse clearance, CED-7, NRF-5, and CED-6 to promote this axonal healing process (Fig. 
4d).  Taken together, our results support a model in which recognition of the separated axon 
fragment by the regrowing axon is achieved by a change in lipid membrane composition and 
mediated by the same molecules involved in recognizing an apoptotic cell, with EFF-1 acting as the 
fusogen necessary to restore membrane and cytoplasmic continuity.  
 Finally, stemming from observations of axonal fusion in invertebrates, highly innovative 
preclinical paradigms are currently being applied to mammalian systems, in which severed nerve 
fibers are surgically reconnected in ‘end-to-end’ or ‘end-to-side’ operations 37,38.  Together with the 
application of high molecular weight substances (such as polyethylene glycol) to the injury site that 
facilitate fusion and restoration of the original nerve tract 39-41, these procedures have generated 
highly encouraging results with respect to functional recovery.  Our results strongly support such 
efforts, providing a detailed characterization of the molecular mechanisms mediating axonal fusion, 
knowledge that will facilitate such strategies. 
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  Methods Summary 
Standard techniques were used for C. elegans maintenance, crosses and other genetic manipulations 
42 and all experiments were performed at 22ºC unless otherwise stated.  Axotomies were performed 
as previously described 7, using a MicroPoint Laser System Basic Unit, with axons severed 
approximately 50 µm anterior to the PLM cell body in L4 or 1 day old adult (for localization of 
TTR-52 and sAnxV) animals.  Animals were analyzed 24 hr post-axotomy for regrowth, 
reconnection, and fusion, and re-analyzed at 48 and/or 72 hr post-axotomy for clarification of 
successful fusion.  Axons were deemed to be reconnected when the proximal and distal axons were 
visually connected and within the same focal plane.  Axonal regrowth was quantified by measuring 
the length of the longest neurite beyond the cut site 24 hr post-axotomy; neurons that underwent 
axonal fusion were excluded from these quantifications.  To study the localization of EFF-1::GFP, 
animals were imaged 16 to 20 hr post-axotomy LSM 510 META confocal microscope and Zen 
2009 software.  To score for the presence of EFF-1::GFP on the membrane of regrowing axons, 
fluorescence profiles of line scans at different sections of the regrowing axon tip were generated 
and EFF-1::GFP was scored as localizing to the membrane if the peak of green intensity (EFF-
1::GFP) and the peak of red intensity (cytoplasmic mCherry) were not overlapping.  Localization 
experiments for TTR-52::mCherry and sAnxV::mRFP were performed in 1 day old adult animals 
(unless stated otherwise) with a LSM 510 META confocal microscope and Zen 2008 software.  
Expression of TTR-52::mCherry and sAnxV::mRFP were induced 4 hr prior to analysis with 
incubation at 30°C for 30 min.  Changes in fluorescence intensity were calculated with line scans.  
To control for changes in focus and intensity, mCherry/mRFP expression was normalized to GFP 
for each image and recorded relative to pre-axotomy levels. 
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  5.3 Supplementary data 
 
Methods 
Strains and genetics 
Standard techniques were used for C. elegans maintenance, crosses and other genetic manipulations 
1.  All experiments were performed at 22ºC unless otherwise stated and all strains were grown on 
OP50 bacteria, except for animals carrying the unc-70(s1502) mutation, which were grown on 
HB101 bacteria.  The following mutations were used: LGI: ced-1(e1735), dlk-1(ju476); LGII: eff-
1(ok1021), eff-1(hy21); LGIII: ced-6(n1813), ced-7(n2690), ttr-52(sm211), ttr-52(tm2078); LGIV: 
ced-2(e1752), ced-5(n1812), ced-10(n3246), psr-1(ok714), psr-1(tm469); LGV: nrf-5(sa513), unc-
70(s1502).  Transgenes used were: smIs119[Phsp16-2::ttr-52::mCherry] 2, smIs95[Phsp16-
2::sAnxV::mRFP] 3, oxIs95[Ppdi-2::unc-70; Pmyo2::GFP] 4, vdEx575[Pmec-4::psr-1(c) (10 
ng/µl), Podr-1::dsRED (30 ng/µl)], vdEx663[Pmec-4::EFF-1::GFP (5 ng/µl); Pmec-4::mCherry 
(20 ng/µl); Podr-1::DsRed (60 ng/µl)], vdEx705[Pmec-4::psr-1(c)(H192A/D194A) (10 ng/µl); 
Podr-1::dsRed (30 ng/µl)], vdEx709[Pmec-4::psr-1(c)(K308E K315E) (10 ng/µl); Podr-1::dsRed 
(30 ng/µl)], zdIs5[Pmec-4::GFP].  
 
Molecular biology 
Standard molecular biology techniques were used.  The Pmec-4::psr-1(c) plasmid was generated 
through insertion of a Bam HI/Age I psr-1 cDNA amplicon in a plasmid between the mec-4 
promoter and the unc-54 3`UTR.  The following primers were used: fwd primer 5’-
tcagtgggatccatgtcattagggcgagatag-3’; rev primer 5’-tcagtgaccggtttaaactagcgagttctgaaaat-3’.  
QuikChange mutagenesis (Agilent Technologies, Santa Clara, CA) was used to introduce the 
K308/K315E and H192A/D194A mutations, with the Pmec-4::psr-1(c) plasmid used as the 
template. 
To build the Pmec-4::EFF-1::GFP plasmid, eff-1 genomic DNA was amplified (fwd primer 5’-
ctagctagcatggaaccgccgtttgagtg-3’; rev primer 5’-gaaccggtttaatgtactggctactgctatag-3`) and cloned 
into pSM-mCherry plasmid using Nhe I and Age I restriction enzymes, to obtain pSM EFF-
1::mCherry.  The mec-4 promoter was then cloned from plasmid pSM Pmec-4::EFF-1 into pSM 
EFF-1::mCherry using Sal I and Sph I restriction enzymes, to obtain Pmec-4::EFF-1::mCherry.  
Finally, an Age I/Apa I fragment from plasmid pCP.179 5, a kind gift of Shai Shaham, was cloned 
into Pmec-4::EFF-1::mCherry to obtain Pmec-4::EFF-1::GFP. 
 
Laser axotomy and microscopy 
Animals were immobilized in 0.05% tetramisole hydrochloride on 4% agar pads.  Axotomies were 
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  performed as previously described 6, using a MicroPoint Laser System Basic Unit attached to a 
Zeiss Axio Imager A1 (Objective EC Plan-Neofluar 100x/1.30 Oil M27).  Axons were severed in 
L4 or 1 day old adult (for localization of TTR-52 and sAnxV) animals approximately 50 µm 
anterior to the PLM cell body, visualized on a Zeiss Axio Imager Z1 microscope equipped with a 
Photometrics camera (Cool Snap HQ2; Tucson, AZ) and analyzed with MetaMorph software 
(Molecular Devices, Sunnyvale, CA).  Animals were analyzed 24 hr post-axotomy for regrowth, 
reconnection, and fusion, and re-analyzed at 48 and/or 72 hr post-axotomy for clarification of 
successful fusion.  Axons were deemed to be reconnected when the proximal and distal axons were 
visually connected and within the same focal plane.  Axonal regrowth was quantified by measuring 
the length of the longest neurite beyond the cut site 24 hr post-axotomy; neurons that underwent 
axonal fusion were excluded from these quantifications.   
 
Visualization of EFF-1 
To study the localization of EFF-1::GFP in regrowing axons, laser axotomies were performed in 
animals carrying the vdEx663 transgene, and individual animals were then imaged 16 to 20 hr later 
using a LSM 510 META confocal microscope and Zen 2009 software.  Green fluorescence was 
visualized with a 488 nm laser (10% power, with a gain of 750-760 and 8x averaging) and red 
fluorescence was visualized with a 543 nm laser (15% power, with a gain of 538 and 8x averaging).  
Image analysis was performed using ImageJ 1.47p.  To score for the presence of EFF-1::GFP on the 
membrane of regrowing axons, fluorescence profiles of line scans at different sections of the 
regrowing axon tip were obtained using the “Plot Profile” tool in ImageJ.  EFF-1::GFP was scored 
as localizing to the membrane if the peak of green intensity (EFF-1::GFP) and the peak of red 
intensity (cytoplasmic mCherry) were not overlapping.  
 
Visualization of TTR-52 and Annexin V 
Localization experiments for TTR-52::mCherry and sAnxV::mRFP were performed in 1 day old 
adult animals (unless stated otherwise) with a LSM 510 META confocal microscope and Zen 2008 
software.  Green fluorescence was analyzed with a 488 nm laser (2.4% power, with a gain of 601 
and 8x averaging) and red fluorescence with a 543 nm laser (100% power, with a gain of 1012 and 
8x averaging).  Expression of TTR-52::mCherry and sAnxV::mRFP were induced 4 hr prior to 
analysis with incubation at 30°C for 30 min.  Changes in fluorescence intensity were calculated 
with line scans performed using ImageJ 1.46r software.  To avoid bright fluorescence associated 
with collateral laser damage, line scans were recorded ~5 µm from the damage on both the proximal 
and distal axon segments for a length of ~15 µm.  Line scans were recorded along the same region 
for the 488 nm and 543 nm channels for each image.  To control for changes in focus and intensity, 
86 | Chapter 5
	  mCherry/mRFP expression was normalized to GFP for each image and recorded relative to pre-
axotomy levels.  For calculation of fluorescence of intact axons, line scans were performed along 
the PLM axon for the initial ~100 µm anterior from the cell body.  Background fluorescence was 
calculated with similar line scans performed ~1 µm dorsally from the PLM axon.  Ratios were 
calculated against GFP fluorescence levels. 
 
Statistical analysis 
Statistical analysis was performed using Primer of Biostatistics 3.01, GraphPad Prism and 
Microsoft Excel.  Error of proportions was used to assess variation across a single population, two-
way comparison was performed using the t-test, and ANOVA for more than two groups. 
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Extended Data Figure 1.  EFF-1 functions cell-autonomously in PLM and localizes to the 
membrane of growth cones.  a, Defective axonal fusion in an eff-1(ok1021); zdIs5(Pmec-4::GFP) 
animal 48 hr post-axotomy.  Arrowhead shows cut site; scale bar 25 µm.  b, Quantification of axonal 
fusion in eff-1(ok1021) animals compared to WT and cell-autonomous rescue with expression of 
Pmec-4::EFF-1::GFP (one of three transgenic lines tested presenting similar phenotype).  Error 
bars represent standard error of proportion; n values within each bar; p-values: ** < 0.01, *** < 
0.001.  c, EFF-1 localizes to the membrane of regrowing axons.  Maximum projections of Z-stack 
confocal images of a regrowing axon with EFF-1::GFP present all along the regrowing proximal 
fragment (arrowheads) and at the membrane of the regrowing tip (box and right panel).  The distal 
fragment is indicated by arrows; scale bars 10 µm.  d, Fluorescence profiles from the line scans 
shown in the top right panel of panel c illustrate the presence of EFF-1::GFP on the membrane.  A 
total of 12 growth cones (from 8 animals) were analyzed and 8 of these (67%) displayed 
membrane-localized EFF-1.
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Extended Data Figure 2.  Analysis of regeneration after heat-shock treatment and in ttr-52; 
eff-1 double mutant animals.  a, Unsuccessful fusion in a ttr-52(sm211) animal.  Regrowth has 
extended from the cut site (arrowhead) and contacted the distal fragment (bracketed region), but 
degeneration of the distal fragment is proceeding.  Scale bar 25 µm.  b, Rate of successful axonal 
fusion in ttr-52(sm211) animals without or with heat-shock (HS) treatment.  c, The average length of 
regrowth in ttr-52(sm211) animals given heat-shock after axotomy compared to those without HS 
treatment.  d, Quantification of regrowth in ttr-52(sm211); Phsp::TTR-52::mCherry animals without 
HS treatment compared to those that received HS immediately after axotomy (0 hr), or at 6 or 9 hr 
post-axotomy.  e, Comparison of the average length of regrowth in zdIs5 animals without HS or 
with HS given at different times after axotomy.  f, Successful axonal fusion in zdIs5 animals without 
HS compared to animals given HS at different times post-axotomy.  g, Successful axonal fusion in 
ttr-52(sm211) and eff-1(ok1021) single mutants compared to ttr-52; eff-1 double mutant animals.  
Error bars represent standard error of proportion (b, f, g) and standard error (c, d, e); n values within 
each bar; p-values: * < 0.05, ** < 0.01, *** < 0.001 compared to WT or no HS (black bars), unless 
marked otherwise on graph; ns = not significant.
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Extended Data Figure 3.  PS is exposed on intact axons in adult animals.  a, Localization of 
TTR-52::mCherry in a representative larval stage 4 (L4, left panels) and a 1 day old adult (1 DOA, 
right panels).  b, Localization of TTR-52::mCherry to additional neuronal processes.  The open 
arrowhead and closed arrowheads highlight additional processes that, based on their morphology, 
are the primary and secondary branches of the PVD dendrite.  c, Relative level of TTR-52::mCherry 
binding to the intact PLM axon in animals of advancing ages compared to background fluorescence 
levels.  d, Representative images demonstrating relative fluorescence levels of sAnxV::mRFP in a 
L4 (left panels) and 1 DOA animal (right panels).  e, Relative binding of sAnxV::mRFP to the intact 
PLM axon in L4 and 1-5 DOA animals.  Data shown are mRFP fluorescence relative to GFP levels 
expressed from the Pmec-4::GFP transgene.  Scale bars 25 µm; n values within each bar; a.u. = 
arbitrary units; error bars indicate standard error; p-values: * < 0.05, ** < 0.01, *** < 0.001 com-
pared to background unless marked otherwise.
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Extended Data Fig. 4.  Quantification of regeneration.  a, Analysis of regrowth, reconnection (as 
a proportion of regrowing axons), and fusion (as a proportion of reconnecting axons) in WT and 
single mutant animals.  b, Average length of regeneration over time in single mutant animals.  c, The 
percentage of animals at different times post-axotomy that displayed regrowth.  d, Average number 
of axons that regrew across the cut site at different time points after axotomy.  e, Quantification of 
the percentage of axons presenting a growth cone at different stages of regeneration.  n ≥ 15; 
p-values: * < 0.05, ** < 0.01, *** < 0.001.
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Extended Data Figure 5.  Mutation of unc-70 causes axonal defects and PLM-PLN fusion 
events that are dependent on eff-1 and dlk-1.  a, In the absence of UNC-70 the PLM mechanosen-
sory neuron develops abnormal morphology with breaks, loop structures (arrowhead) and branch-
ing.  Scale bar 25 µm.  b, Quantification of the penetrance of abnormal loop structures as well as 
axonal breakages; n > 200.  c, Spontaneous fusion between PLM and PLN is completely abolished 
in dlk-1 mutants and shows a large reduction in an eff-1 mutant background.  n > 100; p-value: *** 
< 0.001. 
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Extended Data	  Table 1. Quantification of regeneration in single and double mutant 
animals. 	  
Genotype Number of animals Regrowth Reconnection Fusion 
zdIs5 242 240 (99%) 90 (38%) 75 (83%) 
ced-1(e1735); zdIs5 58 58 (100%) 39 (67%) 26 (67%) 
ced-2(e1752); zdIs5 48 48 (100%) 19 (40%) 15 (79%) 
ced-5(n1812); zdIs5 33 33 (100%) 21 (63%) 17 (81%) 
ced-6(n1813); zdIs5 44 44 (100%) 29 (66%) 9 (31%) 
ced-7(n2690); zdIs5 71 64 (90%) 17 (27%) 8 (47%) 
ced-10(n3246); zdIs5 54 53 (98%) 24 (45%) 20 (83%) 
eff-1(ok1021); zdIs5 60 59 (98%) 49 (83%) 8 (16%) 
nrf-5(sa513); zdIs5 121 120 (99%) 26 (22%) 12 (46%) 
psr-1(ok714); zdIs5 52 51 (98%) 23 (45%) 9 (39%) 
psr-1(tm469); zdIs5 42 41 (98%) 19 (46%) 8 (42%) 
ttr-52(sm211); zdIs5 128 127 (99%) 35 (28%) 19 (54%) 
ttr-52(tm2078); zdIs5 63 62 (98%) 20 (32%) 8 (40%) 
psr-1(ok714); ced-1(e1735); zdIs5 38 38 (100%) 22 (58%) 7 (32%) 
psr-1(ok714); ced-6(n1813); zdIs5 37 37 (100%) 18 (49%) 5 (28%) 
psr-1(ok714); ced-7(n2690); zdIs5 97 95 (98%) 34 (36%) 17 (50%) 
psr-1(ok714); eff-1(ok1021); zdIs5 40 40 (100%) 34 (85%) 2 (6%) 
psr-1(ok714); nrf-5(sa513); zdIs5 79 76 (96%) 21 (28%) 9 (43%) 
psr-1(ok714); ttr-52(sm211); zdIs5 55 54 (98%) 21 (39%) 11 (52%) 
ttr-52(sm211); eff-1(ok1021); zdIs5 56 56 (100%) 43 (77%) 3 (7%) 	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Extended Data Table 2. Average length of regrowth in single and double mutant 
animals. 	  
Genotype Number of animals Length of regrowth (μm) p value to zdIs5 
zdIs5 165 77.49 
 ced-1(e1735); zdIs5 32 71.73 0.43 
ced-2(e1752); zdIs5 33 89.43 0.11 
ced-5(n1812); zdIs5 16 95.74 0.077 
ced-6(n1813); zdIs5 35 66.92 0.15 
ced-7(n2690); zdIs5 56 42.96 8.06E-09 
ced-10(n3246); zdIs5 33 46.72 2.64E-05 
eff-1(ok1021); zdIs5 51 82.07 0.56 
nrf-5(sa513); zdIs5 108 57.79 1.89E-05 
psr-1(ok714); zdIs5 42 51.51 9.35E-05 
psr-1(tm469); zdIs5 33 42.40 1.13E-06 
ttr-52(sm211); zdIs5 108 61.74 0.0046 
ttr-52(tm2078); zdIs5 54 62.18 0.012 
psr-1(ok714); ced-1(e1735); zdIs5 31 51.91 0.0013 
psr-1(ok714); ced-6(n1813); zdIs5 32 59.83 0.016 
psr-1(ok714); ced-7(n2690); zdIs5 78 38.01 1.73E-14 
psr-1(ok714); eff-1(ok1021); zdIs5 38 88.63 0.10 
psr-1(ok714); nrf-5(sa513); zdIs5 67 49.49 1.56E-07 
psr-1(ok714); ttr-52(sm211); zdIs5 43 69.50 0.23 
ttr-52(sm211); eff-1(ok1021); zdIs5 56 74.29 0.59 	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  5.4 Discussion and implications of findings 
 
The identification of a molecular pathway that regulates axonal fusion during regeneration is of 
extreme significance, due to its potential medical implications as well as its importance to the 
advance of knowledge in a rapidly expanding field of research.  Until now the only molecule known 
to regulate axonal fusion during regeneration was the fusogen EFF-1 (Ghosh-Roy et al., 2010).  
Axonal fusion represents a rapid and efficient means of restoring neuronal circuitry following 
damage.  The present study identifies a ‘save-me’ signal in the form of the phospholipid PS, which 
is triggered on the distal fragment of the injured axon in response to damage.  This signal is 
analogous to the so called ‘eat-me’ signal presented by apoptotic cells which is recognized by 
engulfing cells and mediates recognition and engulfment.  Previous studies have speculated that 
such a mechanism may exist (Neumann et al., 2011), but until now none has been identified.  
 
Components of the apoptotic recognition and engulfment pathway have been demonstrated to have 
a role in clearance of the distal axonal fragment following axonal damage in Drosophila and C. 
elegans (reviewed in chapter 1).  Awasaki and colleagues (2006) proposed that axonal degeneration 
resulted in the exposure of an ‘eat-me’ signal analogous to that of an apoptotic cell.  It is not clear if 
the same signal mediates degeneration of the distal fragment and recognition of the distal fragment 
during fusion, although this is an attractive hypothesis.  Such a mechanism would provide a 
competition between degenerative and regenerative mechanisms to facilitate rapid axonal repair.  
 
Understanding the mechanisms of axonal fusion allows the possibility of interventions to facilitate 
axonal fusion during regeneration.  The present study demonstrates that genetically induced axonal 
damage is sufficient to activate similar mechanisms that induce neuronal fusion between two 
closely associated damaged neurons.  The cell-cell fusion between two neurons shares several 
features of axonal fusion during regeneration, and the present study demonstrates that it can be used 
as a model of the latter.  The study presented in chapter 6 uses this new paradigm to perform a 
forward genetic screen for axonal fusion mutants.  
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  5.5 Statement of contribution 
 
I performed the experiments presented in Figure 4 and Extended Data Figure 5, as well as did part 
of the experiments presented in Figure 1d-e, Figure 2b-d, Extended Table 1 and 2.  The application 
of a genetic method of axonal injury to the study of axonal fusion is at the core of my contribution 
to this project.  The paradigm of cell-cell fusion utilized in section 5.2 represents a novel means to 
study axonal fusion during regeneration, and this is the experimental platform on which the work 
presented in Chapter 6 of this thesis is based.   
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Chapter 6:  
Designing a genetic method of axonal injury  
and isolation of novel mutants 
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  6.1 Introduction 
 
A key feature of multicellular organisms is the ability to integrate individual cells into tissue.  This 
requires each cell to precisely maintain its structure and resist the mechanical stresses imposed by 
an active organism moving freely in its environment.  A striking example of this resistance can be 
seen in the nervous system across phyla.  A neuron is often several orders of magnitude longer than 
it is wide and yet is able to withstand significant strain during development and movement of the 
organism.  In neurons this strain resistance is provided, at least in part, by the membrane 
cytoskeleton component β-spectrin (Hammarlund et al., 2007), which has been shown to be part of 
a periodic network with actin, ankyrin, and adducin (Xu et al., 2013).  C. elegans motor neurons 
lacking UNC-70 develop normally but are unable to resist the mechanical stress of movement, 
which generates axon breaks followed by axonal regeneration (Hammarlund et al., 2007).  This 
sensitivity to mechanical strain has been exploited in reverse genetic approaches to discover genes 
essential for regeneration in motor neurons (Hammarlund et al., 2009; Nix et al., 2014).   
 
The study presented in chapter 5 demonstrated that in the absence of UNC-70 the PLM 
mechanosensory neuron undergoes a cell-cell fusion event with the nearby PLN neuron.  This 
fusion event shares similarities with axonal fusion during regeneration in that it requires both axonal 
regeneration and fusion machinery to occur.  The study presented in this chapter reveals that the 
loss of UNC-70 in PLM neurons causes a loss of axonal integrity defined by the formation of 
axonal breaks, and induces further remodelling visible as axonal loops.  Detailed characterization of 
these defects reveals that axonal remodelling is independent of regeneration, but dependent on 
axonal fusion machinery.  A genetic model of axonal injury enables the use of forward genetic 
screening as a method of identifying novel mutants with neuronal fusion defects.  In the present 
study, we isolated and characterized three novel mutants, vd30, vd33, and vd35, which modify unc-
70-induced axonal breaks, remodelling, and neuronal fusion. 
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  6.2 Results 
 
Axonal defects in unc-70/β-spectrin mutants arise in mature neurons  
The study presented in chapter 5 demonstrated that the damage induced by loss of UNC-70 is 
sufficient to induce severe defects in the architecture of the axonal process, and in some cases 
stimulate neuronal fusion between the mechanosensory neuron PLM and its fasciculating neuron 
PLN.  In GABAergic motor neurons UNC-70 is dispensable for normal axon outgrowth, but these 
neurons acquire movement-induced axonal defects as the animals age (Hammarlund et al., 2007).  
To test if the acquisition of the defects we observe in the PLM neuron of unc-70 mutants is similar 
to those in GABAergic motor neurons, we studied PLM morphology at different stages of the 
animal’s development (Fig 6.1d-e), using the same transgenic strain expressing GFP under the 
Pmec-4 promoter as described in chapter 5.  At the first larval stage (L1), the vast majority of PLM 
neurons displayed a completely wild-type morphology (Fig 6.1d-e) and only very rarely presented 
axonal defects.  This indicates that, as occurs in GABAergic motor neurons, the mechanosensory 
neurons PLM left and right also present an overall wild-type morphology, with the axon normally 
guided to its target during development.  Axonal breaks and loops (referred to as axonal 
remodelling) were observed in the fourth larval stage (L4) and in adult animals (Fig 6.1a-b,d-e), 
indicating that these morphological abnormalities arise in PLM axons after development is 
completed; thus, these defects are not likely to be the consequence of a defect in initial axonal 
outgrowth or guidance.  In agreement with this interpretation, the appearance of the PLN neuron via 
neuronal fusion appeared only in adult stages (Fig 6.1c,f).  At both L1 and L4 stages we never 
observed PLM-PLN fusion in unc-70 mutants (Fig 6.1c,f), whereas in adults ~15% of animals 
lacking UNC-70 underwent a neuronal fusion event between PLM and PLN (Fig 6.1f).  These data 
support a model in which unc-70-induced axonal injury in the PLM mechanosensory neuron 
proceeds in a similar manner to that observed in GABAergic motor neurons, with defects appearing 
after the development of the axonal process is completed.  
 
Axonal remodelling does not require regeneration machinery 
We never observed the formation of a distinct growth cone in the PLM neurons in response to unc-
70-induced damage, which is instead a key characteristic of injured GABAergic motor neurons 
(Hammarlund et al., 2007).  The MAP3K DLK-1 is required for axonal regeneration to proceed in 
multiple C. elegans neurons, including PLM (Ghosh-Roy et al., 2010; Hammarlund et al., 2009).  
The study presented in chapter 5 demonstrated that blocking regeneration using a dlk-1 mutant is 
sufficient to prevent the neuronal fusion observed in unc-70 mutants; these data strongly indicate 
that axonal regeneration is a major underlying mechanism in unc-70-induced neuronal fusion.  The 
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Figure 6.1.  Axonal defects in unc-70/β-spectrin mutants arise in mature neurons.  a, an adult 
unc-70(s1502) mutant with GFP visible in the mechanosensory neuron PLM.  Anterior is left and 
ventral is down in this and all images.  Axonal breakage occurs in a proportion of PLM neurons 
(boxed area and arrow in a’).  Scale bar in a = 50 μm; in a’= 25 μm.  b, axonal remodelling visible 
as an axonal loop (boxed area and arrow b’) in the PLM axon of an unc-70(s1502) mutant animal.  
c, an unc-70(s1502) animal after a spontaneous fusion event between PLM (closed arrow in c’) and 
PLN (open arrow in c’), leading to the appearance of GFP in the cell body (open arrow in c’) and 
axon of PLN (open arrowhead in c’).  d, frequency of axonal breakages in L1, L4 and adult unc-
70(s1502) mutant animals.  e, frequency of axonal loops in L1, L4, and adult unc-70(s1502) mutant 
animals.  f, frequency of neuronal fusion in L1, L4, and adult unc-70(s1502) mutant animals.  
n> 102.
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  appearance of axonal remodelling phenotypes could in principle be caused by an axonal 
regeneration process or be independent of any regenerative event.  To discriminate between these 
possibilities we tested the penetrance of this phenotype in animals lacking DLK-1.  In dlk-1; unc-70 
double mutants axonal breakages and remodelling phenotypes appeared with the same frequency as 
in control animals (unc-70 single mutants), demonstrating that DLK-1, and thus regeneration, is not 
required for their formation (Fig 6.2a-b).  Taken together these data support a model in which, 
differently from PLM-PLN cell-cell fusion, the formation of axonal breakages and remodelling 
caused by lack of UNC-70 is not dependent of axonal regeneration.   
 
We next decided to investigate if loss of the neuronal fusion machinery had any effect on the 
formation of axonal breaks and remodelling.  We analysed animals lacking the fusogen EFF-1, 
which is required cell autonomously to regulate various fusion events in the PLM neuron (chapter 
5).  eff-1; unc-70 double mutants presented with a large increase in the frequency of axonal breaks 
and remodelling (Fig 6.2c-d).  EFF-1, a known fusogen and membrane-remodelling molecule, has 
been shown to inhibit the formation of dendritic branches in the C. elegans mechanosensory neuron 
PVD (Oren-Suissa et al., 2010).  One hypothesis is that EFF-1 may inhibit axonal remodelling and 
facilitate neuronal fusion in the PLM neuron.  To test if EFF-1 overexpression was sufficient to 
increase neuronal fusion, wild-type EFF-1 was overexpressed in the PLM neuron and its effect 
observed in unc-70 mutants.  Overexpressing wild-type EFF-1 in the mechanosensory neuron PLM 
in unc-70 mutants had no effect on the frequency of axonal breaks and remodelling (Fig 6.2e-f); 
however, these animals presented with a very large increase in the frequency of neuronal fusion 
between PLM-PLN (Fig 6.2g).  Together these data indicate that regeneration is required for 
neuronal fusion but not axon remodelling, and that EFF-1 acts by facilitating neuronal fusion 
between PLM-PLN and may also non-cell-autonomously inhibit membrane remodelling. 
Alternatively, this phenotype may be non-cell-autonomous and result of a developmental defect in 
the tissue surrounding the axon.  At this stage the exact cause of the axonal remodelling phenotype 
is unknown; it is unclear if these morphological changes are the result of a defect in axonal 
development or maintenance.   
 
Loss of UNC-70/β-spectrin causes multiple defects in PLN neurons 
The axon of each bilateral PLN neuron fasciculates for much of its length with the axon of the PLM 
neuron of the ipsilateral side (White et al., 1986).  To test if the PLN neuron develops similar 
axonal defects in the absence of UNC-70, mCherry was expressed in the PLN neuron using the lad-
2 promoter and its morphology observed.  In adult animals the axon of the PLN neuron developed 
defects similar to those observed in the PLM axon in unc-70 mutants (Fig 6.3a-b).  Interestingly, 
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Figure 6.2.  Axonal remodelling does not require regeneration.  a, quantification of rates of 
axonal breakages in unc-70 and unc-70; dlk-1 animals.  n>147.  b, quantification of rates of axon 
remodelling in unc-70 and unc-70; dlk-1 animals.  n>147.  c, quantification of rates of axonal 
breakages in unc-70 and unc-70; eff-1 mutants.  n> 117.  d, quantification of rates of axon 
remodelling in unc-70 and unc-70; eff-1 mutants.  n> 117.  e, quantification of rates of axonal 
breakages in unc-70 mutants overexpressing EFF-1 specifically in PLM using the Pmec-4 
promoter.  n> 79.  f, quantification of rates of axon remodelling in unc-70 mutants overexpressing 
EFF-1 specifically in PLM using the Pmec-4 promoter.  n> 79.  g, quantification of rates of 
neuronal fusion between PLM and PLN in unc-70 mutants overexpressing EFF-1 specifically in 
PLM using the Pmec-4 promoter.  n> 79.  **= P-value<0.01 and ***= P-value<0.001.
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Figure 6.3.  Loss of UNC-70/β-spectrin causes multiple defects in PLN neurons.  a, frequency 
of axonal breakages in the PLM and PLN neurons in adult unc-70(s1502) mutants.  b, frequency of 
axonal loops in the PLM and PLN neurons in adult unc-70(s1502) mutants.  n>35.
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  similar defects were also observed in the axon of the ALN neuron (Fig S6.1), which fasciculates for 
some of its length with the axon of the mechanosensory neuron ALM (White et al., 1986).  The 
ALM neuron displayed branching defects but breaks and axonal remodelling were rarely observed 
(Fig S6.1).  Consistent with the phenotypes observed in the PLM and PLN neurons, some cases of 
neuronal fusion between ALM-ALN were observed in unc-70 mutants (Fig S6.1).  These data 
support a model in which, following unc-70-induced damage, two closely associated neurons are 
able to undergo a regeneration-dependent neuronal fusion event.  
 
Dynamics of unc-70/β-spectrin induced neuronal fusion 
To investigate the temporal dynamics of unc-70-induced damage time-lapse imaging was 
performed.  As above, PLM-PLN fusion was detected by the appearance of the fluorophore GFP 
(expressed in PLM) diffusing into the PLN neuron.  We found that GFP appeared first in the 
process of PLN, where it transitioned from faint to bright (Fig 6.4a-i); the GFP signal became 
brighter in the PLN process over time, gradually appearing in regions more proximal to the PLN 
cell body, until eventually reaching the cell body itself (Fig 6.4d).  This result supports a model in 
which GFP first enters the PLN neuron at the site of PLM-PLN fusion, and then proceeds to diffuse 
in a retrograde fashion towards the PLN cell body.    
 
Forward genetic screen for mutants with defects in axonal maintenance and neuronal fusion 
Components of the apoptotic engulfment pathway, PSR-1, TTR-52, and CED-6, mediate PLM-PLN 
neuronal fusion in unc-70 mutants (chapter 5).  The fusogen EFF-1 mediates not only neuronal 
fusion in this model, but also modifies the formation of axonal breaks and membrane remodelling 
in unc-70 mutants.  These data suggest that molecules involved in membrane remodelling and 
neuronal fusion can present deficits in an unc-70 sensitized background.  To identify other 
molecules involved in the axonal breaks, loops, and neuronal fusion in an unbiased way, a pilot 
forward genetic screen was performed using ethyl methanosulfonate (EMS) in an unc-70 sensitized 
background.  From this screen we identified three novel mutants: vd30, vd33, and vd35 (Fig 6.5a-c).  
These mutants affected the phenotypes of axonal breakage, remodelling, and neuronal fusion to 
different extents.   
The mutant vd30 was the most severe, presenting highly penetrant axonal breaks, remodelling, and 
PLM-PLN fusion phenotypes.  Almost 50% of PLM axons in vd30; unc-70 mutants contained 
axonal breaks, and approximately 73% of PLM axons displayed some form of axonal looping (Fig 
6.5a-b).  Importantly, the frequency of PLM-PLN neuronal fusion was almost double that of the 
unc-70 mutant (Fig 6.5c).  vd33 mutants presented a large increase in axonal breaks and 
remodelling but no alteration to the frequency of neuronal fusion (Fig 6.5a-c).  This indicates that 
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Figure 6.4.  Dynamics of unc-70/β-spectrin-induced neuronal fusion.   a-i, time-lapse images of a 
neuronal fusion event occurring between the PLM and PLN neuron, in vivo, in the unc-70(s1502) 
mutant.  Filled arrowhead indicates the site of initial GFP transfer first visible at 0hr (a).  Open 
arrowhead indicates site of eventual PLN cell body appearance, which occurs after GFP is visible in 
the axonal process (b-i).  Scale bar = 50 μm.  
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Figure 6.5. Novel mutants with defects in axonal maintenance and neuronal fusion.  
a, frequency of axonal breakages in the PLM neuron of novel mutants vd30, vd33, and vd35 in an 
unc-70(s1502) mutant background, compared to unc-70(s1502) mutants.  b, frequency of axonal 
loops in the PLM neuron of novel mutants vd30, vd33, and vd35 in an unc-70(s1502) mutant 
background, compared to unc-70(s1502) mutants.  c, frequency of neuronal fusion between the 
PLM and PLN neurons of novel mutants vd30, vd33, and vd35 in an unc-70(s1502) mutant 
background, compared to unc-70(s1502) mutants.  n>83.
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  vd33 affects axonal maintenance but is dispensable for neuronal fusion.  The vd35 mutation 
increased both the penetrance of axonal breaks and remodelling in PLM (Fig 6.5a-b), but reduced 
the frequency of PLM-PLN neuronal fusion to less than half that of the background strain (Fig 
6.5c).  Therefore these three mutants support the notion that axonal maintenance, including 
breakage and remodelling, is a biological event that can be genetically separated from PLM-PLN 
neuronal fusion, and that these two processes are thus likely mediated by at least partially different 
molecular machinery.  
 
Novel mutant vd30 has severe defects in axonal maintenance and neuronal fusion  
vd30 impacts all aspects of unc-70-induced damage.  To test if the defects observed in vd30; unc-70 
mutants proceeded similarly to those in unc-70 single mutants, we analysed the developmental 
timing of these defects and their dependence on regeneration, as well as their real-time dynamics 
using time-lapse microscopy. The acquisition of defects over time in vd30; unc-70 double mutants 
was very similar to that of unc-70 mutants although the defects occurred more frequently (Fig 6.6a-
c).  Although vd30 increased the frequency, and in some cases the severity of these defects, they 
occurred at approximately the same developmental stage as in unc-70 animals.  The requirement of 
regeneration for the development of axonal defects in vd30; unc-70 double mutants was also tested 
by blocking regeneration in a dlk-1 mutant.  This experimental condition abolished PLM-PLN 
neuronal fusion in these animals (Fig 6.6d).  Therefore, neuronal fusion in vd30; unc-70 mutants 
also requires regeneration to proceed.  Finally, time-lapse microscopy was performed to visualize 
the dynamics of these defects and to compare them with those in unc-70 mutants.  GFP was first 
observed in the process of the PLN neuron, after which it diffused in a retrograde direction towards 
the soma of PLN (Fig 6.7a-f).  Although this occurred more frequently in vd30; unc-70 mutants, 
there were no obvious differences in the dynamics of this process compared tour observations in 
unc-70 mutants.  Interestingly, in some instances the PLN neuron became brighter than normally 
observed in unc-70 animals, suggesting that the fusion process in vd30 mutants may be more 
efficient (data not shown).  These results demonstrate that the development and acquisition of 
axonal defects in vd30; unc-70 mutants proceeds in the same manner as in unc-70 mutants, albeit at 
a higher frequency and possibly at a higher efficiency.    
 
vd30 is required for axonal fusion during regeneration 
A highly efficient method to repair an injured neuron occurs spontaneously in several invertebrate 
species (Bedi and Glanzman, 2001; Birse and Bittner, 1976; Deriemer et al., 1983; Ghosh-Roy et 
al., 2010; Hoy et al., 1967; Macagno et al., 1985; Neumann et al., 2011).  This process, referred to 
as axonal fusion, occurs when the proximal axon that is still attached to the cell body regrows 
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Figure 6.6.  Defects in vd30 mutants accumulate over time, and increase neuronal fusion in a 
regeneration-dependent fashion.  a, frequency of axonal breakages in L1, L4, and adult vd30; 
unc-70(s1502) mutant animals.  n> 267.  b,  frequency of axonal remodelling in L1, L4, and adult 
vd30; unc-70(s1502) mutant animals.  n> 267.  c, frequency of neuronal fusion in L1, L4, and adult 
vd30; unc-70(s1502) and dlk-1(ju476); unc-70(s1502) mutant animals.  n>147. 
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Figure 6.7.  Dynamics of neuronal fusion in vd30 novel mutant.  a-f, in vivo time-lapse images of 
a neuronal fusion event occurring between the PLM and PLN neuron in the novel mutant vd30; 
unc-70(s1502).  Filled arrowhead indicates the site of initial GFP transfer first visible at 0hr (a).  
Inset (a-f) is a view of the PLM cell body with the site of eventual PLN cell body appearance 
labelled (open arrowhead).  Scale bar = 50 μm.  
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  towards, then reconnects and fuses with its separated distal fragment.  Axonal fusion in the C. 
elegans mechanosensory neurons is a highly specific process that occurs through a fusion event, 
with both membrane and cytoplasmic continuity re-established (Ghosh-Roy et al., 2010; Neumann 
et al., 2011).  Axonal fusion is mediated by the fusogen EFF-1 (Ghosh-Roy et al., 2010) and 
requires the components of the apoptotic recognition and engulfment pathway including PSR-1, 
TTR-52, and downstream components of the TTR-52 pathway (chapter 5).  This molecular 
machinery is also required for neuronal fusion between PLM-PLN in unc-70 mutants (chapter 5).  
To test if vd30 also enhances axonal fusion during regeneration, laser axotomy was performed on 
the PLM axon in vd30 animals in a wild-type background.  To specifically study the process of 
axonal fusion, only severed axons that re-established a connection between the regrowing proximal 
axon and its separated distal fragment were analysed.  As previously described (Neumann et al., 
2011), successful fusion was considered as the maintenance, or inhibition of degeneration of the 
distal axonal fragment after reconnection; on the contrary, degeneration of the distal fragment 
following reconnection was considered as unsuccessful fusion.  In wild-type animals 78% of 
animals that displayed proximal-distal reconnection underwent successful fusion (Fig 6.8a,c).  vd30 
mutants showed a reduction in successful axonal fusion following reconnection with the distal 
fragment after regeneration (Fig 6.8b-c). Furthermore, the defect in axonal fusion was found to be 
specific for PLM, as axonal fusion was unaffected in the ALM neuron (Fig S6.2).  The 
mechanosensory neurons in vd30 animals displayed no morphological defects in a wild-type 
background, indicating that the defects in axonal maintenance are only present in the sensitized unc-
70 background (data not shown).   These findings demonstrate a role for vd30 in the regulation of 
axonal fusion during regeneration as well as PLM-PLN neuronal fusion in the unc-70 background.   
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Figure 6.8.  Axonal fusion during regeneration is reduced in vd30 mutants.  a, successful axonal 
fusion in a wild-type animal, 24hr post-axotomy.  Scale bar = 25 μm.  b, following regeneration and 
reconnection with the distal fragment, axonal fusion has failed to occur in a vd30 mutant animal and 
the distal fragment has proceeded to degenerate.  c, quantification of rates of regeneration, 
reconnection and axonal fusion in wild-type (zdIs5) and vd30 mutant animals.  n> 27.  
*= P-value<0.05, **= P-value<0.01.  Error bars indicate SEM.
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Supplementary Figure 6.1.  Axonal defects in ALM and ALN neuronal fusion.  a, ALM axons 
present with branched axonal processes.  Breaks and axonal looping as observed in PLM were 
rarely seen (data not shown).  b, on rare occasions fusion occurred between ALM and the ALN 
neuron resulting in GFP transfer into the cell body and axon of ALN (arrow).  Scale bar = 25μm. 
Supplementary Figure 6.2.  ALM regenerates normally in vd30 mutant animals.  Quantification 
of rates of regeneration, reconnection and axonal fusion in the ALM neuron in vd30 mutants in a 
zdIs5(Pmec-4::GFP) wild-type background compared to zdIs5 animals.  n> 15.   
6.3 Supplementary data
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  6.4 Discussion and implications of findings 
 
The lack of the membrane cytoskeletal protein UNC-70 induces defects in axonal integrity in C. 
elegans mechanosensory neurons, distinct from spontaneous axonal breakage and regeneration seen 
in motor neurons.  This damage induces axonal breakages without generating growth cones, as well 
as the formation of novel looped structures along the axonal process.  We defined axonal looping as 
remodeling based on the observation that this phenotype is independent of dlk-1, the key axonal 
regeneration gene, and is dependent on the fusogen/membrane-remodeling gene eff-1.  However, 
the exact nature of this phenotype is currently unknown and under investigation.  These axonal 
abnormalities are acquired over time and are not the result of axon outgrowth defects. As both the 
mechanosensory neurons and GABAergic neurons are capable of generating growth cones 
following laser-induced axonal damage (Wu et al., 2007; Yanik et al., 2004), it is likely that the 
differences seen here are caused by differences in the injury itself rather than the regenerative 
capacity of the neurons.  The mechanosensory neurons extend along the anterior-posterior axis of 
the animal, whereas the GABAergic motor neurons extend commissures across the ventral-dorsal 
axis (White et al., 1986).  The location of these processes, and their interactions with the 
surrounding tissue, may be the reason behind the observed difference.  It is possible that the axons 
of the GABAergic motor neurons, which extend circumferentially around the animal’s body, 
experience more tensile force than the mechanosensory neurons, which extend along the 
longitudinal axis of the animal.  As a consequence, the GABAergic motorneurons may suffer a 
more acute injury than the mechanosensory neurons.  Furthermore, during development of the 
animal the PLM axon becomes embedded in the surrounding hypodermis (Chalfie and Sulston, 
1981), which could possibly buffer some of the tensile force of the neuron.  These defects may arise 
during the growth of the animal following axon guidance and extension, and may be the result of 
strain caused by a mis-match in the rate of elongation of the animal’s body and the axonal process 
of PLM.  The PLM neuron has evolved to detect external mechanical force, and as such the nature 
of its surrounding tissue, in combination with intrinsic mechanisms, may act as an additional 
mechanism to protect the axon from damage.  
 
In addition to defects in the axons of mechanosensory neurons in animals lacking UNC-70, 
neuronal fusion events between the PLM mechanosensory neuron and the nearby neuron PLN were 
also observed as previously described in chapter 5.  In the present study this phenomenon has been 
characterized in real time, revealing the sequence of events that starts with rapid uptake of GFP into 
the axon of PLN before diffusion of the fluorophore in a retrograde manner toward the cell body.  
GABAergic motor neurons in unc-70 mutants have been shown to form spontaneous growth cones 
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  on intact regions of their axons, suggesting that mechanical stresses on the animal that are 
insufficient to transect the axon are able to induce growth cone formation (Nix et al., 2014).  It is 
possible that similar localized damage events occurring on both the PLM and PLN axons in regions 
of close apposition are sufficient to induce a regenerative event triggering neuronal fusion.  This is 
supported by the observation that the axons of PLN and PLM simultaneously acquire axonal breaks 
and remodelling.  Similar defects were also observed in the ALM and ALN neurons and some cases 
of ALM-ALN neuronal fusion.  Following transection of both the PLM and PLN axons with a UV-
laser, cell-cell fusion has been observed between the PLM and PLN neurons in small percentage of 
animals (Neumann et al., 2011).  An attractive hypothesis is that neuronal fusion is the result of a 
regenerative event triggered by Ca2+ influx as a consequence of unc-70-induced axonal injury.  The 
requirement of the DLK-1 MAP3K, essential for regeneration, supports this hypothesis.   
    
In addition to DLK-1, neuronal fusion between PLM and PLN requires the fusogen EFF-1, as well 
as components of the apoptotic machinery, PSR-1, TTR-52, and CED-6 (section 5.2).  The present 
study isolated three novel mutants that affect various aspects of unc-70-induced axonal damage as 
well as neuronal fusion.  Analysis of these mutants revealed individual differences that are of 
profound biological significance.  Comparison of these three mutants with animals lacking or 
overexpressing the fusogen EFF-1 suggests that axonal maintenance, including breakage and 
remodelling, are biological events that can be genetically separated from PLM-PLN neuronal 
fusion, and are thus likely mediated by at least partially different molecular machinery.  The genetic 
lesions of the three novel mutants are currently being determined by traditional single nucleotide 
polymorphism (SNP) mapping (Davis et al., 2005; Wicks et al., 2001) combined with whole 
genome sequencing (Zuryn et al., 2010).  The identification of these lesions will reveal the 
molecular elements and cellular mechanisms underpinning the different axonal phenotypes 
discovered, as well as the molecular basis of the cell-cell fusion. 
 
The maintenance of axonal integrity and structure is critical to the correct function and organization 
of the nervous system in any organism.  Defects in axonal integrity and structure, such as breaks, 
sprouting, branching, and varicosities, are associated with axonal degeneration and ageing 
phenotypes (Neumann and Hilliard, 2014; Pan et al., 2011; Tank et al., 2011; Toth et al., 2012).  
The complete set of genes required to maintain an axon for the lifetime of an animal and in response 
to injury remain unknown.  The present study demonstrates that using a sensitized C. elegans strain 
with defects in axonal maintenance, both forward and reverse genetic approaches can be used in 
order to discover the molecules that regulate axonal fusion following injury.  
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  6.5 Materials and methods 
 
Strains and molecular biology 
Nematodes were cultured under standard conditions (Brenner, 1974).  All experiments were 
performed at 22°C.  The wild-type strain N2 Bristol and the zdIs5[Pmec-4::GFP] and oxIs95[Ppdi-
2::unc-70] transgenes were used.  The zdIs5 and oxIs95 strains were a kind gift of Scott Clark and 
Erik Jorgensen, respectively.  Standard molecular biology techniques were used (Sambrook et al., 
1989).   
 
Isolation of mutants 
Animals of genotype unc-70(s1502); oxIs95; zdIs5 were mutagenized using 50 mM ethyl 
methanesulfonate (Sigma) for 4 hr.  The vd30, vd33 and vd35 mutations were isolated from a non-
clonal visual screen of approximately 25,000 F2 progeny.  
 
Laser axotomy   
Axotomies were performed as previously described (Neumann et al., 2011).  A MicroPoint Laser 
System Basic Unit, with axons severed approximately 50 µm anterior to the PLM or ALM cell body 
in L4 animals.  Animals were analysed 24 hr post-axotomy for regrowth, reconnection, and fusion, 
and re-analyzed at 48 and/or 72 hr post-axotomy for clarification of successful fusion.  Axons were 
deemed to be reconnected when the proximal and distal axons were visually connected and within 
the same focal plane with a 63x objective.   
 
Statistical analysis 
Statistical analyses were performed using Primer of Biostatistics 3.01 software.  Error of 
proportions was used to assess variation across a single population.  Two-way comparison was 
performed using the Students t-test. 
  
Microscopy 
Animals were immobilized in 0.05% tetramisole hydrochloride on 4% agar pads and visualized 
using Zeiss Axioimager Z1 and Zeiss Axioimager A1 microscopes.  Images were taken using a 
Photometrics camera (Cool Snap HQ2) and analysed with Metamorph software.  For time-lapse 
microscopy animals were immobilized in 0.05% tetramisole hydrochloride on 10% agar pads sealed 
with vaseline and visualized using a Zeiss Inverted Spinning Disk confocal microscope equipped 
with a Yokogawa W1 disk head and a Piezo z-drive.  Images were captured with a Hamamatsu 
Flash4.0 scientific CMOS camera using Slidebook 5.0 software. 
115 | Chapter 6
	  6.6 Statement of contribution 
 
I performed and significantly participated in the design and planning of all experiments.  This work 
represents the primary focus of my PhD thesis aimed at discovering the molecular mechanisms that 
regulate membrane fusion in neurons.  
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Chapter 7:  
Discussion
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  7.1 Overview  
 
Axonal injury can be induced by a wide variety of insults, which trigger active mechanisms of 
axonal degeneration and regeneration in their respective compartments (reviewed in chapter 1).  
Although a large body of work from multiple model systems has uncovered critical components of 
these pathways, a complete picture of the molecular mechanisms by which axons are destroyed or 
repaired following injury is still lacking.  The intersection of several technological advances has 
allowed these biological events to be studied and approached genetically in the nematode C. 
elegans.  The development of genetically encoded fluorescent molecules, UV- and femtosecond-
laser axotomy techniques, and the rise of next generation sequencing technology, have enabled the 
study of axonal degeneration and regeneration to be performed at single axon resolution, at the 
genomic scale.  
 
The goal of this thesis was to develop paradigms in which specific aspects of axonal degeneration 
and regeneration could be studied with both forward and reverse genetic approaches in C. elegans 
neurons, and to use them to discover molecules that regulate these processes.  The main findings of 
this work include: (i) identification of mutations in mec-7/β-tubulin that stabilize MTs, which 
promotes axon formation and reduces axonal regeneration rates (chapter 2);  (ii) development of an 
optogenetic method of inducing cell ablation and neurodegeneration using the genetically encoded 
photosensitizer KillerRed (chapter 3);  (iii) discovery of a role for the conserved guidance factor 
UNC-6/Netrin in protection against ROS-induced degeneration using genetically encoded KillerRed  
(chapter 4); (iv) identification of conserved components of the apoptotic recognition and 
engulfment pathway that regulate axonal fusion during regeneration (chapter 5); and (v) discovery 
of novel mutants with defects in axonal fusion during regeneration, using a genetically induced 
axonal injury model and forward genetics (chapter 6).   
 
Together these findings provide two new paradigms in which axonal degeneration and regeneration 
via axonal fusion can be studied using forward and reverse genetic approaches.  Furthermore, they 
provide critical new insights into how axons are protected from axonal degeneration induced by 
ROS, as well as an entirely novel function for conserved molecules in regulating axonal fusion 
during regeneration.  
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  7.2 Developmental control of axonal morphology and regeneration 
 
The development of a neuron requires regulated MT dynamics to correctly specify neurite identity 
and initiate axon outgrowth (Jiang et al., 2005; Kishi et al., 2005; Maniar et al., 2012; Yoshimura et 
al., 2005).  More recently, MTs themselves have been implicated as instructive cues in the process 
of axonal specification (Baas, 2002; Hoogenraad and Bradke, 2009; Stiess and Bradke, 2011; Witte 
et al., 2008).  The transformation of a mature stable axon into a regrowing axon following injury 
requires changes to MT dynamics (reviewed in chapter 1).  The findings presented in chapter 2 
demonstrate that normal MT dynamics are required for axon specification during development and 
axonal regeneration following injury.   
 
The hyperstable microtubules present in animals with mutations in the gene mec-7/β-tubulin result 
in ectopic neurite formation with axon-like properties.  This is the first time that MTs have been 
demonstrated to have an instructive role in the regulation of the number of neurites the neuron 
extends.  During ALM development in mec-7/β-tubulin mutant animals, both the primary and 
ectopic neurites are able to extend over long distances.  However, following laser-induced 
transection axon regrowth is reduced in both neurites.  This supports a model in which axonal 
regeneration is distinct from axon outgrowth during development.  
 
The defects in axonal regeneration seen in mec-7/β-tubulin mutants may be a direct result of MT 
stability, or due to secondary axonal transport defects.  Wu et al. (2007) demonstrated that axonal 
regeneration in C. elegans mechanosensory neurons only occurred when the synaptic connection 
was disrupted.  Interestingly, the localization of synaptic machinery is disrupted in mec-7/β-tubulin 
mutants.  It is possible that the mislocalized synaptic machinery may prevent the neuron from 
detecting the loss of the neuron’s primary synapse after axotomy, thus reducing regeneration.  
Alternatively, the defects in axonal transport observed in mec-7/β-tubulin mutants could itself be the 
primary cause of both synaptic defects and disrupted axonal regeneration.  Finally, another possible 
explanation is a defect in injury signalling in mec-7/β-tubulin mutants.  Recently, loss of 
microtubule stability has been demonstrated to trigger axonal outgrowth in a DLK-1-dependent 
manner (Marcette et al., 2014; Richardson et al., 2014).  Microtubule destabilization is a critical 
event in axonal injury signalling.  It is possible that the hyperstable microtubules of mec-7/β-tubulin 
mutants disrupt axonal injury signalling, resulting in a reduction in axonal regeneration.  Further 
study is needed to determine which of these mechanisms are responsible for the reduced axonal 
regeneration observed in mec-7/β-tubulin mutants.   
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  7.3 Molecular mechanisms of axonal and neuronal degeneration induced by ROS 
  
In addition to triggering regeneration in the proximal axonal fragment, injury to an axon causes 
degeneration of the distal fragment, which occurs via an active mechanism.  Although much is now 
known about several of the components involved in this process, a full picture is far from complete.  
Mitochondrial function is essential for the maintenance of a healthy axon.  Altered mitochondrial 
transport, mitochondrial dysfunction, and the accumulation of ROS are all able to cause axonal 
degeneration.  The study presented in chapter 3 demonstrates the ability of the optogenetic tool 
KillerRed to ablate C. elegans neurons in vivo via the generation of ROS.  In addition to its function 
as a cell ablation tool, KillerRed is capable of triggering localized degeneration of C. elegans 
mechanosensory neurons when it is selectively activated in the axon.  The mechanism by which 
ROS induces axonal degeneration in neurons is unknown.  These findings provided an opportunity 
to study the effects of ROS accumulation in vivo in the context of axonal and neuronal 
degeneration.  
 
Axonal injury can trigger axonal regeneration, axonal degeneration, and in some cases neuronal 
death.  Many neurodegenerative diseases have axonal degeneration pathologies in combination with 
neuronal death. In both animal and disease models cell death and Wallerian degeneration function 
via distinct mechanisms (Coleman, 2005).  The nature of KillerRed-induced ROS accumulation 
provided a platform to study both localized axonal degeneration and the pathology of ROS-induced 
neuronal death.  Remarkably, the effect of KillerRed was not universal, with some neurons highly 
vulnerable to KillerRed-generated ROS, and others more refractory.  Selective vulnerability is a 
common theme in neurodegenerative disorders, with specific populations of neurons degenerating 
while others are resistant to the same stimulus (Mattson and Magnus, 2006).  The study presented in 
chapter 4 utilized this differential sensitivity to ROS to identify molecules that function to protect 
cells from KillerRed-induced ROS degeneration.  Through a candidate gene approach, the 
conserved guidance molecule UNC-6/Netrin was identified as a neuroprotective factor. 
 
It is not clear from these results is by which mechanism UNC-6/Netrin confers protection against 
ROS-induced degeneration.  Predictably, loss of the UNC-6/Netrin receptor, UNC-40/DCC, 
increased the rate of KillerRed-induced neuronal degeneration.  However, SAX-3/Robo, the 
receptor for the repulsive guidance cue SLT-1/Slit, also protected against neurodegeneration 
independently of its canonical ligand.  A full genetic analysis is needed to determine if these 
molecules function in the same pathway to protect neurons from ROS-induced degeneration.  
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  7.4 Molecular mechanisms of axonal fusion during regeneration 
 
Invertebrate neurons have been observed to regenerate and reconnect with their separated distal 
axonal fragments via axonal fusion.  In C. elegans mechanosensory neurons this is a highly specific 
process that requires the fusogen EFF-1.  Prior to the study presented in chapter 5, no other 
molecules involved in mediating axonal fusion had been identified. Previous studies from our 
laboratory had challenged regrowing proximal axonal fragments with multiple distal fragments and 
observed a high degree of specificity in the axonal fusion process, suggesting that there is a 
recognition mechanism involving the participation of the distal fragment (Neumann et al., 2011).  
Using a candidate gene approach, the study presented in chapter 5 uncovered a novel role for 
conserved members of the apoptotic recognition and engulfment pathways in mediating axonal 
fusion during regeneration.  In this model, injury to the axon triggers the exposure of a ‘save-me’ 
signal on the distal axonal fragment in the form of the membrane phospholipid PS.  This signal is 
recognized by PS-binding protein PSR-1 on the proximal fragment and the secreted molecule TTR-
52.  These two bridging molecules act via the intracellular adapter CED-6 in the proximal axonal 
fragment to facilitate EFF-1-dependent axonal fusion.  
 
Fascinatingly, as discussed in chapter 1 this process once again involves the intersection of axonal 
degeneration and axonal regeneration machinery.  The transmembrane receptor Draper/CED-1 and 
CED-6 have been demonstrated to mediate clearance of the distal axonal fragment in Drosophila 
following injury (Awasaki et al., 2006; MacDonald et al., 2006).  In addition, unpublished data 
from our laboratory suggest that CED-1- and CED-6-mediated clearance is conserved in C. elegans 
and reduces axonal clearance following injury (Annika Nichols and Massimo Hilliard, personal 
communication).  This raises the possibility that axonal degeneration triggers a universal external 
injury signal that competes as an ‘eat-me’ signal or ‘save-me’ signal in the separated distal fragment 
(Fig 7.1).  In the event of proximal fragment regrowth and reconnection this signal is able to 
facilitate axonal fusion, and in the event of non-reconnection this signal is able to mediate 
engulfment and clearance by phagocytic cells.   
 
In addition to studying axonal fusion during regeneration triggered by axotomy, the study in chapter 
5 provides an alternative paradigm in which to study injury-triggered neuronal fusion using 
spontaneous axonal damage induced by the loss of UNC-70.  This injury model generates cell-cell 
fusion between two closely associated neurons following axonal damage in both cells.  unc-70-
induced neuronal fusion requires regeneration and shares the machinery required for axonal fusion.  
Therefore, the experimental paradigm developed in chapter 5 allows the discovery of novel 
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Figure 7.1.  Conserved components of apoptotic recognition machinery regulate axonal fusion 
and axonal degeneration.  Proposed schematic model for the recognition of the distal axonal 
fragment by the regrowing proximal axonal fragment during axonal regeneration via axonal fusion.  
a, following injury, PS is exposed on the distal fragment where it acts as a ‘save me’ signal, and this 
might be enhanced by CED-7-facilitated secretion of PS-coated vesicles.  PS is recognized by 
secreted extracellular bridging protein TTR-52, and by the transmembrane PSR-1 on the proximal 
axon.  The ‘save me’ signal is transduced intracellularly via CED-6, and possibly also through 
activation of the TTR-52-interacting CED-1 receptor.  CED-1 and CED-6 also mediate clearance of 
the degenerating distal axonal fragment in cases where the regrowing proximal fragment does not 
reach the distal fragment.  In this context, the distal fragment is hypothesized to present an unknown 
‘eat-me’ signal (b) which may compete with the ‘save-me’ signal (c) to facilitate circuit repair.   
a
b c
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  molecules required for both neuronal and axonal fusion.  This finding provided the basis for the 
study presented in chapter 6, where unc-70-induced axonal damage and neuronal fusion was used in 
a forward genetic screen to identify novel mutants.   
 
Thus, the body of work presented here provides the first example in which a forward genetic 
approach has been used to study any aspect of axonal regeneration in any system.  Typically axonal 
injury is induced by UV- or femtosecond-laser axotomy, which although highly specific imposes 
time constraints as each animal requires an individual surgery.  Using this approach, the study 
presented in chapter 6 identified two novel mutants with defects in unc-70-induced neuronal fusion.  
This paradigm has paved the way to a more extensive use of forward genetic screens to discover 
novel molecules required for axonal fusion during regeneration.  
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  7.5 Conclusions 
 
In summary, this thesis provides a substantial contribution to the understanding of the molecular 
mechanisms of both axonal degeneration and regeneration.  In addition to the identification of novel 
roles for conserved molecules in axonal fusion during regeneration, these studies provide two new 
paradigms that allow future investigations to utilize the full power of C. elegans genetics to dissect 
these biological processes. 
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